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2. Abstract 
 
Hematopoietic stem cells (HSCs) are the multipotent cells able to differentiate and 
daily produce a massive number of all mature blood cells (hematopoiesis), while maintaining 
their undifferentiated state long-term. This delicate balance between self-renewal and 
differentiation is regulated by intrinsic mechanisms and extrinsic signals. The main regulator 
of the extrinsic signals responsible for this balance is the anatomical microenvironment where 
HSC reside, the so-called HSC niche. Despite the fact that the concept of the niche is 
decades-old, its exact cellular and molecular composition as well as the underlying 
mechanisms controlling HSC fates remain unknown. 
The main limitation for the improved clinical application of HSCs is our inability to 
maintain or ideally expand them in vitro without genetic modification. In vitro studies 
revealed that the clonal, fetal-liver derived stroma cell line AFT024 can maintain the number 
of co-cultured HSCs, even upon long culture periods, while another cell line failed (2018 
stroma). However, the behavior of HSCs under self-renewing conditions and the key factors 
governing the HSC-niche interaction remain obscure. In the current study, we monitor HSCs 
and multipotent progenitor (MPP) cells in co-cultures with niche stroma cells by 
implementing continuous live-cell imagining, at the single-cell level. We report early 
differences in the behavior of HSCs co-cultured with the different stroma and present 
evidence for an AFT024-mediated pro-survival/proliferation effect upon co-cultured HSCs. 
Also, we show that AFT024 stroma promotes survival/proliferation of early MPPs. 
Conditioned media experiments and stroma-free cultures revealed cell adhesion as the 
predominant mechanism of this interaction. Finally, we propose that delta-like homolog 1 
(Dlk1), dermatopontin (Dpt) and fibroblast activation protein (Fap) are necessary for HSC 
survival and proliferation and that Dpt alone is essential for the in vitro maintenance of HSCs 
in AFT024-based in vitro cultures. 
 
   
 
- 10 - 
 
 
3. Introduction 
 
3.1. Hematopoietic stem cells: A historical overview and current 
concepts 
Every second of our life, millions of cells die in different tissues of our body. Blood is 
such a tissue with high turnover rate, with 200 billion (2x10
11
) erythrocytes and 2 billion 
(2x10
9
) granulocytes dying every day. The same number has to be replenished to secure 
homeostasis (Dexter et al., 1984). Hematopoietic stem cells (HSCs) are the adult stem cells 
responsible for the lifelong production of all mature blood cells (multipotency), in a process 
called hematopoiesis. HSCs are also capable of maintaining their undifferentiated state even 
after numerous cell divisions (self-renewal), therefore avoiding exhaustion. It is widely 
accepted that HSCs are currently the best understood adult stem-cell system, mainly due to 
decades of research and the tens of thousands of scientific papers published on this topic. 
3.1.1. The first discoveries 
The first impetus for HSC research dates back to the late 19
th
 century, when it was 
reported that mature blood cells vary in their morphology, therefore belonging to different 
lineages (Ehrlich, 1879). Some scientists believed that lymphoid and myeloid cells originate 
from a common precursor cell, which they called “stem cell” (Stammzelle) (Pappenheim, 
1896; Maximov, 1909). Pappenheim, who is coined the term, also drew one of the first 
hematopoietic trees in 1905 (reviewed by Ramalho-Santos and Willenbring, 2007).  
An important year for hematopoietic research was 1945, when exposure to nuclear 
bomb radiation caused severe hematopoietic failures to the exposed civilians in Hirosima and 
Nagasaki. A few years later, Jacobson and colleagues showed that mice which had their 
spleens shielded with lead, were protected from lethal doses of irradiation, suggesting that 
some spleen cells could reconstitute the blood system (Jacobson et al., 1949). In 1951, Lorenz 
and colleagues went one step further showing that injection of spleen or bone marrow cells 
successfully rescued recipient mice from fatal irradiation injury (Lorenz et al, 1951), thus 
paving the way for HSC transplantations (Figure 3.1). It is important to note that the 
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transplantation assays are still the gold-standard method for the assessment of HSC function. 
Following that observation, Barnes and Loutit, as well as Main and Prehn showed 
independently that what orchestrates the post-transplantation recovery of irradiated recipients  
is the transplanted cells (Barnes and Loutit, 1954; Main and Prehn, 1955) and not some 
“humoral” element in their spleen or bone marrow, as it was initially hypothesized (reviewed 
by Thomas, 2000; Little and Storb, 2002; Weissman and Shizuru, 2008).  
The early 1960’s were marked by major progress in the hematopoietic field due to the 
pioneering work of Till and McCulloch who reported the ability of transplanted bone marrow 
cells to form colonies in the spleen of lethally irradiated mice (Till and McCulloch, 1961). 
They described the first quantitative hematopoietic assay by reporting the linear correlation 
between the number of transplanted cells and the spleen colonies (104 bone marrow cells 
give rise to one spleen colony). Based on chromosomal markers, they identified the clonal 
origin of individual spleen colonies which were formed by the progeny of a single 
transplanted cell, the so-called spleen colony-forming cell or CFU-S (Becker et al., 1963). In 
addition, they proposed that the CFU-S were hematopoietic stem cells in which the decision 
between self-renewal and differentiation is stochastic (Till et al., 1964). Till later named his 
model as “Hematopoiesis is engendered randomly” or “HER”, in response to Trentin’s 
“HIM” model (see below).  Finally, they reported the multipotency of the CFU-S, which 
could give rise to both, myeloid (granulocytes, megakaryocytes, macrophages), as well as 
erythroid colonies in the spleen of lethally irradiated recipients (Wu et al., 1967).  
3.1.2. The “niche/microenvironment” era  
In 1968, Wolf and Trentin sought to investigate the effect of stroma upon HSC 
differentiation potential. For this reason, they performed a key experiment in which plugs of 
bone marrow stroma from primary reconstituted mice were implanted into the spleen of 
secondary recipients (Wolf and Trentin, 1968). They reported that most of the bone-marrow 
colonies were granulocytic, whereas colonies residing in the spleen stroma were mostly 
erythroid. This observation combined with their previous data (Curry and Trentin, 1967; 
Curry et al., 1967) led them to the proposal of the “Hematopoietic Inductive 
Microenvironments” concept (“HIM” model), according to which the microenvironment can 
instruct the differentiation of the stem cell progeny towards a certain lineage  (Curry et al., 
1967; Trentin, 1971).  
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During the mid 1970’s, Dexter made a major contribution to the field by establishing 
an ex vivo system capable of maintaining hematopoiesis for long culture periods (Dexter et 
al., 1973; Dexter et al., 1977). Dexter’s long-term culture was based on the cultivation of 
bone marrow fractions consisting of both hematopoietic cells and heterogeneous stroma 
populations. Some of the main characteristics of his system were: 1) the lineage skewing 
towards granulopoiesis, 2) the absence of secreted-factor activity in the conditioned media 
(called colony stimulating activating – CSA) and 3) the importance of HSC-stroma 
interactions for the maintenance of hematopoiesis (no CFU-S maintenance in stroma-free 
cultures). 
In addition to the data mentioned above, Schofield showed that the transplanted HSCs 
homing to the bone marrow support hematopoiesis more robustly than those homing to the 
spleen (Schofield, 1978).  Based on these findings, as well as on Dexter’s published work 
(Dexter et al., 1973; Dexter et al., 1977), Schofield introduced the concept of the HSC niche. 
He envisioned the niche as the anatomical microenvironment within which HSC reside and 
self-renew and out of which, they undergo differentiation (Schofield, 1978). That was the 
first time that a self-renewing anatomical environment was proposed (in addition to the 
“differentiation” niche introduced by Trentin). In a follow up study,  Whitlock and Witte 
developed another ex vivo culture system allowing production of lymphoid cells (Whitlock 
and Witte, 1982). 
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Figure 3.1. Historical overview of the key findings in the field of hematopoietic stem cell 
research.  
 
3.1.3. Identifying markers for HSC enrichment/isolation 
Despite the major advances in the hematopoietic field during the thirty years outlined 
above, the extremely low number of repopulating cells within the heterogeneous mix of bone 
marrow cells was still a significant hurdle for hematopoietic research. For scientific and 
therapeutic purposes, the need for HSC enrichment protocols became an issue of pivotal 
importance, therefore efforts were directed towards the identification of cellular properties 
that could distinguish stem cells from differentiated blood cells.  
It is important to note that such efforts would have been impossible without two 
groundbreaking inventions coming from different fields: the development of the fluorescent-
activated cell sorting (FACS) methodology by Leonard Herzenberg (Hulett et al., 1969) and 
the nobel-prize winning work from Georges Kohler and Cesar Milstein (Nobel Prize in 
Physiology or Medicine 1984, together with Niels Jerne), who introduced the concept of 
monoclonal antibodies against specific cellular antigens (Köhler and Milstein, 1975). The 
combination of those two technological advances allowed the isolation of cells with a defined 
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expression profile from a heterogeneous cell mixture and they are still a routine technique in 
almost all hematology laboratories. 
One of the main groups contributed to the identification of markers for different 
hematopoietic populations (including HSCs) was the group of Irving Weissman. As he 
describes in one of his reviews (Weissman, 2002), the “key moment in the search for stem 
cells” was the finding that B-cell progenitors did not express the major marker of the B 
lineage, B220 (Muller-Sieburg et al., 1986). This led to the hypothesis that primitive blood 
cells would be negative for all markers expressed by terminally differentiated blood cells. For 
this reason, a cocktail of antibodies against surface proteins expressed by different types of 
mature blood cells (lineage cocktail) was utilized. Until today, a cell or a number of cells are 
experimentally defined as HSCs when their transplantation into lethally irradiated mice 
results in long-term survival of the recipients (longer than 16 weeks) and reconstitution of 
both the myeloid and the lymphoid lineage. To test the hypothesis, Muller-Sieburg 
transplanted lethally irradiated mice and found that all the HSC activity was indeed found in 
the Thy1
low
 lineage- (Lin-) fraction of bone marrow cells (Muller-Sieburg et al., 1986). It is 
important to note that Christa Muller-Sieburg was therefore the first to prospectively isolate 
HSCs.   
Two years later, Gerald Spangrude (also from Weissman’s group) introduced another 
marker (stem cell antigen 1, Sca1 or Ly-6 A/E) dividing further the Thy1
low
 Lin- 
compartment into two sub-populations, from which only the Sca1+ population contained 
HSCs (Spangrude et al., 1988). In the next years, more HSC markers were identified, such as 
c-Kit (kit oncogene) from the Suda lab (Okada et al., 1991) and CD34 from the Nakauchi lab 
(Osawa et al., 1996). Inevitably, different labs developed different sorting strategies to isolate 
HSCs (see Table 3.1): Thy1
low
 Sca1+c-Kit+ from the Weissman group, Hoechst dye efflux 
(defining the so-called side population - SP), Sca1+Lin- from the Mulligan group (Goodell et 
al., 1996), SLAM code from the Morrison lab (Kiel et al., 2005) and the E-SLAM code from 
the Eaves group (Kent et al., 2009). Interestingly, all those strategies yielded different HSC 
purities (number of sorted HSCs that indeed have HSC properties as shown by functional 
assays). Currently, the highest sorting purity (56%) has been achieved by Kent and 
colleagues, who used the endothelial protein C receptor (EPCR) in addition to CD45, CD48 
and CD150 markers (abbreviated as E-SLAM) to isolate HSCs (Kent et al., 2009).  
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Table 3.1. Overview of the different immunophenotypes used for HSC isolation via flow 
cytometry and their respective purities. Abbreviations are Thy1: thymus cell antigen 1, theta, KSL: 
cKit+ Sca1+ Lineage-, SP: side population, ND: not determined. 
This illustrates that even with the best currently available sorting method, almost 
every second cell is still not a stem cell. However, a technically demanding approach for 
calculating the purity of isolated HSCs was implemented (single-cell transplantations) in the 
studies achieved the highest purities (Kiel et al., 2005; Kent et al., 2009). Therefore it is not 
clear if the reported impurities originates from technical problems or really reflect 
inadequacies in the enrichment protocols. Lately, additional HSC-specific markers have been 
reported, such as CD49b which sub-divides the HSC compartment into long-term and 
intermediate-term reconstituting cells (Benveniste et al., 2010). In conclusion, the current 
“technical” heterogeneity within the isolated HSC populations underlines the necessity for 
single-cell level analysis, since population averaging can mask the behavior of single HSCs. 
3.1.4. HSCs are not all the same: Functional heterogeneity in the HSC 
compartment   
In addition to the “technical” heterogeneity due to the absence of exclusive HSC 
markers and technology-related limitations (precision of HSC sorting due to FACS 
- 16 - 
 
software/hardware or general handling), the HSC compartment itself is heterogeneous. The 
first report for such intrinsic heterogeneity regarding the differentiation potential of HSCs 
was published in 1990 (Jordan and Lemischka, 1990). HSCs have been classified into distinct 
subtypes based on reported heterogeneity in their differentiation potential (Muller-Sieburg et 
al., 2004; Dykstra et al., 2007), repopulation kinetics (Sieburg et al., 2006), self-renewal 
ability (Dykstra et al., 2007), proliferation kinetics or response to extrinsic factors (Muller-
Sieburg et al., 2004; Challen et al., 2010).  
Using the differentiation potential of HSC as a readout, Muller-Sieburg and 
colleagues identified three distinct subsets of HSCs: 1) the balanced HSCs capable of 
generating equal numbers of myeloid and lymphoid cells, 2) the myeloid-biased (My-bi) 
HSCs generating more myeloid than lymphoid cells and inversely 3) the lymphoid-biased 
(Ly-bi) (Muller-Sieburg et al., 2004). Notably, all three subsets are multipotent giving rise to 
all different blood lineages, but in different ratios. Further studies based on single-cell 
transplantation experiments revealed that transplanted HSCs reconstitute the hematopoietic 
system of host mice following 16 distinct repopulation patterns (Sieburg et al., 2006).  
Dykstra and colleagues combined the self-renewal capacity of HSCs with their 
differentiation potential and identified four HSC subtypes; alpha (α) cells exhibit robust self-
renewal capacity and a bias towards the myeloid lineage, beta (β) cells were also robustly 
self-renewing but balanced for lymphoid and myeloid lineages, the multipotent gamma (γ) 
cells with reduced self-renewal activity after 16 weeks (potentially downstream of beta) and 
the delta (δ) cells with limited self-renewal and skewed differentiation potential towards 
lymphoid cells (Dykstra et al., 2007).  
Despite the solid proof for the functional heterogeneity of the HSC compartment, the 
current know-how in purifying individual HSC subtypes is limited. However, a study by 
Challen and colleagues revealed that the lower side population (SP) KSL cells show a bias 
towards the myeloid lineage, whereas the high SP KSL are lymphoid biased (Challen et al., 
2010). In addition to Hoechst dye efflux, CD150 expression could further dissect the lower 
SP KSL population to cells with robust self-renewal and higher myeloid bias (CD150+ SP 
KSL). Recently, CD229 expression was also reported to distinguish those two HSCs subtypes 
(Oguro et al., 2013).  
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The two current models attempting to predict HSC behavior (stochastic or 
deterministic/environmental models) can also be applied to explain the observed HSC 
heterogeneity. According to the stochastic model, the decision between self-renewal or 
differentiation (from stem cells to progenitors) is random. Likewise, the downstream lineage 
choice could also occur randomly, therefore leading to balanced or biased HSC progeny. 
However, this concept is difficult to reconcile with a process as crucial and as tightly 
controlled as hematopoiesis. On the other hand, the notion that HSC behavior is determined 
by extrinsic cues requires either distinct in vivo microenvironments favoring one behavior 
over the other or a gradient of different niche factor(s) producing differential outcomes on 
HSCs. Although the idea of distinct HSC niches has already been proposed (Wilson and 
Trumpp, 2006), functional evidence is still lacking. An alternative model which could explain 
this heterogeneity is the Generation Age Hypothesis, according to which all HSCs have 
initially equal self-renewal capacity and differentiation potential (Rosendaal et al., 1976). 
Dividing HSCs gradually lose their robust self-renewal ability with cumulative cell divisions 
and therefore heterogeneity is introduced to the stem cell compartment (due to asynchronous 
division kinetics of HSCs). Although this hypothesis could successfully explain HSC 
subtypes with differences in their self-renewal potential, it does not explain the reported 
lineage bias.  
3.1.5. The hematopoietic differentiation tree: from HSCs to mature 
blood cells 
As mentioned above, hematopoiesis is the biological process through which all 
different types of mature blood cells are produced from multipotent HSCs. HSCs first 
differentiate to multipotent progenitors (MPPs) which still have the potential to form mature 
blood cells of all lineages (myeloid and lymphoid), but lack long-term self-renewing potential 
(Figure 3.2). Noteworthy, MPPs can be sub-divided into immunophenotypically distinct sub-
populations differing in their repopulation potential and cell-cycle progression (Wilson et al., 
2008). MPPs further differentiate into committed progenitors, either the common lymphoid 
progenitors (CLPs) or the common myeloid progenitors (CMPs). CLPs finally give rise to T, 
B or natural killer cells, whereas CMPs produce different granulocytes and monocytes 
(through e.g. the granulocyte/monocyte progenitors - GMPs) or erythrocytes and 
megakaryocytes/platelets (through the megakaryocyte/erythrocyte progenitors - MEPs).  
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Figure 3.2. Depiction of the murine hematopoietic hierarchy showing distinct hematopoietic 
populations and their respective marker expression. Abbreviations are LT-HSC: long-term 
hematopoietic stem cell, IT-HSC: intermediate-term hematopoietic stem cell, MPP: multipotent 
progenitor, CLP: common lymphoid progenitor, CMP: common myeloid progenitor, ETP: earliest 
thymic progenitor, proB: B-cell progenitor, GMP: granulocyte/monocyte progenitor, MEP: 
megakaryocyte/platelet progenitor (picture modified from Doulatov et al., 2012). 
 
3.2. HSCs in regenerative medicine: Clinical potential and 
current limitations 
The unique ability of adult stem cells to reconstitute certain tissues by producing all 
mature cell types (multipotency) while maintaining their undifferentiated state (self-renewal), 
makes them an important tool for regenerative medicine. In the case of HSCs, autologous or 
allogeneic stem cell transplantations have been used against injury or blood disorders, such as 
anemias or different types of leukemias, lymphomas and myelomas (Anisimov et al., 2010). 
Importantly, HSC transplantations can be also implemented in cases of non-hematological 
conditions, such as Parkinson’s disease (Anisimov, 2009), autoimmune diseases (Tyndall and 
Gratwohl, 1997) or cardiovascular repair after myocardial infarction (Harris et al., 2007). 
Lately, they have been used after cancer treatments (such as irradiation or chemotherapy) to 
improve hematopoietic recovery (Forsberg and Smith-Berdan, 2009; Wagers, 2012). 
3.2.1. The clinical need for HSC maintenance/expansion in vitro 
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A critical factor for applying such approaches is the number of HSCs available for 
clinical use. Current isolation methods do not yield sufficient HSC numbers for therapeutic 
purposes. One method to circumvent this limitation is to manipulate HSC numbers during 
their in vitro cultivation. For this reason, a variety of cytokine combinations have been used, 
but often result in increased levels of dead and/or differentiated cells and a dramatic decrease 
of HSC numbers. It is only under few cytokine conditions that the numbers of HSCs can be 
maintained ex vivo, but only for very short culture periods (Ema et al., 2000).  
Genetic manipulation of freshly purified HSCs is another alternative for maintaining 
or expanding their numbers in vitro. Work from Humphries group showed that over-
expression of the homeobox transcription factor HOXB4 led to 40-fold expansion of HSC 
numbers (Antonchuk et al., 2002). In a follow-up study, even greater expansion over input 
cells was achieved (1000 to 10000 fold), by over-expressing the Nucleoporin98-Homeobox 
fusion construct (Ohta et al., 2007). However, direct genetic manipulation of transplanted 
HSCs is a highly controversial method, due to the unpredictable consequences of such 
manipulation in the human system (oncogenic transformation through insertional 
mutagenesis, leukemia).  
In vivo, HSCs are always in association with stroma cells comprising the HSC niche. 
Based on this observation, stroma-based co-culture systems have been used to achieve long-
term HSC maintenance or expansion, by mimicking the interaction of HSCs with their 
physiological microenvironment. Importantly, such culture systems allow indirect 
manipulation of HSCs, by manipulating their stroma counterparts.  
Several stroma-based culture systems have been screened by independent groups for 
their potential to maintain or expand HSCs in vitro. However, a description of hematopoiesis 
during development as well as of the different in vivo niches (from which those systems were 
derived) is necessary, before analyzing the characteristics of the currently available stroma-
based in vitro culture approaches. 
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3.3. Mammalian hematopoiesis during development: Different 
niches for HSCs 
Hematopoiesis is a crucial procedure directly linked with organism’s viability. For 
this reason, it is initiated early during embryogenesis and lasts until the death of the 
organism. During this time frame, HSCs sequentially reside in distinct tissues functioning as 
HSC niches (Figure 3.3A). The fact that HSCs are always associated with niche cells 
highlights the importance of the microenvironment in regulating hematopoiesis. Interestingly, 
HSCs exhibit different behaviors in the different niches suggesting that the microenvironment 
might influence HSC decisions. In the current chapter, I briefly present the different HSC 
niches during murine development and adulthood. 
3.3.1.  Embryonic hematopoiesis 
3.3.1.1. The yolk sac 
Mammalian hematopoiesis is initiated in the yolk sac (YS) with the generation of 
erythrocytes (to meet the growing need for tissue oxygenation), macrophages (for tissue 
remodeling and recycling) and megakaryocytes (for platelet formation and homeostasis) at 
embryonic day 7.5 (E7.5) in mice. This transient production of differentiated blood cells is 
known as the “primitive” wave of hematopoiesis and is replaced by the “definitive” wave, 
through which long-term reconstituting HSCs are generated. Interestingly, Yoder and 
colleagues showed that E9.0-E10.0 murine yolk sac also contains “definitive” hematopoietic 
cells capable of multilineage reconstitution of primary and secondary recipients (Yoder and 
Hiatt, 1997; Yoder et al., 1997). Although later studies challenged the lymphoid potential of 
those YS-derived definitive blood cells (Rampon and Huber, 2003), lineage tracing 
experiments have proven their contribution to the adult HSC pool in the murine bone marrow 
(Samokhvalov et al., 2007).  
3.3.1.2. The aorta-gonad mesonephros (AGM) region 
It is important to note that due to the early onset of circulation (E8.0-E8.5 in mice, 
Figure 3.3B), migration of repopulating hematopoietic cells may mask the site of their true 
emergence (Orkin and Zon, 2008). However, it is currently accepted that the first murine 
HSCs appear in the ventral wall of the dorsal aorta within the embryo proper (Godin et al., 
1995), which together with the genital ridges and the mesonephros constitute the Aorta-
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Gonad Mesonephros (AGM) region. The AGM region is capable of generating repopulating 
HSCs in the absence of the yolk sac, as shown by isolated organ cultures (Medvinsky and 
Dzierzak, 1996). Currently, it is believed that definitive (multipotent) hematopoietic cells 
arise in the YS and AGM region from specialized endothelial cells, the so-called hemogenic 
endothelium. The hematopoietic activity of the AGM region starts before E8, peaks at around 
E11 and then decreases due to the migration of HSCs to the fetal liver and potentially to 
placenta. Similar kinetics in the hematopoietic potential of the AGM region have also been 
described for the corresponding human developmental stages (Mikkola and Orkin, 2006). 
3.3.1.3. The placenta 
The next site of embryonic hematopoiesis is the placenta (from E10.5 until E13.5). 
The origin of placental HSCs is currently debated; whether they migrate via circulation or 
they are formed de novo in the placenta due to its hemogenic potential, or due to a 
combination of both scenarios. Nevertheless, transplantation experiments have shown that 
placental HSC are capable of long-term repopulation of recipient mice (Gekas et al., 2005; 
Ottersbach and Dzierzak, 2005).  
3.3.1.4. The fetal liver 
Around the same time frame (from E10.5), the fetal liver is another embryonic tissue 
functioning as a HSC niche. Unlike placenta where hematopoiesis diminishes quickly, the 
hematopoietic potential of the fetal liver persists until the end of the gestational life. At this 
stage, the stem cell pool increases in numbers (HSC expansion). This observed expansion is 
not related to de novo generation of HSCs, but to their extensive proliferation and self-
renewing divisions. The fact that HSCs in the fetal liver are cell-cycle active, whereas in the 
bone marrow are mainly quiescent (see below) may reflect differences between the molecular 
composition of those niches. Unfortunately, the exact mechanism responsible for this 
expansion is currently unknown, despite efforts to recapitulate this phenomenon in vitro 
(Moore et al., 1997a). In an attempt to identify differences between fetal liver and adult 
HSCs, Kim and colleagues compared their gene expression profiles and identified that the 
transcriptional regulator Sox17 was exclusively expressed by the fetal liver HSCs (Kim et al., 
2007). It was also shown that Sox17 is essential for the maintenance of fetal liver HSCs, 
since its conditional deletion severely impaired fetal, but not adult hematopoiesis. However, 
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this requirement for Sox17 during fetal hematopoiesis was cell autonomous and did not 
reflect any differences between fetal liver and the adult hematopoietic niches. 
3.3.2. Adult hematopoiesis: The bone marrow and the spleen 
A few days before birth, HSCs migrate from the fetal liver to the bone marrow, the 
main site of hematopoiesis in postnatal animals (Orkin and Zon, 2008). HSCs in the bone 
marrow are thought to be mainly quiescent and protected from signals inducing 
differentiation. Adult hematopoiesis also occurs in extramedullar sites such as the spleen, 
especially under stress conditions or injury. Details about the cellular composition and the 
molecular players of the bone marrow niche are described in the chapter below. 
Figure 3.3. Sequential HSC niches during mouse development. A. Murine embryos in different 
developmental stages with HSC niches highlighted. B. HSC niches and their respective time windows 
in murine development (modified from Orkin and Zon, 2003). 
 
3.4 Uncertainty about the in vivo bone marrow HSC niche(s)  
In addition to the advances in isolating HSCs, considerable progress has also been 
made in identifying cell populations contributing to the in vivo HSC niche. Before describing 
the current concept for the bone marrow niche, it is important to mention the basics of bone 
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formation, since the exact anatomy, complexity and dynamics of its cellular components is 
often underestimated.    
3.4.1. Bone formation (Skeletogenesis) 
The skeleton (from the greek word skeletos (σκελετός) for dried body) is the organ 
providing support and structure to the body of all vertebrates (endoskeleton) and many 
invertebrates (exoskeleton), while protecting internal organs. Despite its reported complexity, 
it consists of two distinct tissues (cartilage and bone) and three cell types (chondrocytes, 
osteoblasts and osteoclasts) with different properties and functionality (Karsenty et al., 2009). 
Developmentally, the process of bone formation (skeletogenesis) is divided into two 
main phases. Initially, mesenchymal cells form aggregates generating the scaffold for future 
skeletal tissue (Figure 3.4A). During the second phase, the centrally-located mesenchymal 
condensations differentiate into proliferative chondrocytes, the main cell type of the cartilage 
(E10.5). At the same time, cells in the periphery form a surrounding structure, the 
perichondrium. Few days later, some of the chondrocytes stop proliferating and undergo 
progressive maturation into pre-hyperthrophic, hypertrophic and terminally hypertrophic cells 
(Long and Ornitz, 2013). Hypertrophic chondrocytes regulate matrix mineralization and 
control the differentiation of perichondrial cells into osteoblasts, which later form the bone 
collar. Finally, the hypertrophic chondrocytes apoptose allowing osteoblasts and blood 
vessels to invade the central hypertrophic area of the cartilage (Figure 3.4A), where they form 
the primary spangiosa. It is important to note that the bone collar will develop into the 
cortical bone, while the primary spangiosa into trabecular bone (Kronenberg, 2003).  
The procedure described above (mesenchymal cells differentiate first into 
chondrocytes and then to osteoblasts) is called endochondral ossification and it is the main 
mechanism for bone formation. In some bones however (parts of skull and clavicle), no 
(chondrocytic) intermediate step is required for the production of osteoblasts, which develop 
directly from mesenchymal cells (intramembranous ossification). 
In adults, most bones share a characteristic architecture (from distal to proximal) with 
the epiphysis, the growth plate or epiphyseal line, the metaphysis and the diaphysis (Figure 
3.4B). The epiphysis is the terminal region of long bones, where they often connect with 
adjacent bones through the joint. The growth plate is the skeletal region responsible for bone 
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lengthening. It consists of different types of chondrocytes which progressively apoptose. As 
soon as the bone has reached its final length, the growth plate is replaced by the epiphyseal 
line. The bone region proximal to the epiphyseal line is the metaphysis followed by the 
diaphysis which is located in the central part of the bone.  
A cross section of a bone reveals two types of osseous tissue covered by an internal 
layer (endosteum) and an external layer of connective tissue (periosteum). The first type is 
the cortical bone facilitating most of the skeletal functions, due to its hardness and stiffness. 
The other type is the trabecular bone which is softer, heavily vascularised and more centrally 
located. It contains the bone marrow stroma which functions as the niche for hematopoiesis. 
 
Figure 3.4. Bone development (endochondral ossification) and architecture. A. Initial 
condensations of mesenchymal cells differentiate into chondrocytes (c), whereas peripheral cells 
generate the perichondrium (brown line). Chondrocytes proliferate and mature into hypertrophic cells 
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(h) at the centre of the skeletal mould. Hypertrophic chondrocytes undergo apoptosis and blood 
vessels (red line) invade the central area of the bone resulting in the formation of the marrow and 
eventually of trabecular bone (dark grey). At the same time, the bone collar (green rectangular) will 
develop into cortical bone (panel modified by Kronenberg et al., 2003) B. Immunostaining of a 
section depicting half murine femur (thickness  100μm) with annotation of the different regions and 
cell types (blue is DAPI and white is CD31 antibody for blood vessels).   
 
The current concept of the HSC niche dichotomizes the bone marrow into the 
endosteal and the vascular microenvironment. Despite the fact that anatomically the bone 
marrow is heavily vascularized with blood vessels being only few cell diameters away from 
the endosteum, the candidate niche populations mentioned below will still be classified 
according to the currently accepted model. 
3.4.2. The endosteal niche 
The endosteum is the anatomical area between the inner side of the bone and the bone 
marrow. Its importance in hematopoiesis has been documented since the mid-1970s, when 
transplanted CFU-S cells were found to preferentially home/reside in the endosteum rather 
than the central bone marrow of irradiated recipients (Lord et al., 1975; Gong, 1978). 
Anatomically, the endosteal surface is covered by a heterogeneous mix of bone-lining cells, a 
proportion of which  are osteoid-depositing osteoblasts (Kiel and Morrison, 2008). Together 
with the osteoclasts, osteoblasts control the dynamic process of bone remodeling (formation 
versus resorption). 
3.4.3. Cellular composition of the endosteal niche  
3.4.3.1. Osteoblasts 
Osteoblasts (from the greek words osto (οστό) for bone and vlastos (βλαστός) for 
blast/germ) are the cells orchestrating bone formation, through production and mineralization 
of extracellular matrix rich in collagen 1 and osteocalcin.  In 2003, two groups proposed 
independently that osteoblasts are the key players of the bone marrow HSC niche. In both 
studies, increased numbers of osteoblasts (activation of the osteoblast-specific receptor from  
the parathyroid hormone - Pth (Calvi et al., 2003) or by the conditional inactivation of the 
bone morphogenic protein receptor type 1a (Bmpr1a) (Zhang et al., 2003)) led to a net 
increase of the HSCs numbers (KSL cells). Attempting to reveal the downstream signalling, 
Calvi and colleagues proposed that osteoblasts express Jagged 1 which binds to Notch 
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(expressed by HSCs) resulting in increased HSC proliferation (Calvi et al., 2003). Zhang et al 
on the other hand, proposed that the underlying mechanism is mediated through N-cadherin 
homophilic interactions (Zhang et al., 2003).   
Despite their significant impact on the field, both studies and the proposed 
mechanisms were dealt with major skepticism. In terms of the experimental design, both 
studies have been criticized for limited specificity, since the described manipulations affected 
also other cell types in the bone marrow besides osteoblasts (Isern and Méndez-Ferrer, 2011). 
The fact that the conditional deletion of  Jagged 1 from bone marrow cells had no effect on 
hematopoiesis, along with the ability of Notch-deficient HSC to reconstitute those mice 
(Mancini et al., 2005) strongly challenged Calvi’s model. Also, Zhang’s model has been 
challenged by a study from Morrison’s group reporting undetectable N-cadherin expression 
in HSCs (Kiel et al., 2007). It is important to note that in addition to the underlying molecular 
mechanisms, the role of osteoblasts in maintaining HSCs in vivo has also been challenged. 
This criticism originated from the observation that mice with reduced numbers of osteoblasts 
(in biglycan deficient mice) had normal HSC numbers (Kiel et al., 2007).  
It has been shown that osteoblasts produce several key factors controlling HSC 
maintenance, such as angiopoietin (Arai et al., 2004), the chemokine C-X-C motif ligand 12 
(CXCL12) (Petit et al., 2002), osteopontin (Nilsson et al., 2005) and thrombopoietin 
(Yoshihara et al., 2007). However, whether osteoblasts are indeed the critical source of these 
factors in the bone marrow is still controversial, since conditional deletion experiments are 
still pending (Kiel and Morrison, 2008). The fact that hematopoiesis can occur in tissues 
devoid of osteoblasts (extramedullary hematopoiesis) suggests that osteoblasts are 
dispensable for HSC maintenance (Ellis and Nilsson, 2012). In line with this, confocal 
imaging of bone marrow sections revealed that around 60% of stained HSCs (CD150+CD48-
CD41-Lin-) were found adjacent to sinusoids and only 20% to the endosteum (Kiel et al., 
2005). However, since osteoblasts also produce soluble factors (as mentioned above), direct 
contact with bone marrow HSCs may not be a prerequisite for their contribution to the in vivo 
HSC niche.  
In contrast, recent studies provided additional evidence for a functional role of 
osteoblasts in the HSC niche. Kieslinger and colleagues reported that ablation of early B cell 
factor 2 (Ebf2)-expressing immature osteoblasts negatively affected the numbers of HSCs 
and committed progenitor cells (Kieslinger et al., 2010). In addition, Sugimura et al showed 
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that N-cadherin expressing osteoblasts protect HSCs from activation via non-canonical Wnt 
signalling (flamingo and Frizzled receptor 8) (Sugimura et al., 2012).  
3.4.3.2. Osteoclasts 
Osteoclasts (from the greek words “οστό” for bone and “κλάσις” for fracture/break) 
are the cells responsible for bone resorption by removing the mineralized matrix deposited by 
osteoblasts. To achieve that, osteoclasts secrete proteases such as cathepsin K and matrix 
metallopeptidases (Mmp9 and Mmp13). During bone resorption, osteoclasts also release 
calcium ions from hydroxyapatite (calcium-phosphate ceramic) and enzymatically process 
CXCL12 (via cathepsin K) (Kollet et., 2006), an important molecule for HSC maintenance 
and function (Barker, 1994).  
Current data suggest an important role of osteoclasts in hematopoiesis under steady-
state conditions. Administration of bisphosphonate alendronate (ALN), an inhibitor of 
osteoclast-mediated bone resorption, results in decreased HSC numbers (defined as Flt3
-
KSL), loss of quiescence and delayed hematopoietic recovery upon transplantation in treated 
mice (Lymperi et al., 2011). Using a mouse model with defective osteoclastic activity (oc/oc 
mouse), Mansour and colleagues revealed that osteoclasts play an important role in the 
formation of the bone marrow niche and HSC homing, by controlling the differentiation of 
osteoblasts from mesenchymal progenitors (Mansour et al., 2012).  
3.4.4. The vascular niche 
The bone marrow vasculature contains different types of blood vessel structures and 
its architecture has been visualized through electron microscopy (Tavassoli, 1981) or 
injection of India ink into the circulation (Fliedner et al., 2002). In general, blood vessels are 
the main structures of the blood circulation and can be divided into three different types: the 
arteries (taking blood away from the heart), the veins (returning blood to the heart) and the 
capillaries (allowing the exchange of blood’s components with body tissues). They all share 
common anatomy having three basic layers: the tunica intima (the inner layer of all vessels 
consisting of an endothelial layer being in contact with the blood flow and an internal layer of 
elastic tissue - elastic lamina), the tunica media (the middle layer with the smooth muscle 
cells) and the tunica externa (the outer layer of connective tissue). In the bone marrow, blood 
flows from the arteries to the capillaries, through small vessels called arterioles. Capillaries 
are themselves divided into three different types: the continuous, the fenestrated and the 
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sinusoids. Continuous capillaries are covered by a solid, uninterrupted layer of endothelial 
cells and allow diffusion of small molecules (ions). Fenestrated capillaries are characterized 
by the presence of gaps between endothelial cells, thus allowing small proteins to exit from 
the blood stream. Sinusoids which are very abundant in the bone marrow, are specialized 
capillaries with bigger pores (than fenestrated capillaries) enabling exchange of medium size 
proteins.  
3.4.5. Cellular composition of the vascular endothelial niche  
3.4.5.1. Vascular Endothelial cells 
As previously mentioned, the bone marrow is a heavily vascularized tissue with 
numerous arterioles and capillaries providing oxygen and nutrients to the neighboring cells. 
The walls of blood vessels are composed of endothelial cells, which allow different levels of 
permeability. Billions of differentiated blood cells are directed to the circulation every day, 
through the extended network of sinusoidal blood vessels. It is currently thought that HSCs 
(similarly to differentiated cells) periodically pass the “barrier” of sinusoid endothelial cells, 
circulate in the peripheral blood and then return back to the bone marrow (Méndez-Ferrer et 
al., 2008).  
Developmentally, endothelial cells are closely related to hematopoietic cells 
(Kennedy et al., 1997). In fact, it was recently shown that blood cells arise from hemogenic 
endothelium in vitro (Eilken et al., 2009). During embryonic development in both mice and 
humans, hematopoiesis occurs in the absence of bone tissue. After birth, HSCs have been 
found in extramedullary areas, such as the liver and the spleen. It is important to note that in 
several vertebrate species hematopoiesis is not associated with bones; in zebrafish for 
example the kidney and the thymus are the main hematopoietic sites (Murayama et al., 2006). 
Morrison’s group has provided proof for the connection between adult, bone marrow 
HSCs and endothelial cells. Their study showed that the 60% of bone marrow HSCs 
(CD150+CD48-CD41-Lin-) are adjacent to vascular endothelial cells, whereas 20% was 
found in the endosteum (Kiel et al., 2005). The authors also revealed that all HSCs were 
located within 5 cell diameter from sinusoids suggesting that endothelial cells are the key 
players in the in vivo bone marrow niche (Kiel et al., 2007). However, their results should be 
handled with care since they are based on frozen sections distorting the exact tissue 
morphology and architecture. 
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The described heterogeneity of the stem cell compartment, which consists of various 
subsets of HSCs distinct properties, might imply the existence of several different niches in 
the bone marrow. Additionally, what remains questionable and needs to be addressed is the 
current notion that more primitive HSCs reside in the endosteal niche, whereas activated ones 
are located in the sinusoid endothelium (Wilson and Trumpp, 2006). 
3.4.6. Cellular composition of the perivascular niche  
3.4.6.1. CXCL12-abundant reticular (CAR) cells 
It has long been appreciated that hematopoietic cells are in close association with 
reticular cells in the bone marrow of rodents (Weiss, 1976).  A more recent study reported 
that some reticular cells in the murine bone marrow express high levels of the chemokine 
CXCL12, hence their name CXCL12-adundant reticular (CAR) cells (Sugiyama et al., 2006).  
Interestingly, CAR cells have been found in both the endosteal and vascular region, a unique 
feature which could potentially link/unify those niches. The fact that 97% of HSCs 
(CD150+CD48-CD41-) were found adjacent to those cells in the bone marrow (Sugiyama et 
al., 2006), makes CAR cells the cell type with the most significant correlation with HSCs up 
to now. In a recent study, Omatsu and colleagues showed that ablation of CAR cells leads to 
a 2-fold decrease of HSC numbers, increase of their quiescence and a skewing towards the 
myeloid lineage (Omatsu et al., 2010). They also reported the ability of CAR cells to 
differentiate in vitro and in vivo to osteoblasts and adipocytes, a property compatible with 
stem or progenitor cell types.  
3.4.6.2. Nestin+ mesencymal cells (MSCs) 
Another cell type in the bone marrow known for its high CXCL12 expression are the 
nestin expressing (Nes+) mesenchymal cells (Méndez-Ferrer et al., 2010).  The authors 
reported that ablation of Nes+ cells leads to loss of HSC function and impaired homing to the 
bone marrow. However, a recent study ablating CXCL12 from the Nes+ cells revealed minor 
or no effects upon HSC function and homing in the bone marrow (Ding and Morrison, 2013) 
arguing that CXCL12 is not the relevant molecule promoting HSC maintenance by the Nes+ 
cells.  
3.4.6.3. Mature blood cells  
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Until recently, only non-hematopoietic cells were acknowledged as candidate niche 
elements for HSCs. However, recent studies provided evidence for the role of mature 
hematopoietic cells in the bone marrow niche.  Megakaryocytes share the Tpo receptor (c-
Mpl) with HSCs, thus antagonizing for Tpo’s availability in the bone marrow. In cases of 
increased numbers of megakaryocytes, HSCs loose quiescence and eventually their self-
renewal potential (De Graaf et al., 2010). Another mature blood type, macrophages, have 
been shown to influence HSC retention in the niche, since their ablation causes HSC 
mobilization  (Winkler et al., 2010; Chow et al., 2011). It is important to note that despite the 
importance of the studies mentioned above, observed phenotypes can be the result of 
secondary effects (for example impaired bone remodeling having downstream effect on 
osteoblasts or other cell types). 
3.4.6.4. Adipocytes 
The adipocytes, the specialized fat-storing cells, is another cell type found in the adult 
bone marrow. The numbers of bone-marrow adipocytes are increased with age (Neumann, 
1882) and obesity (Hamrick et al., 2004). Until recently, it was thought they only fill marrow 
space and have no role in hematopoiesis (Wang and Wagers, 2011). However, using the 
obese leptin-deficient (ob/ob) (Ingalls et al., 1950; Zhang et al., 1994) and leptin receptor-
deficient mice (db/db), recent studies revealed impaired HSC function in vivo (Claycombe et 
al., 2008; Pietramaggiori et al., 2009). The negative effect of adipocytes in hematopoiesis was 
later confirmed by the work of Naveiras and colleagues. They reported a gradient of 
adipocytic tissue in the mouse spine, with thoracic vertebrae possessing low numbers (if any) 
and tail vertebrae being very rich. HSCs (Flt3-KSL) isolated from tail vertebrae (highly 
adipocytic) showed reduced repopulation potential upon transplantation when compared with 
the ones from the thoracic vertebrae (Naveiras et al., 2009). In the same study, it was also 
reported that genetic or chemical inhibition of adipogenesis partially restored the impaired 
HSC phenotype.  
Considering the studies mentioned in this chapter, whether the in vivo BM niche 
consists of one or more HSC niches, their precise role on hematopoiesis, their exact cellular 
composition and the underlying molecular mechanisms are still controversial and require 
further clarification. 
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3.5. Establishing an in vitro HSC niche: Stroma cell types and 
molecular players 
As mentioned above, stroma-based culture systems are a robust method to culture 
HSCs in vitro, since they mimic the interaction between HSCs and niche cells and allow 
indirect HSC manipulation. The pioneer of the in vitro culture of hematopoietic cells was 
T.M. Dexter (Dexter et al., 1973). Later efforts focused on the isolation of stroma cells from 
tissues known to function as hematopoietic niches during development. Below, several 
stroma cells lines isolated from different hematopoietic niches during murine development 
are described. 
 3.5.1. Yolk sac-derived stroma cell lines 
In the mid 90’s, Yoder and colleagues sought to understand the role of the yolk sac 
(YS) microenvironment in hematopoiesis, since this is the initial site where it arises. To 
address this, they established cell lines from the endodermal (YSE) and mesodermal (YSM) 
layers of murine yolk sac from E9.5 embryos (Yoder et al., 1994). Bone marrow (BM) cells 
were isolated from mice treated with 5-fluorouracil (5-FU) to enrich for more 
primitive/quiescent hematopoietic cells. Then, these cells were co-cultured with the different 
YS-derived stroma lines while were compared with BM-derived stroma (summary of all 
described cell lines in Table 3.3). The analysis showed that both YS stroma increased the 
proliferation of colony forming cells (Yoder et al., 1995). Interestingly, the authors reported 
that conditioned media supplemented with recombinant growth factor(s) could restore the 
observed effects in the absence of YS stroma.  
 3.5.2. AGM-derived stroma cell lines 
The next hematopoietic site during embryonic development is the AGM region, which 
gives rise to the first hematopoietic cells with repopulation capacity (definitive 
hematopoiesis) in the mouse embryo (Medvinsky and Dzierzak, 1996). The proximity of 
hematopoietic cells with endothelial cells in the ventral wall of dorsal aorta, led Ohneda and 
colleagues to isolate endothelial cells from E11 mouse embryos and to screen their effect on 
co-cultured fetal liver CD34+KSL HSCs (Ohneda et al., 1998). Interestingly, they identified 
one endothelial cell line (DAS 104-4) able to maintain HSC numbers for 7 days of in vitro 
culture (as measured by primary transplantation for 15 weeks). Another line (DAS 104-8) 
promoted differentiation of co-cultured HSCs towards the myeloid lineage, which 
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necessitated cell-cell contact, was also established (Ohneda et al., 1998). Importantly, the 
secondary transplantations required to confirm maintenance of fetal liver HSCs were not 
performed. In a study published few months later, Xu and colleagues established another 
AGM-derived stroma cell line from E10.5 mouse embryos (AGM-S3), which supported 
differentiation of adult BM HSCs (KSL cells) and maintenance of human cord blood 
repopulating cells, as shown by transplantations in non-obese diabetic severe combined 
immunodeficient NOD/SCID mice as recipients (Xu et al., 1998). Despite confirming 
previous findings that mouse stroma can also support human hematopoiesis ex vivo 
(Sutherland et al., 1991; Issaad et al., 1993), important technical limitations regarding the 
purity of co-cultured human hematopoietic cells and the heterogeneity of the non-clonal 
stroma cells were not addressed.   
It is important to note that the AGM region can be anatomically divided into two 
different, morphologically distinct regions (dorsal aorta/mesenchyme [AM] and urogenital 
ridges [UG]) with different hematopoietic potential. In an exhaustive study, Oostendorp and 
colleagues isolated 25 stroma cell lines from the different AGM compartments (AM and 
UG), the embryonic liver (EL) and the gastrointestinal region (GI) of E11 mouse embryos, 
which were subsequently cloned to generate 100 different subclone lines (Oostendorp et al., 
2002). The potential of those lines to support colony forming cells (CFC) and to maintain 
repopulation potential of co-cultured adult HSCs (CD31+cKit+Ly6C-) was screened by long-
term culture (LTC)-CFC assays. Two UG (UG26-1B6 and UG26-2D3) and one EL line 
(EL08-1D2) were the most potent lines, with UG26-1B6 being the more robust in supporting 
repopulating HSCs after 4 weeks of co-culture (6/13 repopulated mice) (Oostendorp et al., 
2002).  
In a follow-up study, Buckley and colleagues revealed that UG26-1B6 stroma 
maintained repopulating cells through secretion of Wnt5a in non-contact cultures, whereas 
EL08-1D2 require direct contact (Buckley et al., 2011). Addition of Wnt5a-neutralising 
antibody inhibited this potential of UG26-1B6 cells illustrating that Wnt5a is among the 
molecules responsible for this interaction (Buckley et al., 2011). However, due to the 
considerable heterogeneity of the starting hematopoietic population co-cultured with the 
UG26-1B6 stroma (Lin- cells), the effect of Wnt5a might be a result of an indirect effect 
rather than a direct one upon HSCs. A recent study further support this hypothesis, since the 
exogenous addition of Wnt5a in a cell population more enriched for HSCs (KSL cells) did 
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not maintain, but rather decreased the number of repopulating cells, in stroma-free cultures 
(Schaap-Oziemlak et al., 2013). The inability of Wnt5a to maintain HSCs in stroma-free 
cultures might mean that other secreted factors are also required. Alternatively, it might 
illustrate the importance of the presence of the stroma cells, even in the case of non-contact 
cultures, due to the presence of a cleaved form of membrane or extracellular-matrix related 
molecule. Another molecule reported to be involved in the interaction between AGM-derived 
stroma and hematopoietic cells was pleiotrophin (Ptn). Interestingly, it was showed that the 
loss of Ptn had a positive effect upon the maintenance of repopulating cells (Istvanffy et al., 
2011). 
Unfortunately, despite the expectation for potential HSC expansion mediated from 
AGM-derived niche cells, such an effect was not observed. Also, to our knowledge, no gene 
expression profile of those cell lines is currently available, thus impeding their efficient 
molecular manipulation in large-scale. 
3.5.3. Fetal liver-derived stroma cell lines 
In an attempt to establish a culture system for HSC expansion, Kateri Moore and 
colleagues dissected the fetal liver (FL) of murine embryos and generated 225 clonal stroma 
cell lines. These cells lines were immortalized (insertion of temperature-sensitive simian 
virus 40 large T antigen – SV40T) and screened for their potential to support hematopoiesis 
over long culture periods (Wineman et al., 1996). The initial screening included “cobblestone 
area forming cell” (CAFC) assays by co-cultivation of BM cells with the different FL derived 
stroma cell lines. Cobblestone areas (CA) have been shown to correlate with the 
primitiveness of the cobblestone forming units (CFU), more primitive cells will need longer 
time to generate CA (Ploemacher et al., 1989). In addition, the presence of CA 28 days after 
the initiation of the co-culture, has been reported to highly correlate with in vivo repopulation 
potential (Van der Sluijs et al., 1990; Ploemacher et al., 1991; Van Os et al., 2008).This 
laborious screening revealed only few stroma cell lines being capable of supporting 
hematopoiesis for long co-culture periods (>6 weeks). From those, only AFT024 cells could 
qualitatively and quantitatively maintain repopulating cells as shown by competitive 
transplantation experiments (Moore et al., 1997a). Interestingly, HSCs (or repopulating cells) 
cultured on AFT024 showed the same potency for long-term multilineage reconstitution (56 
weeks) as freshly purified (uncultured) HSCs, thus illustrating the potential of AFT024 for 
qualitative and quantitative HSC maintenance. Additional cell lines with intermediate 
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potential to maintain repopulating cells were also identified, such as the 2012 line. 
Unfortunately, no proof of HSC expansion in co-culture experiments with fetal-liver derived 
stroma was reported, as initially expected.  
In a follow-up study, Moore and colleagues attempted to shed light upon the 
molecular mechanism of the AFT024-drived maintenance of murine HSCs, by investigate the 
role of delta-like or pre-adipocyte factor 1 (dlk1) (see Table 3.2). DLK1 protein, a 
transmembrane glycoprotein with epidermal growth factor-like repeats, was identified to be 
expressed exclusively in the supportive stroma cells (Hackney et al., 2002). Addition of either 
the soluble or transmembrane form of dlk1 had no effect on the colony-formation of fetal 
liver (AA4.1+, Sca-1+, c-Kit+, Lin low/-) or bone marrow (KSL) HSCs cultured on semi-
solid media. A 2-fold increase in the number of cobblestone area colonies (CAC) was 
reported upon exogenous addition of the soluble protein form, when HSCs were cultured with 
non-supportive stroma (BFC012) in Dexter-type co-cultures (Moore et al., 1997b). Also, a 4- 
to 6-fold increase was observed, when BFC012 cells over-expressing the transmembrane 
form of dlk1 were used as stroma. However, the maintenance of the CACs was transient and 
competitive transplantation experiments revealed low levels of maintenance of HSCs pre-
cultured in dlk-expressing conditions (Moore et al., 1997b). These results led authors to 
hypothesize the existence of additional factors which are responsible for the AFT024-driven 
maintenance of co-cultured HSCs in vitro.  
Importantly, there is strong evidence that the AFT024 stroma can also support the ex 
vivo maintenance of human HSCs. Cord blood- and bone marrow-derived CD34+CD38- 
cells were co-cultured on AFT024 or primary human stroma and their potential to generate 
cobblestone-area forming cells (CAFC) after long-term culture was monitored and compared. 
AFT024 cells were found more potent in maintaining human HSCs in vitro necessitating 
direct contact (Thiemann et al., 1998). These results were later confirmed by long-term 
culture initiating-cell experiments (LTC-IC), a more objective method in vitro assay to 
estimate HSC potential. Bone marrow-derived CD34+Lin- human cells that were cultured on 
AFT024 stroma for 5 weeks, showed a 3-fold higher potential to generate LTC-IC colonies 
than those cultured on the murine bone-marrow cell line M2-10B4 (Punzel et al., 1999a). 
Although CAFC and LTC-IC assays are currently the best in vitro methods to estimate the 
numbers of HSC in a heterogeneous population, they do not measure engraftment and self-
renewal potential. Such properties required in vivo transplantation experiments. Nolta and 
- 35 - 
 
colleagues compared the potential of the AFT024 and the human stroma to support human 
HSCs, by performing transplantations using a xenograft mouse model (beige/nude/xid mouse 
- bnx). Cord-blood derived human CD34+CD38- HSCs co-cultured with AFT024 stroma for 
two or three weeks showed at least 2-fold higher percentage of engraftment, 12 months after 
transplantation (Nolta et al., 2002). Also, the number of primitive cells 
(CD45+CD34−CD38− and CD45+CD34−Lin−) present in the bone marrow of mice 
transplanted with human cells maintained on AFT024 stroma was 3-fold higher.   
 
  In an attempt to reveal the molecular mechanism involved in the AFT024-driven 
maintenance of human HSCs in vitro, Punzel and colleagues reported that a higher 
percentage of CD34+ cells were in cycle when co-cultured in contact with AFT024 (29,8% 
±1,7%) compared to M2-10B4 stroma (21,2% ±2,3%). Based on those differences, they 
suggested that M2-10B4 stroma leads to reduced LTC-IC potential of cultured cells by 
blocking cell-cycle progression (Punzel et al., 2002). Protein expression analysis revealed 
size differences on heparan sulfates (HS) produced by both cells types (AFT024 have bigger 
HS), leading them to postulate the involvement of large size O-sulfated HS in the cell-cycle 
progression of human HSCs. It is important to note that direct contact was reported as the 
predominant mechanism (Punzel et al., 2002) confirming earlier studies (Thiemann et al., 
1998). However, the notion that AFT024 maintain human HSCs through direct contact or 
cell-matrix interactions has been challenged by later studies. CD34+ umbilical cord blood-
derived human cells were cultured on transwells in the presence of stem cell factor (SCF), 
thrombopoietin (Tpo), interleukin 7 (IL-7) and fms-related tyrosine kinase ligand (Flt3L), 
without contacting the AFT024 stroma (Lewis et al., 2001). After 14 days in culture, the 
progeny of those cells or non-cultured, freshly purified cells were transplanted into non-obese 
diabetic/severe combined immunodeficiency (NOD-SCID) mice. The levels of engraftment 
were found similar, whereas the frequency of repopulating cells was increased by 2 folds in 
the cultured cells. These results suggest that AFT024 non-contact cultures can also maintain 
if not expand human CD34+ cells for culture periods not exceeding two weeks (Lewis et al., 
2001).  
Similar results were published few years earlier by the Verfaillie group, in which the 
reported poor ability of non-contact AFT024 cultures to maintain LTC-ICs was significantly 
improved by the addition of a cocktail of human cytokines (GM-CSF, G-CSF, SCF, LIF, 
MIP-1a, IL-6) (Punzel et al., 1999b). Finally, Hutton and colleagues reported that the bone 
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morphogenic protein 4 (BMP4), a secreted protein which is abundant in the AFT024 
condition media, played a key role in the reported interaction. Blocking of the BMP4-
downstream signalling abated the reported effect of AFT024 stroma on cord blood HSCs, 
arguing against the necessity of direct contact for the maintenance of human HSCs by the 
AFT024 stroma (Hutton et al., 2006). 
   
Table 3.2. Experimental details of studies using the AFT024 co-culture system . Abbreviations 
are: HSC immunophenotype column (FL: fetal liver, BM: bone marrow, CB: cord blood, UCB: 
umbilical cord blood, AA4.1: cell surface antigen AA4 or CD93, KSL: cKit+ or Kit oncogene, Sca1+ 
or stem cell antigen 1, Lineage-), Culture conditions column (FCS: fetal calf serum, HS: horse serum, 
2-Me: 2-Mercaptoethanol, HC: hydrocortisone, BSA: bovine serum albumin, IL-3: interleukin 3, IL-
6: interleukin 6, IL-7: interleukin 7, IL-8: interleukin 8,  SCF: stem cell factor, MIP1a: macrophage 
inflammatory protein 1-alpha, FL or Flt-3l: fms-related tyrosine kinase 3 ligand, MCP-1: monocyte 
chemoattractant protein 1, VEGF: vascular endothelial growth factor, Tpo: thrombopoietin), Readout 
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column (CAFC: cobblestone area forming cell, CFU: colony forming unit, LDA LTC-IC: limiting 
dilution long-term culture initiating cell, NOD/SCID: non-obese diabetic/severe combined 
immunodeficiency), Mechanism column (ND: not determined, DC: direct contact, SF: secreted 
factor(s)). 
 
Collectively, these data illustrate that the AFT024 stroma cell line is capable of 
maintaining primitive murine and also human HSCs over long-culture periods ex vivo. 
Stroma-free or non-contact AFT024 cultures of human HSCs require exogenous addition of 
cytokines to yield similar results as the contact cultures. Despite those extensive studies, the 
exact mechanism and the molecules responsible for their supportiveness remain 
controversial. 
3.5.4. Bone marrow-derived stroma cell lines 
In addition to cell lines derived from embryonic tissue, bone marrow stroma cells 
isolated from newborn (PA6, OP9) or adult mice (MS-5) have also been studied. In the early 
80’s, Kodama and colleagues isolated calvaria from P1 (postnatal day 1) newborn mice and 
established the pre-adipocytic MC3T3-G2 cell line, which was later sub-cloned to seventeen 
different lines (Kodama et al., 1982a). From those, the MC3T3-G2/PA6 line (a subclone of a 
heterogeneous population of bone marrow cells) was initially selected based on its high 
potential for adipocytic differentiation in response to administration of glucocorticoids 
(Kodama et al., 1982a). In a follow-up study, Kodama illustrated the potential of the MC3T3-
G2/PA6 line to increase the numbers of CFU-S cells (currently thought to correspond to 
multipotent progenitors, MPPs) through direct contact with co-cultured bone marrow cells 
(Kodama et al., 1982b). Few years later, sub-clones of the MC3T3-G2/PA6 cell line 
(MC3T3-G2/PA6/S-2 and MC3T3-G2/PA6/S-12) failing to support long-term hematopoiesis 
were also identified (Kodama et al., 1992). Recently, Shimizu and colleagues performed a 
microarray analysis (Affymetrix Gene Chip Mouse Genome 430 2.0 array) comparing the 
parental line MC3T3-G2/PA6 with the two sub-clones lines. The analysis revealed 144 genes 
being down-regulated in both non-supporting lines (Shimizu et al., 2008). Selected gene 
over-expression (1110007F12Rik) in the non-supporting lines slightly rescued their 
hematopoietic potential (although results were not statistically significant). Despite the 
importance of those findings the non-clonal nature of the parental MC3T3-G2/PA6 stroma 
cell line again precludes efficient molecular manipulation and questions sensitivity in the 
performed high-throughput analysis. 
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Another widely known line derived from mouse calvaria is the OP9 stroma. This line 
was generated from B6C3F1 osteopetrotic mice (op/op) with a mutation in the gene coding 
for the macrophage colony stimulating factor (M-SCF) protein (Kodama et al., 1994). These 
mice lack osteoclasts and have deficient phagocytes. OP9 stroma has been used for the 
multilineage hematopoietic differentiation of co-cultured mouse embryonic stem (ES) cells in 
the absence of additional cytokines (Nakano et al., 1994; Nishikawa et al., 1998). These 
results led researchers to hypothesize that the OP9 stroma should express some of the genes 
necessary for the regulation of hematopoiesis. Indeed, Ueno and colleagues illustrated the 
potential of OP9 to support co-cultured KSL cells and also identified a mammalian 
homologue of a Drosophila melanogaster gene (mKirre) as one of the key molecules 
involved in the this interaction (Ueno et al., 2003).  
An interesting approach was followed by Itoh and colleagues who generated the MS 
stroma cell lines by irradiating the adherent layer during a long-term bone marrow culture 
assay (Itoh et al., 1989). The authors established different MS lines starting from single cells 
(MS-1 to -7) from which MS-5 cells were the most potent in supporting expansion of CFU-S 
and granulocyte-macrophage colony forming cells (GM-CFC) for over 2 months in vitro 
(cell-cell contact required). MS-5 cells produce extracellular matrix proteins, such as laminin, 
collagen I and fibronectin (Itoh et al., 1989) and important cytokines such as granulocyte-
macrophage colony stimulating factor (GM-CSF), interleukin 6 (IL6) and stem cell factor 
(SCF) (Suzuki et al., 1992). 
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Table 3.3. Detailed outline of stroma cell lines isolated from different regions during mouse 
development and their reported effect upon hematopoietic cells. Abbreviations are SF: secreted 
factor, SF*: cleaved extracellular domain of a membrane protein, DC: direct contact, E: embryonic or 
days post coitum - dpc, P: postnatal or days after birth, NA: not available. 
 
3.5.5. AFT024: a stroma cell line supporting robust HSC 
maintenance, while allowing efficient molecular manipulation 
Most of the in vitro systems described above consisted of heterogeneous stroma cell 
populations (Table 3.3). The importance of the AFT024-based in vitro culture system lies in 
the clonality of the stroma cell compartment. This is a prerequisite for the identification of the 
molecular mechanisms involved, since the existence of different cell types (stroma 
heterogeneity) might lead to experimental inconsistencies and technical variation. This 
critical difference enabled in-depth genomics analysis revealing unique molecules 
differentially expressed between AFT024 and the non-supportive lines. In a follow-up study, 
the molecular profile of the supporting stroma cell line (AFT024) was identified through 
functional genomics approach (Hackney et al., 2002). For this reason, cDNA libraries from 
the supportive (AFT024) and a non-supportive stroma cell line (2018) were sequenced and 
compared. Further bioinformatics analysis enabled functional annotation of all the sequences 
found preferentially or exclusively in supportive cells, thus revealing the molecular profile of 
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AFT024 (http://stromalcell.mssm.edu/). An additional follow-up study utilized a high-
throughput analysis (Affymetrix microarrays) further confirming and updating the molecular 
signature of the AFT024s (Charbord and Moore, 2005). This published list of genes 
expressed in AFT024 cells allows molecular manipulation of the supportive stroma in order 
to identify the key molecule(s) responsible for the in vitro maintenance of HSCs. Taking into 
consideration the properties and available data of all stroma cell lines described above, it is 
obvious that AFT024 stroma cells was the most potent line to be used in this study due to its 
clonal origin and available gene expression profile. 
Unfortunately, the studies mentioned above provided limited or no information 
regarding the effect upon HSC behavior. Also, the molecular mechanism through which the 
AFT024 stromal cell line supports the in vitro maintenance of HSCs is currently unknown. 
The main limitation of those studies is that their results were based on endpoint analysis 
conducted on heterogeneous populations of blood cells. Such analysis cannot reveal the 
sequence of fate-choice events of single cells over time and is thus not informative regarding 
the underlying molecular mechanism or the effects of molecular manipulations.  
Continuous observation of living cells is necessary when studying dynamic biological 
processes. A time-lapse imaging approach with single-cell resolution would allow monitoring 
HSCs’ behavior upon co-culture with the AFT024 stroma. Without single-cell observation, 
opposing interpretations could be used to explain the finding that the number of HSCs with 
long-term repopulation capacity is maintained when co-cultured with AFT024: increased 
levels of cell division and/or reduced levels of apoptosis or even complete absence of HSC 
divisions would be a possible explanation of the published experimental data. In addition, due 
to the size of the published gene lists (Hackney et al., 2002), conventional methodology 
including long co-cultures in vitro (4-6 weeks) and subsequent primary (>16 months) and 
secondary (4 months) in vivo transplantation experiments hinders high-throughput screening 
of individual molecules. Therefore, a high resolution and high throughput in vitro imaging 
system had to be utilized.  
3.6. Time-lapse imaging: a brief historical perspective 
Time-lapse imaging is a powerful technique allowing continuous observation of 
dynamic processes. The ancestor of the modern time-lapse imaging is chronophotography 
(from the greek words chronos (χρόνος) for time, photos (φωτός) genitive of phos (φως) for 
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light and grafi (γραφή) for drawing) invented by the French physicist Étienne-Jules Marey 
around 1880. The term describes a series of photos acquired with determined time intervals in 
order to analyze a continuous motion into individual still images. Marey’s inventions allowed 
him to depict animal movements that were too fast for the human perception, such as the 
movement of wings during a pelican’s flight or horse’s leg during gallop. He achieved this by 
acquiring 12 pictures per second all depicted in a single picture. His passion for physiology 
led him to propose during an International Physiology Congress (1898, Cambridge) the 
creation of an International Commission aiming at the standardisation of available 
instruments for physiology studies. He became the president of this commission and the 
building hosting the commission’s meetings was named after him (Marey Institute, Parc de 
Princes, Paris).  
Marey’s inventions quickly paved the way for continuous observation in the 
microscale. Time-lapse microcinematography was then introduced to enable imaging through 
a microscope. The principle was almost identical than chronophotography; imaging 
microscopic subjects with pre-defined time interval and projecting multiple images per 
second into a film. The first time-lapse microcinematography movie of growing bacteria was 
acquired by Bull and Pizon in 1904 (Talbot, 1931; Burton, 1962). A few years later (1907), 
the first time-lapse movie of fertilization and embryonic development of sea urchin eggs was 
recorded by Julius Ries (Ries, 1907). Ries projected to his medical students a 14-hour long 
developmental process into a 2-minute movie, which he used to demonstrate that all cells in 
an organism are derived from other cells (Landecker, 2009). However, the name which is 
historically more related to microcinematography is that of Jean Comandon. Comandon, a 
French medical doctor, established his own microcinematography lab in 1907, where he 
recorded movies of syphilis spirochete infecting blood cells (Gastou and Comandon, 1909; 
Roux et al., 2004) and the first movie monitoring the dynamic process of cell division 
(reviewed in Landecker, 2009).  
Modern time-lapse imaging required major advances in many different scientific 
fields, such as the in vitro cultivation of mammalian cells, different image acquisition 
methods (phase contrast, fluorescence microscopy), discovery of fluorescent 
dyes/proteins/antibodies, invention of mechanical parts (filter cubes, charge-coupled device 
cameras, fluorescent light sources), progress in computer sciences (software for high 
throughput acquisition and image analysis). Currently, successful incorporation of those 
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advances enables biologists to monitor dynamic processes at the single cell level with high 
temporal resolution. However, commercially available hardware and software for multi-
positional time-lapse imaging of single cells and most importantly for post-acquisition 
processing and analysis of cell progeny have limited functionality and flexibility.  
3.6.1. Continuous time-lapse imaging with single-cell resolution is 
indispensable when studying the behavior of living cells 
The need for continuous observation of dynamic biological processes has long been 
appreciated by natural scientists. For example, in 1882 Ilya Metchnikov hypothesized that 
cells of a transparent starfish larva would respond to inserted rose thorns. Indeed, after hours 
of continuous observation through his microscope, Metchnikov witnessed larva cells actively 
migrating and surrounding the intruding thorns (Metchnikoff, 1887) thus giving birth to the 
field of immunology. Noteworthy, he was later rewarded with the Nobel Prize (Nobel Prize 
for Physiology or Medicine, 1908) for his work on phagocytosis and immunity (for more 
details see Tauber, 2003; Dunn and Jones, 2004).  
Comprehensive understanding of dynamic processes, such as the behavior of living 
cells, requires continuous monitoring over time (Schroeder, 2008; Kokkaliaris et al., 2012). 
Many modern analyzes are based on snapshots of heterogeneous populations, which may 
easily mask the behavior of individual cells with low frequencies. Snapshot analyzes 
conducted at the single-cell level (FACS, immunohistochemistry) overcome this limitation, 
but fail to illustrate the dynamics of cellular and molecular behaviors over time leading to 
conflicting interpretations (Schroeder, 2008; Schroeder, 2011). For these reasons, continuous 
time-lapse imaging with single-cell resolution is indispensable when studying living cells 
(Kokkaliaris et al., 2012). Ideally, such analysis should be implemented in living organisms, 
since cells could then be observed under physiological conditions. However, due to technical 
limitations (limited penetration depth of current imaging technology, need for animal 
immobilization), such in vivo analysis is not feasible for periods more than few hours. On the 
contrary, in vitro time-lapse imaging of single cells allows long-term monitoring of cellular 
and molecular behaviors for weeks.  
The bioimaging technology established in the Schroeder lab (Schroeder, 2005; Eilken 
et al., 2009; Rieger et al., 2009) offers a series of advantages, such as: 1. flexibility in multi-
positional time-lapse imaging 2. automated acquisition of different fluorescent wavelengths 
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3. equal time intervals between different cycles 4. long-term imaging of living cells for 
periods over 2 weeks 5. manual or automated restoration of the progeny of single cells (cell 
tracking) in different wavelengths 6. functional monitoring and annotation of different 
cellular properties (division, cell death, migration, speed, etc) 7.background correction 
algorithms 8. single-cell quantification of fluorescent markers and 9. statistical analysis of 
cellular behaviors. This technology consists of three main parts, the time-lapse imaging 
software (Timm’s Acquisition Tool, TAT), the tracking software (Timm’s Tracking Tool, 
TTT) with the QTFy algorithm and the staTTTS tool for statistical analysis. Taking 
advantage of such cutting-edge technology will enable to elucidate the behavior of 
hematopoietic stem cells and all their progeny followed for up to two weeks continuously and 
at the single cell level.  
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4. Goals of the thesis 
Ex vivo maintenance of HSCs is a prerequisite for their improved clinical application 
in regenerative medicine against blood disorders and injury. It has been reported that AFT024 
stroma cells promote HSC self-renewal in vitro for long co-culture periods. However, the 
behavior of single HSCs as well as the molecules involved in this interaction are unknown. 
In my thesis, I plan to first identify the behavior of HSCs under maintenance 
conditions, by implementing continuous time-lapse imaging at the single-cell level. In 
addition, unravelling the mechanism of the interaction between HSC and stroma cells is 
required. This will enable me to efficiently screen candidate molecules with selected 
properties in order to identify the key factor(s) governing HSC maintenance in AFT024-
based co-cultures in vitro.  
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5. Results 
 
5.1. Identifying the behavior of single HSCs under conditions 
promoting in vitro HSC maintenance  
5.1.1. Continuous time-lapse imaging and single-cell tracking allows long-
term observation of individual HSCs and their progeny in vitro 
 
 The technology developed in the Schroeder lab allows both long-term, continuous 
observation of living cells through long-term bioimaging and tracking of single cells and their 
progeny through the tracking software TTT (Timm’s Tracking Tool). This enabled me to 
perform high-throughput imaging of living murine HSCs co-cultured with a panel of 
irradiated stroma cells, with high temporal resolution for up to two weeks in vitro (Figure 
5.1).  
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Figure 5.1. Schematic representation of the experimental approach followed in the current 
study. A. Left: Method for isolation of the bone marrow-derived HSCs and MPP populations from 
transgenic mice expressing yellow fluorescent protein (YFP) under the chicken beta actin promoter 
(B6J;129-Tg(CAG-EYFP)7AC5Nagy/J, with C57Bl/6J background).  Bone marrow cells with 
selected immunophenotypes were sorted by flow cytometry. Top right: stroma cell preparation. 
Stroma cells were irradiated to prevent future divisions. Later, primary blood cells and irradiated 
stroma cells were co-cultured and imaged for up to 2 weeks. The history of initially plated blood cells 
was then reconstructed in cellular pedigrees (‘trees’) through the TTT software. B. Flow cytometry 
analysis showing the sorting scheme for HSC and MPP isolation. 
  
 HSCs were isolated from transgenic mice (“YVI mice”) with ubiquitous expression of 
the yellow fluorescent protein (YFP) to facilitate efficient cell tracking in visually complex 
co-culture with the stroma cells (Figure 5.2A). Freshly isolated and plated HSCs (so-called 
“generation 0” cells) and their progeny (cells of later generations) were monitored (phase 
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contrast pictures every 7-10 minutes, fluorescent pictures every 14-20 minutes) and their 
genealogy was re-constructed in tree structures (Figure 5.2B). Such trees provide information 
about the cell fates of the entire cell progeny of a “generation 0” cell, as well as the kinetics 
(absolute time after the culture initiation) when those fates occurred. Three distinct cell fates 
were quantified through this approach: i) cell division, ii) cell death and iii) cells that 
survived without division (non-dividing cells).  
 
Figure 5.2. Continuous time-lapse imaging allows monitoring of the cell fates of single, living 
cells for long culture periods in vitro. A. Fluorescent pictures of YFP expressing blood cells co-
cultured with non-fluorescent stroma cells were acquired with 10 to 15-minute intervals continuously 
for up to 2 weeks. B. Example trees depicting the history of initially plated cells over experimental 
time were generated by single-cell tracking. Three cell fates were monitored: cell division, cell death 
and surviving cells without any divisions until the end of the movie.  
 
5.1.2. Continuous time-lapse imaging reveals the behavior of single HSCs 
co-cultured in different stroma microenvironments  
 
- 48 - 
 
As mentioned in the introduction, the fetal-liver derived stroma cell line AFT024 is 
capable of maintaining HSC numbers in long-term, Dexter-type co-cultures. In contrast, the 
“sister” stromal lines 2018 and BFC012, which were derived from the same experiment as 
AFT024 cells, failed to maintain HSCs (Moore et al., 1997a). These findings illustrate that 
cultured HSCs follow distinct cell fates depending on their micro-environment. However, 
previous studies analyzing the composition of these cultures only at very few time points 
(snapshot analysis) failed to identify the environment-specific HSC behavior. To be able to 
qualitatively and quantitatively assess those differences, continuous single-cell analysis is 
required to avoid population averaging, especially in a population with known heterogeneity, 
such as the HSCs (Jordan & Lemischka, 1990; Muller-Sieburg et al., 2004; Sieburg et al., 
2006; Dykstra et al., 2007). In addition, only through continuous monitoring of living cells 
their behavior can reliably be identified and quantified (timing of cell division or cell death).  
Indeed, HSCs showed distinct cell behaviors upon co-culture with the different stroma 
(Figure 5.3A). Three different fates were analyzed: cell division, cell death and cells that 
survived without division until the end of the time-lapse experiment (Figure 5.3B). The 
majority of the HSCs co-cultured with AFT024 divided (80,0%±8,0%), whereas 
15,8%±7,8% died in generation 0. In conditions not supporting HSC maintenance (with 2018 
or BFC012 stroma), the majority of HSCs died in generation 0 (71,6%±5,8% and 78,8%±4,2 
respectively), and only a small proportion divided (26,2%±4,0 and 21,3%±2,5 respectively) 
resulting in a clear in vitro readout system. A small proportion of single HSCs (5,6%±3,8) 
survive without division until the end of the time-lapse movie. Interestingly, HSCs cultured 
on the stroma with the intermediate supportive capacity (2012 stroma) also showed 
intermediate levels of division/cell death suggesting that stroma’s capacity to maintain 
repopulating cells correlates with their initial survival rates.  
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Figure 5.3. HSCs’ survival correlates with stroma’s ability to support self-renewal. Percentage of 
single HSCs following different fates (division, cell death or non-dividing cells) upon co-culture with 
AFT024 supportive stroma (black bars), 2012 intermediate-supportive stroma (dark grey bars), 2018 
non-supportive stroma (light grey bars) and BFC012 non-supportive stroma (white bars) in generation 
0. Mean of 7 experiments for HSC co-cultured on AFT024 cells (290 trees), 3 experiments on 2012 
cells (112 trees), 5 experiments on 2018 (264 trees) and 4 experiments on BFC012 (160 trees). Error 
bars are ±SD, **p<0,01 and *p<0,05 .  
 
5.1.3. Stability of the stroma-mediated effects on HSCs behavior over 
generations 
 
The high temporal resolution imaging approach applied in this study, allowed us to 
follow the fates of the progeny of “generation 0” cells with high precision. Comparing cell 
fates over several generations revealed only minor changes in the levels of environment-
dependent cell division or cell death for cells of later generations (Figure 5.4). “Generation 0” 
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HSCs cultured on AFT024 share similar frequencies of cell division (80,0% ±8,0%) with 
cells of later generations (77,0% ±5,5 for generation 1 and 68,0% ±8,2% for generation 2) 
(Figure 5.4A). The same holds true for the cell-death rates (Figure 5.2B). Interestingly, cells 
co-cultured with the 2012 or BFC012 stroma demonstrated the same behavior; the rate of 
dividing or dying cells is stable regardless of the generation. These data suggest that the 
effects of Dexter-type co-cultures upon HSCs fates are stable for at least the first three 
generations of in vitro culture. 
 
Figure 5.4. Stroma-dependent cell-fate decisions of single HSCs and their progeny do not 
change over generations. A. Percentage of dividing cells in the different stroma cell lines per 
generation. Mean ±SD of 290 trees from 7 experiments for cells on AFT024, 112 trees from 3 
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experiments on 2012, 264 trees from 5 experiments on 2018 and 160 trees from 4 experiments on 
BFC012. B. Dying cells is shown in the bar graph. Mean ±SD. 
 
5.1.4. The genetic background of HSCs has minor effects on stroma-
dependent cell-fate decisions  
  
In order to validate these results, HSCs isolated from a different reporter mouse line 
(mT/mG), but with the same genetic background as YVIs (C57BL/6J), were co-cultured with 
stroma cells revealing similar cell-fate behaviors (divisional rates were 78,4%±4,8% 
compared to 80,0%±8,0% on control)(Figure 5.5). Also, to identify potential differences due 
to genetic background variation, the same analysis was conducted with HSCs isolated from 
YVI mice with mixed background (75% CD1, 25% C57Bl6), showing elevated cell-death 
(24,7%±9,0% compared to 15,8%±8,0% in YVI-C57Bl/6J) and reduced division levels 
(66,5%±6,1% compared to 80,0%±8,0%)(Figure 5.5).  
 
Figure 5.5. Genetic background has minor effects on the cell fates of co-cultured HSCs. Bar 
graphs are representing the percentage of single HSCs following different fates (division, cell death or 
non-dividing cells) upon co-culture with AFT024 supportive cells. Data from single HSCs isolated 
from YVI backcrossed with C57Bl/6J (black bars, 7 experiments, 290 trees), from mT/mG mice with 
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C57Bl/6J background (dark grey bars, 3 experiments, 125 trees) or YVI mice with mixed background 
(light grey bars, 6 experiments, 312 trees) are plotted. Error bars are ±SD. 
 
5.1.5. Early differences in HSC division and cell-death kinetics on different 
stroma allow the establishment of a fast readout system  
 
In addition to monitoring the cell fates of individual cells, continuous time-lapse 
imaging can also provide us with the kinetics of the observed fates. Such analysis revealed 
that more than 96% of the HSC co-cultured with AFT024 stroma cells (n=7, 290 total trees) 
divided within the first 7 days of co-culture, with the main population dividing between 30 
and 80 hours  (50% of HSCs divided at 50,4 hours, T50%
AFT024-Gen0
) (Figure 5.6A). Likewise, 
the large proportion of HSCs co-cultured on 2018 died within the first 7 days (Figure 5.6B). 
Overall, individual cell-fate decisions in either condition occurred within the first 7 days of 
co-culture allowing the establishment of a fast readout system for studying the effects of 
stroma manipulation on HSC fates. It is important to note that this readout system offers a 
significant advantage over the conventional methodology, which includes long-term 
cultivation of isolated cells (4 to 6 weeks) and subsequent transplantation (at least 16 weeks) 
to reveal potential differences.  
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Figure 5.6. Kinetics of HSC fates co-cultured with the different stroma cells. A. Histograms 
depicting the divisional kinetics of freshly purified HSCs (Generation 0) co-cultured on AFT024 (left 
side) or 2018 stroma cells (right side). B. Histograms depicting the cell-death kinetics of freshly 
purified HSCs (Generation 0) co-cultured with AFT024 or 2018. The events occurred within the first 
7 days are highlighted by the red frame. Five independent experiments, with 188 and 261 HSC trees 
for AFT024 and for 2018 co-culture, respectively. Individual bars represent the number of cells 
undergoing cell division at a specific time point.  
 
5.1.6. Identical influence of different stromal lines on HSC cell-cycle 
progression  
 
 As mentioned above, long-term continuous time-lapse imaging and single-cell 
tracking allow following the fates and the kinetics of single cells and their progeny over 
different generations. Monitoring the fates of HSCs on different stroma over the first 
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generations revealed that 50% of  generation 0 HSC cultured on AFT024 stroma (T50%
AFT024-
Gen0
) divided after 50,4 hours, whereas the respective value for HSCs cultured on 2018 is 52,1 
hours (T50%
2018-Gen0
). In generation 1, the T50%
AFT024-Gen1 
value was 94,9 hours (after cell 
isolation) compared to the
 
T50%
2018-Gen1
, which was 99,7 hours (Figure 5.7A). In generation 2, 
the T50%
AFT024-Gen2 
value was 160,1 hours versus
 
approximately 150 hours on 2018. Similar 
analysis on HSCs co-cultured with the intermediate supportive 2012 stroma revealed similar 
kinetics for at least the first two generations (the T50%
2012-Gen0
 was 58,8 hours, the T50%
2012-Gen1
 
approximately 92 hours and the T50%
2012-Gen2
 was 124 hours) (Figure 5.7B). This shows that 
the divisional kinetics of HSCs under co-culture with different stromata are similar for the 
initial generations (except generation 2 between HSC cultured on AFT024 or 2012). 
However, comparison with stroma-free cultures revealed faster kinetics for dividing HSCs, 
since the T50%
stroma free-Gen0 
value was 34,9 hours, the T50%
stroma free-Gen1
 value was 56,2 hours 
and the T50%
stroma free-Gen2
 value was 77,7 hours (Figure 5.7C). These results imply that 
although the cell fates of HSCs are influenced by the type of the microenvironment (different 
stroma cell lines), the cell cycle progression is influenced by stromal co-culture, but is 
independent of the tested stroma types.  
 
 
 
 
  
- 55 - 
 
 
- 56 - 
 
Figure 5.7. The divisional kinetics of HSCs over different generations are independently of the 
co-cultured stroma. A. Generation-based comparison of divisional kinetics between HSCs cultured 
on AFT024 (7 experiments, 232 trees) and 2018 stroma (5 experiments, 74 trees). B. Similar analysis 
comparing the kinetics between HSCs cultured on AFT024 and 2012 (3 experiments, 54 trees) or C. 
stroma-free conditions in serum-free media supplemented with stem cell factor (SCF) and 
thrombopoietin (THPO) (3 experiments, 124 trees).  
 
5.2 The effect of AFT024 stroma upon less primitive 
hematopoietic populations 
We next sought to investigate the effects of the Dexter-type co-cultures on different 
multipotent progenitor cell populations (MPPs). The current marker combinations used for 
HSC isolation result in a heterogeneous mix of cells containing only 50% HSCs (Kiel et al., 
2005). It is postulated that the remaining 50% of non-stem cells mainly consist of some kind 
of progenitor cells. Therefore, these experiments would allow us to identify the specificity of 
the AFT024-mediated effects on the stem cell compartment.  
5.2.1 AFT024-based cultures also promote survival of co-cultured MPP 
populations 
 
For this reason, we sorted different MPP populations and co-cultured them with the 
fetal-liver stroma. Early MPPs were identified as CD150+ CD48- CD34+ KSL and late 
MPPs as CD150-CD48+CD34+ KSL. Our experimental approach revealed that 54,5%±6,0% 
of early MPPs divided when co-cultured with the AFT024 stroma, and 45,1%±5,2% died 
(Figure 5.8A). In contrast 18,6%±16,8% of the late MPP divided on AFT024 with the 
remaining 81,5%±16,8% dying. As shown in figure 5.8B, the majority of early/late MPPs 
died at the initial generation, when co-cultured with the 2018 stroma. 
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Figure 5.8. AFT024-based culture support intermediate levels of survival of co-cultured MPPs. 
A. Bar graphs represent the percentage of single HSC (CD150+CD34-CD48-KSL) and MPP 
populations (early MPPs are CD150-CD34+CD48-KSL, late MPPs are CD150-CD34+CD48+KSL) 
following different fates (division, cell death or non-dividing cells) upon co-culture with AFT024 
supportive cells in generation 0. Mean ±SD of 4 experiments with 213 early MPP trees, and 3 
experiments with 150 late MPP trees. B. The same analysis on 2018 stroma. Mean ±SD of 3 
experiments with 257 early MPP trees and 184 late MPP trees. **p<0,01.  
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Analysis of later generations showed high levels of division, (76,6% ±7,0% of 
generation 1 and 80,9% ±8,1% of generation 2) for early MPPs (Figure 5.9A). The progeny 
of late MPPs also showed high divisional rates, with 73,6% (±30,7%) and 88,2% (±11,5%) of 
cells dividing in generation 1 and 2 respectively. The complementary analysis of the cell-
death rates confirmed that after the initial high frequencies of dying cells (Generation 0), co-
cultured cells had similar levels of observed cell death in later generations (Figure 5.9B). 
These results imply the presence of an early selection mechanism based on the primitiveness 
of the co-cultured hematopoietic cell populations. After this selection, the progeny of 
surviving cells is then equally supported in AFT024 co-cultures. 
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Figure 5.9. AFT024 co-cultures also support survival of progenitor cells, after initial selection. 
A. Bar graphs represent the percentage of single dividing HSC (CD150+CD34-CD48-KSL) and MPP 
populations (early MPPs are CD150+CD34-CD48+KSL, late MPPs are CD150-CD48+CD34+KSL) 
upon co-culture with AFT024 supportive cells over different generations. They are the mean of 4 
experiments for early MPP trees (213 early MPP trees for generation 0, 227 trees for generation 1 and 
321 for generation 2) and 3 experiments for late MPP (150 late MPP trees for generation 0, 59 trees 
for generation 1 and 82 for generation 2). B. The same analysis for dying HSCs and MPP cultured on 
2018 stroma over different generations. Bars are the mean of 4 experiments for early MPP trees and 3 
experiments for late MPP. Error bars are ±SD, **p<0,01. 
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5.2.2 HSCs and MPPs divisional and cell-death kinetics on AFT024 and 
2018 stroma 
 
The comparison of the HSC and MPP fates cultured on AFT024 stroma over different 
generations revealed that the main differences occurred in the percentage of dividing/dying 
cells in generation 0. However, such analysis provides no information about the experimental 
time required for cells to divide or die. For this reason, I further analyzed the divisional and 
cell-death kinetics of HSCPs and MPPs cultured under supportive conditions, in order to 
identify potential differences. 
According to our analysis, 50% of generation 0 HSC on AFT024 stroma needed 50,4 
hours (T50%
HSC-Gen0
) to divide, whereas early and late MPPs needed 40,1 hours (T50%
early MPP-
Gen0
) and 31,3 hours (T50%
late MPP-Gen0
), respectively (Figure 5.10A). This suggests that more 
primitive cells require longer time periods before they divide. This trend was less obvious in 
generation 1, in which HSCs needed 94,9 hours to divide further, early MPPs 84,5 hours and 
late MPPs 86.9 hours. Finally, in generation 2, HSCs required 160,1 hours before their 
second division, early MPPs 140 hours and late MPPs 137,9 hours. Analysis of the cell-death 
kinetics confirmed the finding that more primitive cells also require longer time to cell death , 
since generation 0 HSCs died at 30 hours, early MPPs at 7,7 and late MPPs at 4,1 hours 
(Figure 5.10B). Furthermore, generation 1 HSCs died at around 113,9 hours, early MPPs at 
79,8 hours and late MPPs at 4,1 hours. Finally, generation 2 HSCPs died at 172,8 hours, early 
MPPs at 128,3 and late MPPs at around 120 hours. These results illustrate that AFT024 co-
cultures synchronise the cell-cycle progression of co-cultured HSCs and MPPs after their first 
division.   
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Figure 5.10. Divisional and cell-death kinetics correlate with the primitiveness of the co-cultured 
population, with less primitive cells having faster kinetics. A. Generation-based comparison of the 
divisional kinetics between HSCs (7 experiments, 232 trees), early MPPs (3 experiments, 116 trees) 
and late MPPs (3 experiments, 45 trees) on AFT024 stroma over the initial three generations. B. 
Similar analysis comparing the kinetics between HSCs (3 experiments, 54 trees), early MPPs (3 
experiments, 96 trees) and late MPPs (3 experiments, 149 trees) cultured on AFT024 stroma.  
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5.3 Is cell-to-cell contact required for the effect of AFT024 
stroma?  
 The unique molecular signature of the HSC maintaining stroma (AFT024) was 
revealed by functional genomics (cDNA subtracted library) and bioinformatics analysis 
(Hackney et al., 2002). It was later confirmed by microarray experiments (Charbord and 
Moore, 2005). These analyzes revealed almost 1000 genes preferentially or exclusively 
expressed by the AFT024 stroma when compared with non-supportive lines (2018, BFC012). 
The reported genes were classified in different categories, such as genes coding for 
membrane molecules, extracellular matrix-related proteins, secreted factors, cytoskeleton-
related proteins and transcription factors. However, given the large number of differentially 
expressed genes, the selection of relevant molecules for HSC maintenance requires additional 
filtering mechanisms. Elucidating the necessity of secreted factors versus adhesion molecules 
would allow better filtering of the long list of candidate genes and more efficient stroma 
manipulation.  
 
5.3.1 Absence of active migration towards the AFT024 stroma 
 
 Among the differentially expressed genes, several chemokines were reported. 
Chemokines are secreted proteins with the ability to trigger active migration (chemotaxis) 
towards the secreting cell. In order to functionally investigate whether AFT024 stroma 
secretes chemokines (or other molecules) capable of attracting HSCs, HSCs were plated on 
sparsely seeded AFT024 stroma and monitored through time-lapse microscopy. As a positive 
control, HSCs were plated on sparsely seeded PA6 stroma, where they were monitored to 
actively migrate towards PA6 cells (Figure 5.11, Dirk Loeffler, personal communication). On 
the contrary, no migration of HSCs was observed towards AFT024 cells. In addition, HSCs 
plated on gelatin-coated surface between AFT024 and 2018 showed no migration towards 
AFT024 stroma. Collectively, we report no detectable chemokine activity from the AFT024 
stroma on freshly shorted murine HSCs, therefore excluding the possibility that they play a 
key role in the reported interaction.  
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Figure 5.11. Example of active migration of HSCs towards PA6 stroma cell. Continuous time-
lapse imaging of sparsely seeded PA6 cells (highlighted by the yellow arrow) co-cultured with HSCs 
(bright dots). Image was acquired with a 10x Plan-Neoluar objective. Phase contrast images were 
acquired and kindly provided by Dirk Loeffler. 
 
5.3.2 AFT024 conditioned media exhibit minor effects upon HSC cell fates  
 
To identify whether cell to cell contact or signaling by soluble factors is the 
predominant mechanism through which AFT024 stroma maintains HSCs, I performed 
experiments with exchange of conditioned media. In those assays, media from cultured 
AFT024 stroma (conditioned media) was collected and used to substitute media of co-
cultures of HSCs with the 2018 cells (Figure 5.12A). Co-cultures without media exchange 
were used as controls. 
Our analysis showed that 34,3% ±3,5% versus 26,2%±4,0% of HSCs  divided with 
conditioned media versus control. 65,2%±2,9% died (versus 70,8%±5,4% in the control) and 
0,5%±1,0% survived without division (versus 3,0%±3% in the control) (Figure 5.12B). 
Similarly, 28,4%±3,2% of HSCs exposed to 4 days AFT024-conditioned media divided, 
70,3%±2,1% died and 1,3%±0,5% survived without dividing. These results from the 2-day 
conditioned media revealed a slight increase in the divisional rates of “generation 0” HSCs in 
AFT024 conditioned medium leading to the conclusion that factors secreted by the AFT024 
stroma can improve HSCs’ survival, although the effect is only minor. Further analysis of 
later generations revealed no statistically significant increase of the survival rates of HSC 
progeny (Figure 5.12C). Interestingly, the percentage of cell death decreased in the presence 
of AFT024 conditioned media for cells in generation 1 and 2 (Figure 5.12D). However, the 
reduced levels of dying cells did not lead to dividing cells, but to cells that survived without 
further division (possibly senescent cells). 
These results illustrate that factor(s) secreted from the AFT024 stroma have only 
minor effects on the survival and proliferation of freshly purified HSCs and their progeny. 
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The main mechanism supporting HSC survival and cell cycle progression maintenance by 
AFT024 stroma therefore is through cell adhesion. However, since the stability of potential 
secreted factors contained in the conditioned media can be irreversibly damaged during 
isolation, additional assays were necessary to confirm these results. 
 
Figure 5.12. AFT024-derived secreted factors have only limited influence on HSCs fates. A. 
Schematic representation of the experimental approach. B. Percentage of tracked HSCs (generation 0) 
following different fates (division, cell death or non-dividing cells) in co-cultures with 2018 stroma in 
the presence or absence of conditioned media from AFT024 stroma cells. Mean of 5 experiments of 
264 trees for HSCs cultured on 2018 stroma without media change (white bars), 3 experiments of 127 
trees for HSCs cultured on 2018 stroma with AFT024 conditioned media for 2 days (dark grey bars) 
and 3 experiments of 165 trees for HSCs cultured on 2018 stroma with AFT024 conditioned media 
for 4 days (light grey bars). C. Generation-based analysis depicting the numbers of HSCs and their 
progeny that divided over the first three generations under conditions mentioned in panel B. D. 
Similar analysis as in panel B with the number of HSCs and their progeny that died over the first 3 
generations.  Error bars are SD.  
 
5.3.3 Cell adhesion is the predominant mechanism mediating the AFT024 
effect on HSCs 
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To cope with the potential stability issues of the secreted factors contained in the 
collected conditioned media, I applied an alternative method of stable media conditioning. 
HSCs were cultured on 2018 stroma, while being exposed to media stably conditioned by 
AFT024 cells. A silicon insert was used to physically separate the two different stroma types 
(Figure 5.13A). Freshly isolated HSCs were then cultured on top of the 2018 stroma plated 
inside the silicon insert, while being exposed to the media produced and conditioned from the 
AFT024 stroma. It is important to note that the inner surface of the silicon insert is 0,42cm
2
, 
while the culture area of the entire well (of a 12-well plate) is around 8 times bigger (3,5cm
2
). 
HSCs cultured in contact with 2018 while exposed to AFT024-conditioned media 
showed a 1,5-fold increase in survival/proliferation (dark grey bar – Figure 5.13B) and 
reduced levels of cell death. In more detail, 42,1%±2,7% of HSC divided (versus 
27,9%±3,2% in the control), 56,8%±4,5% died (versus 71,6%±5,8%) and 1,08%±1,86% 
survived without division (versus 3,0%±3,0%). Further analysis of later generations showed 
no significant increase in the levels of division for generation 1, since 19,0%±6,4% cells 
divided (Figure 5.13C, grey bars) compared to in the control (14,9%±6,8%) (Figure 5.13C, 
white bars) and generation 2 cells (19,1%±8,3% versus 12,3±11,6% in the control), 
suggesting that factor(s) secreted by AFT024 have only a transient positive effect upon HSC 
proliferation.  
Generation-based analysis of the cell-death rates showed a trend of reduced number of 
dying cells, however results were not statistically significant. In generation 1, the percentage 
of dying cells was 65,0%±23,0% (versus 82,8%±7,6% in the control) with that of generation 
2-dying cells being 42,9%±28,6% (versus 81,0%±20,7% in the control) (Figure 5.13D). 
These results, thus, confirm that our previous finding from the conditioned media 
experiments that: 1. AFT024-secreted factors can only partially rescue HSC survival and 2. 
adhesion molecule(s) are the main mediators of the AFT024-mediated maintenance of co-
cultured HSCs. 
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Figure 5.13. AFT024-derived secreted factor(s) partially rescue survival of co-culture HSCs. A. 
Graphical presentation of the experimental approach. B. Bar graphs depicting the percentage of 
“generation 0” HSCs following different cell fate under co-culture with AFT024 stroma only (n=7, 
290 trees, black bars), 2018 stroma only (n=5, 264 trees, white bars) or on 2018 stroma with AFT024 
stably conditioned media (n=3, 194 trees, grey bars). C. Bar graphs representing the percentage of 
dividing HSCs and their progeny cells for the first three generations after plating under the conditions 
mentioned above. D. Similar analysis of the percentage of dying cells over different generations. 
Errors bars are ±SD, *p<0,05.   
 
5.3.4 AFT024 stroma cells are essential for HSC survival 
 
To further investigate the importance of cell adhesion for HSC survival and 
subsequently for AFT-mediated maintenance, I performed stroma-free HSC cultures using 
fresh or conditioned Dexter media. In those experiments, HSCs were cultured without stroma 
in media conditioned by AFT024 (three or four days). In some cases, different coating 
proteins (gelatin, fibronectin) were used to minimize migration during the time-lapse 
imaging. All HSCs plated in gelatin-coated wells, fibronectin-coating wells or non-coated 
wells with fresh media died in generation 0. The same was observed for HSCs cultured in 
AFT024-conditioned media on fibronectin-coated wells (98,89% death), gelatin-coated wells 
(100% death, n=1, 9 trees) or uncoated plates (100% death, n=2, 63 trees) (summarized in 
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Figure 5.14A). In addition, all generation 0 HSCs cultured in 2018-conditioned media also 
died (Figure 5.14A, white bars). These results clearly illustrate the importance of the stroma 
and the prevalence of adhesion molecules as the key mediators of the AFT024-driven 
maintenance of HSCs in vitro. 
Interestingly, analysis of the cell-death kinetics revealed differences between the 
different conditions. HSCs cultured with the AFT024-conditioned media survived longer 
before they eventually died suggesting that the AFT024-produced secreted factors can delay 
but not inhibit HSC death. In conclusion, adhesion to the stroma is essential for long-term 
survival and proliferation. 
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Figure 5.14. Adhesion to AFT024 stroma cells is essential for HSCs survival in Dexter-type in 
vitro cultures. A. Bar charts representing the percentage of dying HSCs cultured in fresh Dexter 
(black bars, 4 experiments, 104 trees), AFT024 conditioned media for 4 days (grey bars, 3 
experiments 54 trees) or 2018 conditioned media (white bars, 1 experiment, 27 trees). B. Dot plots 
representing the number of dying HSCs cultured in stroma-free cultures supplemented either with 
fresh Dexter media, AFT024-conditioned media or 2018-conditioned media. Black lines represent the 
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median and the statistical test was one-way analysis of variance (Kruskal-Wallis test with Dunn’s 
post-hoc test). ***p<0,001, *p<0,05  
 
5.4 Is the differential HSC behavior a result of a positive effect 
from AFT024 or a negative effect from 2018 stroma? 
The observed differential HSC behaviors (division on the AFT024 stroma, cell death 
on the 2018 stroma) could be explained either by a molecule promoting survival and 
proliferation expressed exclusively by the AFT024 stroma (positive effect, Figure 5.15A) or 
by the presence of a factor leading to cell death expressed only by the 2018 stroma (negative 
effect, Figure 5.15B). Alternatively, a combination of both scenarios could also be possible 
(Figure 5.15C). Identifying the “direction” of the observed differential HSC behavior upon 
co-culture with the different stroma cells (survival on AFT024, cell death on 2018) could be 
an additional layer for screening the published gene lists (Hackney et al., 2002; Charbord and 
Moore, 2005) for molecules with a profile matching our observations. Potential synergistic 
effects requiring the presence of more than one factors to promote an effect on co-culture 
HSCs’ cell fates are also possible. 
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Figure 5.15. Possible scenarios explaining the differential behavior of HSCs upon co-culture 
with AFT024 or 2018 stroma. A. In the first scenario AFT024 stroma cells express a molecule 
promoting long-term survival and proliferation of co-cultured HSCs, whereas its absence from the 
2018 stroma leads to the observed cell death (positive effect from AFT024). B. In the second scenario, 
2018 stroma expresses a factor leading to HSCs cell death (negative effect from 2018). AFT024 
stroma does not express this factor, thus HSCs survive. C. The last scenario is a combination of both 
previous scenarios, with both a positive pro-survival and proliferation effect from AFT024 and a 
negative effect leading to cell death from the 2018 stroma. Synergistic effects, in which more than one 
molecules/interactions are essential to lead to a cell fate are possible, but not depicted in this figure for 
simplicity reasons. 
   
5.4.1 Secreted factor(s) produced by the 2018 stroma have minor negative 
effects upon HSC survival and proliferation 
 
 As we report in the current study, bone marrow-derived HSCs die when co-cultured 
with 2018 stroma in Dexter-type culture in vitro. To investigate whether the 2018 stroma 
promotes death of co-cultured HSCs, I first tested 2018-conditioned media for negative 
regulators of survival/proliferation.  
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To do this, I used the conditioned media assay, in which HSCs were exposed to 2018-
conditioned media while having direct physical contact with AFT024. Analysis of the results 
revealed no statistically significant difference from the controls. In more detail, Figure 5.16A 
shows that 78,1%±10,6% of the HSCs co-cultured with AFT024 and exposed to 2 days 2018-
conditioned  media divided (versus 82,6%±3,3% in the control), 12,6%±8,8% underwent cell 
death (versus 11,9%±5,1% in the control) and 9,3%±6,0% survived without division (versus 
5,6%±3,8% in the control). In addition, 67,6%±9,3% of HSCs exposed to 4 days 2018-
conditioned media divided, 28,7%±6,0% died and 3,8%±4,0% survived without division 
(Figure 5.16A). These results suggest that potential factors secreted from the 2018 stroma 
cells have only a minor negative effect upon HSCs survival, or their influence is surpassed by 
a positive AFT024 factor.  
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Figure 5.16. 2018-conditioned media has minor effects on the balance between proliferation and 
cell death of co-cultured HSCs. A. Schematic representation of the experimental approach. 2018 
stroma cells were irradiated and cultured in Dexter media for two or four days. Then, conditioned 
media was collected and added in the cultures of freshly sorted HSCs (via flow cytometry) with 
AFT024 stroma cells. B. Bar graph representing the percentage of HSCs followed a certain fate in 
generation 0. HSCs were either co-cultured on AFT024 stroma i) without any conditioned media 
exchange (black bars, 7 experiments, 290 trees), ii) with 2018 media conditioned for two days (grey 
bars, 3 experiments, 186 trees) or iii) with 2018 media conditioned for four days (white bars, 3 
experiments, 148 trees). C. Bar graphs depicting the percentage of dying cells under the conditions 
mentioned above (same colour-code) over different generations. Error bars are ±SD. 
 
 Additional experiments in which the culture media was continuously conditioned by 
2018 stroma cells being physically separated by the AFT024 stroma, were also conducted 
(Figure 5.17A). In those assays, HSCs were cultured in direct contact with the AFT024 
stroma and their cell-fate decisions were monitored over the first three generations. No 
differences in the behavior of generation 0 HSCs cultured under those conditions was 
observed, since 82,8%±5,0% divided (compared to 80,0%±8,0% in AFT024 conditions), 
14,2%±6,9% died (compared to 15,8%±8,0%) and 2,1%±2,6% survived without divisions 
(compared to 4,2%±4,4%) (Figure 5.17B). Further analysis of the HSCs progeny revealed 
that cells cultured on AFT024 stroma while exposed to factors secreted by 2018 stroma had 
no difference in the cell-death rates for the first three generations, from cells cultured 
exclusively on AFT024 stroma and media (Figure 5.17C). In more detail, 22,4%±12,4% of 
generation 1 cells died (compared to 18,6%±5,9% in the control conditions), while 
11,1%±9,0% of generation 2 cells also did not survive (compared to 22,8%±6,6% in the 
control). It is important to note that under those culture conditions, the percentage of dividing 
cells in generations 1 and 2 was decreased (compared to the control conditions), while the 
percentage of non-dividing cells increased (data not shown). However, since the levels of cell 
death observed in this assay were not altered, we suggest that factors secreted by 2018 do not 
have any effect on the balance between proliferation and cell death of cultured HSCs.  
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Figure 5.17. Factor(s) secreted by 2018 stroma cells does not alter the survival of co-cultured 
HSCs. A. Graphical representation of the experimental approach. HSCs were isolated via flow 
cytometry and cultivated in contact with AFT024 stroma in media constantly conditioned by spatially 
separated 2018 stroma cells. B. Bar graphs showing the percentage of HSCs following different cell 
fates in generation 0, under different conditions. HSCs were cultured on i) AFT024 stroma cells 
exclusively (black bars, 7 experiments, 290 trees), ii) on AFT024 stroma with factors mostly secreted 
by 2018 stroma (grey bars, 3 experiments, 141 trees) or iii) 2018 stroma exclusively (white bars, 5 
experiments, 264 trees). C. Analysis of the percentage of dying cells over different generation in the 
conditions mentioned above (same colour-code). Error bars are ±SD. 
 
5.4.2. Quantifying the cell-fate decisions of HSCs cultured in mixed stroma 
conditions  
 
Since 2018-secreted factors have only minor influence in the cell death of co-cultured 
HSCs, I then sought to investigate the role of 2018-derived adhesion molecules. For this 
reason, I cultured HSCs in a mixed environment comprising of different percentages of 
supportive and non-supportive stroma cells. This analysis revealed that, in a mixed 
environment consisting of 90% AFT024 stroma and 10% 2018 stroma, the majority of the 
HSCs divided (75,8%±4,9%, Figure 5.18, dark grey bars), whereas some died (22,0%±7,9) 
and few survived without division (4,4%±6,0%), showing a slight decrease compared to the 
described behavior on 100% AFT024 (Figure 5.18, black bars). Altering the percentage of the 
mix (50% AFT024 stroma - 50% 2018 stroma) resulted in a significant decrease of the 
divisional rate of HSCs (57,1%±4,0%, grey bars) and in an increase of cell-death rate 
(20,9%±8,7%). Additional decrease in the percentage of supportive cells (10% AFT024 - 
90% 2018) caused additional decrease in the levels of HSC division (23,8%±7,4%, light grey 
bars) and increase in cell death (72,9%±7,7%)  to levels similar as HSC cultured in 100% 
2018 (Figure 5.18). Notably, these experiments revealed that supportive and non-supportive 
cells control HSC fates in a dose-dependent manner, but they provide no information 
regarding the “direction” of the interaction. 
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Figure 5.18. Adhesion to mixed stroma consisting of AFT024 and 2018 cells in different ratios 
has a dose-dependent effect upon the observed HSCs’ cell-fate decisions. Bar graphs representing 
the percentage of dividing (left panel) or dying HSCs (right panel) upon co-culture with a mixed 
environment of 90% AFT024 and 10% 2018 cells (dark grey bars, 6 experiments, 231 trees), 50% 
AFT024 and 50% 2018 cells (grey bars, 4 experiments 122 trees) or 10% AFT024 and 90% 2018 
cells (light grey bars, 4 experiments 132 trees). Co-cultures with exclusively AFT024 (black bars) or 
2018 cells (white bars) were used as controls.  
 
5.4.3. Quantifying the adhesion of HSCs to the different stromata under 
mixed culture conditions 
 
In order to observe the entire cell volume, cells from the different stromata were 
transduced with lentiviral vectors expressing fluorescent reporters (distinct for each cell line) 
fused with a membrane anchoring signal (c-HA-Ras farnesylation signal). This enabled us to 
quantify the time for which HSCs adhere to AFT024-tdTOMATO expressing cells or 2018-
mseCFP expressing cells in a 50%-50% mixed environment and correlate it with their future 
fate through time-lapse imaging (Figure 5.19A). This analysis revealed that dividing mother 
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HSC were adherent mostly to AFT024 cells (75,5% of their lifetime) and less to 2018 
(17,0%) (Figure 5.19B). On the contrary, dying cells stayed longer adherent to 2018 (60,3%) 
and less to AFT024 (19,6%).  These results directly link stroma adherence with the future 
fate of HSCs, but again the direction of the effect has not been clarified. 
Figure 5.19. Stroma adherence determines the fate of co-cultured HSCs. A. Snapshot from time-
lapse imaging experiment showing the different acquired wavelengths in addition to phase contrast. 
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Cells from different stromata were differentially transduced with lentiviral vectors expressing distinct 
fluorescent proteins fused with membrane anchoring domains. AFT024 stroma cells were transduced 
with constructs expressing tandem TOMATO protein, whereas 2018 cells with mseCFP protein. The 
membrane anchoring signal allows visualisation of the entire cell volumes (for example cell 
protrusions). HSCs were isolated from the  B6J;129-Tg(CAG-EYFP)7AC5Nagy/J mouse strain, 
therefore expressing YFP B. Bar chart representing the percentage of the cell life time, for which 
dividing (left panel) or dying HSCs (right panel) were adherent to AFT024 (black bar) or 2018 stroma 
(white bar) or both (grey bar) (47 trees). 
 
5.4.4. Adhesion to 2018 stroma does not result in immediate cell death of 
co-cultured HSCPs 
 
 We have previously shown that the observed death of co-cultured HSCs does not 
occur due to factors secreted by the 2018 stroma. To investigate whether adhesion molecules 
are responsible for the observed high cell-death rates of HSCs cultured on 2018 stroma, I 
further analyzed the cell-death kinetics under different conditions. A direct negative effect of 
2018 stroma upon co-cultured HSCs would decrease their life time (faster occurrence of cell 
death) when compared to other culture conditions.   
 To test this, freshly sorted HSCs were cultured in medium allowing self-renewal and 
some survival for short culture periods (serum free media with stem cell factor and 
thrompbopoietin) (Ema et al., 2000) or in co-culture with different stroma cells (AFT024, 
2012, 2018). Analysis of the cell-death kinetics revealed that HSCs that died in co-cultures 
with 2018 stroma exhibited the longest cell-life time of all groups tested, since the 50% value 
(T50%
2018-Gen0
) was 45,6 hours after culture initiation (Figure 5.20). The respective values for 
dying HSCs cultured on AFT024 were 30 hours, on 2012 19,5 hours and on stroma-free 
conditions 35,30 hours (Figure 5.20). Notably, almost half of the HSCs cultured on 2018 
stroma lived for more than 100 hours after culture initiation, whereas very few of the dying 
cells in the other conditions survived that long. These data allows us to propose that it is 
rather the absence of a positive factor promoting survival and proliferation (on e.g. AFT024 
cells), rather than a cell-death promoting factor on the 2018 stroma which leads to the 
observed death of co-cultured HSCs. However, knock down of certain candidate molecules 
expressed by the AFT024 stroma which affect HSC survival and proliferation is required to 
further strengthen this model.  
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Figure 5.20. Long cell life time of HSCs dying on 2018 stroma reveals the absence of a negative, 
adhesion factor leading to cell death of co-cultured cells. Dot plot depicting the cell life time of 
dying HSCs under different culture conditions. HSCs were cultured on AFT024 (7 experiments, 49 
trees), 2018 (5 experiments, 184 trees), 2012 (3 experiments, 75 trees) or under stroma-free conditions 
(4 experiments, 104 trees).  
 
5.5. Identification of key molecule(s) promoting HSC survival and 
in vitro maintenance  
Continuous, time-lapse imaging at the single-cell level enabled us to get an improved 
understanding of the type and kinetics of HSC behavior induced by AFT024 stroma, as well 
as of the cellular interactions involved. This allowed us to generate a profile of the candidate 
molecules governing the observed HSC behavior in Dexter-type co-cultures, with cell surface 
proteins promoting survival, proliferation and/or self-renewal being the most promising 
candidates. To test their function robust molecular manipulation of stromal cells was 
required. 
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5.5.1. Confirming the published lists of differentially expressed genes 
between AFT024 and 2018 stroma cells 
 
 The published lists of genes which are preferentially or exclusively expressed on the 
AFT024 stroma were identified using subtractive libraries (Hackney et al., 2002) and micro-
array analysis (Charbord and Moore, 2005). These high-throughput approaches enable 
processing of large amounts of data, but lack sensitivity of complementary methods, such as 
the quantitative real-time PCR (qRT-PCR). Thus, confirmation of the differential expression 
of genes matching our time-lapse imaging observations (transmembrane, cell surface or 
extracellular matrix molecules promoting survival/proliferation or block 
apoptosis/differentiation) was performed by qRT-PCR, prior to the molecular manipulation 
of the AFT024 supportive stroma.  
Intron-separated (if applicable) gene-specific PCR primers were designed for each 
gene of interest (340 primers designed, 170 genes checked in total). For this analysis, non-
irradiated AFT024 cells were compared with non-irradiated 2018. Since our in vitro, time-
lapse data illustrated the importance of adhesion molecules, I focused on genes coding for 
membrane-bound and extra-cellular matrix (ECM) proteins. qRT-PCR experiments 
confirmed the published gene lists for the Rho, GDP dissociation inhibitor (GDI) beta 
(Arhgdib), transmembrane 4 superfamily member 1(Tm4sf1), plasminogen activator 
urokinase receptor (Plaur), vascular cell adhesion molecule 1 (Vcam1), thrombospondin 2 
(Thbs2), decorin (Dcn), matrix metalloprotease 9 (Mmp9), dermatopontin (Dpt), fibroblast 
activation protein (Fap), collagen type VI, alpha 3 (Col6a3), transforming growth factor, beta 
induced (Tgfbi) and lysyl oxidase-like 1 (Loxl1), which were found to be preferentially 
expressed by the AFT024 stroma and showed less than 30-fold difference in expression 
between the two stromata (Figure 5.21A). Genes showing higher fold differences were also 
revealed, such as the delta-like 1 homolog (Dlk1), solute carrier organic anion transporter 
family, member 2a1 (Slc02a1), solute carrier family 38, member 4 (Slc38a4), biglycan (Bgn), 
insulin-like growth factor binding protein 6 (Igfbp6) and pentraxin related gene (Ptx3) 
(Figure 5.21B). To better mimic the co-culture conditions, I also analyzed irradiated stroma 
cells cultured for two days in modified “Dexter” media. This approach further confirmed the 
differentially expressed genes shown before in non-irradiated stroma cells, but revealed lower 
fold differences between the irradiated AFT024 and 2018.  
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Importantly, only approximately 20% of the published genes could be confirmed by 
qRT-PCR experiments as being differentially expressed between the two different stroma cell 
lines. 
Figure 5.21. Quantitative real-time PCR analysis confirms differentially expressed genes 
between AFT024 and 2018 stroma. Bar graphs showing the fold difference (ΔΔCt method) in the 
gene expression between non-irradiated or irradiated AFT024 versus 2018 stroma, at the RNA level 
(n=3). Differentially expressed genes with differences between 2- and 30 fold are shown in figure A 
and above 30-fold in figure B. Error bars are ±S.D. 
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5.5.2. Gene-specific shRNAs viral constructs for stroma manipulation 
 
The next step after confirming the differentially expressed genes, was to generate 
shRNA constructs targeting the relevant molecules. Since the properties of available shRNAs 
(knock-down efficiency, off-target effects, stability) are cell-type dependent, multiple 
shRNAs (four to six) were designed against each gene through the online shRNA library of 
the Broad Institute (“The RNAi Consortium shRNA Library”). The gene-specific shRNA 
sequences are provided in the Materials and Methods section. Next, shRNA oligonucleotides 
were introduced into lentiviral backbones and viruses expressing the shRNA of interest were 
generated.  
  
5.5.3. Stroma manipulation via viral transduction with shRNA constructs 
 
 Generating stroma cells with stable expression of the viral constructs was an 
important step to assess the roles of selected genes on fates of co-cultured HSCs. For this 
reason, lentiviral vectors were implemented, in which shRNA expression was driven by the 
human U6 promoter (transcription via RNA polymerase III). To distinguish transduced from 
non-transduced stroma cells, a fluorescent reporter protein (tandem dimer TOMATO) was 
driven by the human phosphoglycerate kinase (PGK) promoter (Figure 5.22A). This allowed 
us to use flow cytometry to isolate transduced cells (co-expressing the the tdTOMATO 
fluorescent protein with the gene-specific shRNA). Interestingly, stroma cells were easy to 
transduce (Figure 5.22B), since relatively low MOIs (multiplicity of infection) of 5 to 10 
already resulted in high transduction efficiency (usually higher than 75%). Importantly, 
stroma cells sorted for the expression of tdTOMATO maintained its expression after several 
passages and multiple thawing/freezing rounds (data not shown). 
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Figure 5.22.  Lentiviral vectors enable robust expression of transgenes in fetal-liver derived 
stroma cells transduced with low MOI’s. A. Schematic depiction of the viral construct used for 
shRNA and fluorescent-reporter expression. B. Flow cytometric analysis of AFT024 stroma cells 
transduced with different shRNA vectors at a MOI of 5. The indicated gate was used for sorting of 
transduced tdTOMATO positive cells. 
 
5.5.4. Identification of the most efficient shRNA  
 
 The quantification of the knock-down efficiency of different shRNAs designed 
against selected genes was accomplished by flow cytometry, immunoblot or qRT-PRC 
analysis. Flow cytometry allows fast quantification of relative protein levels in large 
populations at the single-cell level. A prerequisite for such analysis is the existence of 
specific antibodies against the protein of interest suitable for flow cytometric analysis. Such 
analysis was pursued for membranes proteins (such Dlk1). 
The results of the analysis of AFT024 cells transduced with shRNA constructs against 
DLK1 are depicted in Figure 5.23A,B. Non-transduced AFT024 and 2018 cells were used to 
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assess the levels of the DLK1 protein in wild-type cells. AFT024 stroma cells transduced 
with a scrambled shRNA control construct had no alteration in DLK1 expression. Six shRNA 
constructs against DLK1 were tested; the best clone reduced DLK1 expression by 11 folds 
(3125 versus 285 mean intensity in wild type versus transduced cells, Figure 5.23A bottom 
right plot and 5.23B green histogram). It is important to note that reduced DLK1 levels 
remained stable in the transduced stroma cells even after series of cell passages and repetitive 
rounds of cell freezing/thawing (data not shown).  
Figure 5.23.  Quantification of the knock-down efficiency of different shRNA clones against 
delta-like homolog 1 (Dlk1). A. Density plots of wild-type, non-transduced AFT024, 2018 stroma 
cells as well as transduced stroma with scrambled shRNA control and one clone against DLK1 
protein. Gate design was based on negative controls and the percentages of each population are 
shown. Thirty thousand cells were acquired for each analysis. B.  Histogram showing DLK1 
expression of the stroma shown in panel A. 
In the case of DPT and FAP detection, the use of currently available FACS antibodies 
was problematic (minor shifts in stained sample versus unstained control, even after long 
incubation periods). Also, immunoblot analysis showed unspecific binding of the used 
antibodies (data not shown). For this reason, quantification of the knock-down efficiency of 
the different shRNAs against DPT and FAP was performed by qRT-PCR, in the RNA level. 
Such analysis has often been used to determine the efficiency of different shRNA against a 
gene of interest (Kim et al., 2006). In addition, qRT-PCR analysis of the shRNA clones 
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against DLK1 verified our previous FACS results regarding the most efficient shRNA clone 
(data not shown). 
qRT-PCR analysis of shRNA clones against Dpt showed that stroma cells transduced 
with clone 3 had low relative Dpt expression (Figure 5.24A). Interestingly, clone 3 reduced 
Dpt expression to levels comparable to 2018 (Figure 5.24B). Similar analysis for Fap 
expression (Figure 5.24C) revealed that clone 2 is the most efficient leading to 95% knock 
down (Figure 5.24D). Further experiments were therefore conducted only with stroma cell 
lines transduced with the most efficient shRNA clones. 
 
 
Figure 5.24.  Quantification of the knock-down efficiency of different shRNA clones against 
dermatopontin (Dpt) and fibroblast activation protein (Fap). Bar charts showing the relative 
expression of Dpt (A.) or Fap (C.) and the percentage of Dpt (B.) or Fap knock down (D.) on 
AFT024, 2018 and AFT024 stroma transduced with virus containing different shRNA clones. 
Expression was normalised to GAPDH abundance. Bar graphs are the average of three technical 
triplicates.  
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5.5.5. Delta-like 1 (DLK1), dermatopontin (DPT) and fibroblast activation 
protein (FAP) are necessary for the AFT024-mediated survival of HSCs in 
Dexter-type co-cultures 
  
Potential effects of genes found to be differentially expressed between the supportive 
(AFT024) and non-supportive stroma (2018) were first investigated through gene knock-
down approach via gene specific shRNAs. Out of eighteen genes screened in this study, three 
were found important for the AFT024-mediated survival and proliferation of HSCs in Dexter 
type co-cultures. AFT024 stroma cells with reduced levels of delta like 1 (DLK1), 
dermatopontin (DPT) or fibroblast activation protein (FAP) showed reduced potential to 
support HSC survival in vitro. In detail, 58,6% of HSCs co-cultured with DLK1 knocked-
down AFT024 stroma (DLK1
KD
) divided compared to 82,6% in the wild type AFT024 
showing a 1,4 fold reduction (Figure 5.25A). No further decrease in HSCs survival was 
observed upon FACS isolation of the DLK1 negative, AFT024 knocked-down cells (Figure 
5.25A,”-Dlk1 sorted” column). A 1,9- and 2-fold reduction on HSCs’ survival was observed 
upon co-culture with DPT (DPT
KD
) and FAP knocked down AFT024 (FAP
KD
). Interestingly, 
preliminary experiments revealed no additional decrease on HSC survival/proliferation upon 
co-culture with double knocked-down stroma (DLK1
KD
FAP
KD
 or DLK1
KD
DPT
KD
). AFT024 
stroma transduction with scrambled shRNA had no influence on the survival/proliferation of 
co-cultured HSCs (Figure 5.25A, “Scrambled shRNA” column).  
 Analysis of HSCs’ progeny revealed that DLK1, DPT and FAP knock-down had an 
effect also on later generations (Figure 5.25B). These data, together with the increased levels 
of cell death (Figure 5.25C) suggest that knock down of specific genes in the AFT024 stroma 
cell line results in a non-transient impairment of HSC survival/proliferation potential.  
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Figure 5.25. Membrane protein DLK1 and extracellular matrix proteins DPT and FAP are 
essential for HSC survival and proliferation in AFT024-based, Dexter-type long-term cultures. 
A. Bar graphs showing the percentage of dividing or dying “generation 0” HSCs upon co-culture with 
different stroma cell lines, such as AFT024 (7 experiments, 290 trees), AFT024 transduced with 
scrambled shRNA control (3 experiment, 103 trees), AFT024 transduced with shRNAaDlk1clone 1 
(knock-down efficiency 20%, 3 experiments, 179 trees), AFT024 transduced with shRNAaDlk1 clone 
2 (DLK1
KD
, knock-down efficiency 90%, 4 experiments 163 trees), AFT024 transduced with 
shRNAaDlk1 sorted negative for DLK1 expression (knock-down efficiency 100%, 2 experiments, 55 
trees), AFT024 transduced with shRNAaDpt (DPT
KD
 knock-down efficiency 99% measured by qRT-
PCR in the RNA level, 6 experiments, 211 trees), AFT024 transduced with shRNAaFap (FAP
KD
 
knock-down efficiency 95% measured by qRT-PCR in the RNA level, 4 experiments, 109 trees) and 
2018 stroma cells (5 experiments, 264 trees). B. Generation-based analysis of the dividing HSCs and 
their progeny on co-culture with the different stroma cell lines. C. Similar analysis for the dying 
HSCs and their progeny. Error bars are ±SD.  
 
5.5.6. Effect of stroma manipulation upon MPPs  
 
 To further investigate the specificity of the negative effect of the knocked-down 
AFT024 stroma upon the survival/proliferation of co-cultured HSCs, I tested the effect of 
manipulated stroma upon early MPPs. As mentioned in paragraph 5.2.1 (Figure 5.8A), 
AFT024 stroma also supports proliferation of co-cultured MPPs, since 54,5% (±6,0%) of the 
cells divided compared to 80,0% (±8,0%) of HSCs, in generation 0.  
 Comparison of the divisional rates between HSCs and early MPPs co-cultured with 
the DLK1
KD
 stroma (Figure 5.26) revealed a 1,4-fold decrease for HSCs (from 80,0%±8,0% 
to 58,6%±5,9%) and a 1,2-fold increase for MPPs (from 54,5%±6,0% to 64.1%±7,7%). 
Similar comparison for the DPT
KD
 stroma showed a 1,75-fold decrease for HSCs (from 
80,0%±8,0% on AFT024 to 45,6%±6,5% on knocked-down AFT024) and a 4,25-fold 
decrease for early MPPs (from 54,5%±6,0% to 12,8%±2,6% on knocked-down AFT024). 
Finally, for the FAP
KD
 stroma, the divisional rates of HSCs were decreased by 1,8-fold (from 
80,0%±8,0% to 43,5%±8,7%) and 1,3-fold for MPPs (from 54,5%±6,0% to 42,3%±4,3 
respectively). These data suggest that DLK1
KD
 and FAP
KD
 decreased the percentage of 
dividing HSCs while having a minor effect upon early MPPs. In contrast, DPTKD affected 
both HSCs and early MPPs.  
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Figure 5.26. Knocked-down AFT024 stroma also reduced survival/proliferation of co-culture 
early progenitors (MPPs). Bar graphs showing the percentage of dividing HSCs (black bars) or early 
MPPs (grey bars) upon co-culture with different stroma cell lines, including knocked-down AFT024, 
such as DLK1
KD
 (for HSCs: 4 experiments, 163 trees and for early MPPs: 3 experiments, 108 trees), 
DPT
KD
 (for HSCs: 6 experiments, 211 trees and for early MPPs: 3 experiments, 91 trees) and FAP
KD
 
(for HSCs: 4 experiments, 109 trees and for early MPPs: 4 experiments, 184 trees). Error bars are 
±SD. **p<0,01. 
 
5.5.7. Over-expression or exogenous addition of recombinant DLK1, DPT 
or FAP robustly rescue HSC survival on 2018 stroma  
 
 Protein over-expression in non-supportive cells (2018) is a critical step to confirm the 
specificity of the observed effects of DLK1, DPT and FAP on HSCs survival. For this reason, 
2018 cells were transduced with viral vectors containing the open reading frames of Dlk1 or 
Dpt (Fap is currently under construction) under the control of the human PGK promoter. 
Transduced stroma cells were sorted and plated in co-cultures with freshly isolated HSCs, the 
behavior of which was monitored over the first three generations (Figure 5.27). Viral over-
expression of DLK1 (“voDLK1” column) resulted in a 1,9-fold increase of HSC survival of 
generation 0 cells (51,7%±7,6% versus 27,9%±3,2% on 2018). Similar results (2-fold 
increase) were observed from the viral over-expression of DPT upon HSC 
survival/proliferation (60,2%±8,9% versus 27,9%±3,2% on 2018). Interestingly, the levels of 
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cell divisions in the progeny of HSCs were constantly higher than the non-supporting 
conditions (wild type 2018), illustrating that the effect of DLK1 and DPT on HSCs survival 
was robust and stable over generations. 
Exogenous addition of recombinant proteins was also implemented as an alternative 
method to investigate the role of DPT or FAP on HSC survival, without genetic manipulation 
of the non-supportive stroma. Addition of 5ug of recombinant mouse DPT in HSC co-
cultures with 2018 (“rmDPT (5ug)” column) showed similar potential in rescuing HSC 
survival/proliferation (2,2-fold increase) as the viral over-expression. Interestingly, human 
recombinant DPT (“rhDPT (5ug)” column) was equally capable of rescuing 
survival/proliferation of murine HSCs (2-fold increase). Finally, preliminary experiments 
showed that exogenous addition of recombinant mouse FAP protein had also a positive effect 
of HSC proliferation (“rmFAP (5ug)” column). Importantly, the effect of recombinant 
proteins upon rescuing HSC survival/proliferation were maintained over future generations. 
  
Figure 5.27. Viral over-expression or exogenous addition of DPT protein stably rescues the 
survival/proliferation potential of HSCs. Bar graphs representing the percentage of dividing HSCs 
and their progeny over different generations in co-culture with AFT024 stroma (black bars), 2018 
stroma (white bars), 2018 stroma transduced with DLK1 over-expression construct (3 experiments, 69 
trees), 2018 stroma transduced with DPT over-expression constructs (3 experiments, 117 trees), 
exogenously added mouse recombinant DPT protein (3 experiment, 115 trees), exogenously added 
human recombinant DPT (3 experiments, 105 trees) and exogenously added mouse recombinant FAP 
(1 experiment, 47 trees). Error bars are ±SD. Abbreviations are; vo: viral overexpression, rp: addition 
of recombinant protein.  
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5.5.8. Knocked down AFT024 stroma reduces the “cobblestone-area 
forming” and “long-term culture initiating-cell” potential of co-cultured 
HSCs 
  
 The data presented so far in this thesis clearly illustrate that AFT024 stroma cells with 
impaired expression of DLK, DPT or FAP lead to reduced levels of survival/proliferation of 
co-cultured HSCs. To investigate whether the reduced levels of HSCs survival leads to 
observable defects in HSC function/potential, I performed “cobblestone-area” and long-term 
culture initiating-cell (LTC-IC) in vitro assays.  
 The ability of HSCs to form “cobblestone-area” (CA) colonies after long-term culture 
is a well-established assay to retrospectively measure primitive colony forming potential 
(lineage and proliferation potential) as an in vitro surrogate measure for HSC potential 
(Ploemacher et al., 1989). Potential to form CA colonies after 4 weeks in culture correlates 
with in vivo repopulating potential as tested by transplantation experiments (Van der Sluijs et 
al., 1990; Ploemacher et al., 1991). In addition, executing CA forming-cell (CAFC) assays in 
a limiting-dilution mode can reveal the frequency of cells with CA-forming potential.  
For these reasons, specific dilutions of HSCs were directly sorted in 96-well plates 
coated with different stroma cell lines and their ability to form CA colonies after six weeks in 
culture was monitored (Figure 5.28A). 38,9%±9,6% of the initially sorted HSCs produced 
CA colonies after a 6-week culture with AFT024, whereas the respective percentage for the 
2018 stroma was only 5% (5,1%±0,7%) (Figure 5.28B). Interestingly, HSCs co-cultured with 
knocked-down stroma revealed reduced levels of CA forming potential, since only 
15,9%±7,1% (2,5-fold reduction) of HSCS cultured in DLK1
KD
, 5,1%±2,3% (7,6-fold 
reduction) HSCs cultured in DPT
KD
 and 15,6%±6,3% HSCs cultured on FAP
KD
 stroma 
showed CA potential (Figure 5.28B). These results confirm our hypothesis that the reduced 
survival/proliferation of HSCs in knocked-down stroma leads to impaired HSC potential.  
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Figure 5.28. HSPs have reduced potential of forming cobblestone-area colonies after co-cultured 
with knocked-down AFT024 stroma. A. Schematic representation of the experimental approach for 
the cobblestone-area forming cell (CAFC) assay. Different doses of freshly purified HSC or early 
MPP cells were directly sorted into 96-well plates on top of different stroma cell lines. Co-cultures 
were continued for six weeks, with weekly half-media changes. At the sixth week, individual wells 
were scored for the presence of cobblestone areas and statistics were used to calculate the respective 
frequencies of cobblestone-forming units (CFU) in the initial population. B. Bar graphs representing 
the frequencies of HSCs with CAFC potential after co-culture with different stroma conditions (3 
experiments). Error bars are ±SD.  
 
To further confirm the link between HSC survival/proliferation and HSC potential, I 
also performed long-term culture initiating-cell (LTC-IC) assays, a more stringent assay for 
HSC function. Like in CAFC assays, the potential of cells to generate LTC-IC colonies 
correlates well with their repopulating potential in in vivo transplantation experiments (Cho 
and Müller-Sieburg, 2000). To do this, single HSCs were directly sorted in 96-well plates on 
top of different stroma cell lines. After six weeks of co-culture with weekly half-media 
changes, cells were placed on semi-solid, methylcellulose media and scored after an 
additional period of two weeks (Figure 5.29A). Approximately 50% of the HSCs cultured on 
AFT024 stroma (49,3%±17,7%) versus 21,1%±11,7% on 2018 stroma showed LTC-IC 
potential. The LTC-IC potential of HSCs co-cultured with knocked-down stroma was again 
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reduced, with 19,8%, 41,7% and 30,8% of HSCs scored positive upon co-culture with 
DLK1
KD
, DPT
KD
 or FAP
KD
 stroma respectively (Figure 5.29B, left panel). These results 
further confirm that reduced DLK1, DPT or FAP expression levels in the AFT024 stroma has 
a negative effect upon HSC function.  
 
Figure 5.29 HSPs have reduced potential for forming long-term culture initiating-cell colonies 
after co-culture with knocked-down AFT024 stroma. A. Schematic representation of the 
experimental approach for the long-term culture initiating-cell (LTC-IC) assay. Single HSC cells were 
directly sorted into 96-well plates on top of different stroma cell lines. Co-cultures were continued for 
six weeks, with weekly half-media changes. After six weeks, individual wells were placed in 
methylcellulose semi-solid media and were scored for the presence or absence of colonies (wells with 
>25 cells were scored as positive) after two additional weeks. B. Bar graphs representing the 
frequencies of HSCs (left panel) or early MPPs (right panel) with LTC-IC potential after co-culture 
with different stroma (3 experiments). Error bars are SD. 
 
5.5.9 DPT is essential for HSC maintenance in vitro 
 
It is important to note, however, that the results from the CAFC and LTC-IC in vitro 
assays may emanate from the impaired ability of the knocked-down stroma itself to support 
the outgrowth of colonies, instead of a direct effect on HSC potential. In any case, the 
ultimate method required to show whether DLK1, DPT or FAP are essential for the in vitro 
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maintenance of HSCs is the in vivo transplantation experiments. For this reason, different 
doses of HSCs from CD45.1 mice were co-cultured with the different stroma cell lines for 7 
days. Then, their progeny was transplanted (together with the surviving stroma cells) into 
sub-lethally irradiated CD45.2 recipient mice (Figure 5.30A).  
The analysis of the peripheral blood from the CD45.2 recipient mice revealed a dose-
dependent effect in their chimerism, since the progeny of 100 (CD45.1) HSCs co-cultured 
with AFT024 stroma led to 1% contribution, the progeny of the 350 HSCs to 24,5%±4,1% 
and the progeny of 1250 HSCs to 53,4%±5,9% (Figure 5.30B). Similar dose-dependent 
contribution effects were also observed in the other co-cultures. HSCs co-cultured with 2018 
stroma gave low contribution, since the progeny of 100 HSCs gave 1,6%±1,8%, the progeny 
of 350 cells 1,2%±1,6% and the progeny of 1350 HSCs 9,6%±6,9%. The chimerism in 
recipient mice transplanted with cells co-cultured with DLK1
KD
 or FAP
KD
 stroma was 
slightly lower compared to the AFT024 controls. However, mice transplanted with cells co-
cultured with DPT
KD
 stroma showed approximately 2,5-fold lower percentage of chimerism 
(10,4%±1,0% versus 24,5%±4,1% in the control for the 350 cell dose and 20,5%±11,7% 
versus 53,4%±5,8% in the control for the 1250 cell dose) (Figure 5.30B). These results 
illustrate that DLK1 and FAP have minor effects, whereas DPT is essential for the in vitro 
maintenance of HSCs under AFT024-based co-cultures in vitro. It is important to note that 
the percentage of chimerism has to be calculated also in later timepoints (16-24 weeks) in 
order to further support our findings.  
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Figure 5.30 DPT is essential for the in vitro maintenance of HSCs. A. Schematic representation of 
the experimental approach. CD45.1 HSCs were isolated through flow cytometry and co-cultured with 
different stroma cell lines in different cell numbers (100, 350 and 1250 starting HSCs). After seven 
days of co-culture, the content of each well was transplanted into a CD45.2 sub-lethally irradiated 
recipient. Each dose/condition was conducted in quadruplicates. B. The peripheral blood (PB) of 
recipient mice was analyzed for the presence of CD45.1+ cells, twelve weeks after the transplantation. 
The bar graphs show the percentage of the PB donor contribution per condition. Error bars are ±SD. 
 
5.5.10 DPT’s expression in the bone marrow of adult mice 
 
 Despite the fact that the purpose of this study is to identify molecules promoting HSC 
maintenance in vitro, I sought to investigate the presence of DPT in the in vivo, bone-marrow 
niche. Current methodologies include cryo-sections of bone fragments which inevitably 
distort cell morphology and architecture. To circumvent this limitation, 100μm thick sections 
from decalcified femurs were isolated and bone-marrow sections were stained for DAPI, 
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CD150, CD31 (blood vessels), Dpt and a cocktail of lineage antibodies (a method developed 
in collaboration with Daniel Coutu, PhD.). The epiphysis, growth plate and metaphysis of the 
bone were visible in those sections. Combination of CD150 expression and lineage markers 
allowed us to identify CD150+Lin- cells (HSCs) (Kiel et al., 2005). Our analysis revealed 
that DPT expression in the adult bone marrow is localized to blood vessels, differentiated 
blood cells (megakaryocytes) and to bone surfaces (Figure 5.31). However, only few 
CD150+Lin- cells were found adjacent to DPT expressing cells. 
 
Figure 5.31 Dermatopontin’s expression in the in vivo bone-marrow niche. Bone-marrow sections 
of murine femur (100μm) were stained for CD150 (green), DAPI (blue), CD31 (white), 
Dermatopontin – Dpt (red) and a cocktail of different lineage markers for HSC identification (CD4, 
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CD8, CD41, CD48, CD34, Mac1, Gr1 - magenta). The upper panel shows the 3D-projection of the 
entire imaged area. In the panels below, CD150 and lineage markers are shown together to allow 
identification of CD150+Lin- cells (white circles), while DAPI and CD31 show the nucleus of 
individual cells as well as blood vessels. In the last panel, DPT expression is observed in different 
parts of the bone marrow, such as in blood vessels, megakaryocytes and bone surfaces (yellow 
arrows).  
 
6. Discussion 
Culturing HSCs ex vivo results in loss of their potential. They fail to self-renew and 
repopulate the blood system of mouse recipients upon transplantation, especially when 
cultured in stroma-free conditions (Ema et al., 2000). The current inability to maintain 
stemness of HSCs ex vivo hampers their clinical application. To circumvent this limitation, 
many groups since decades focus on the establishment of culture conditions capable of HSC 
maintenance or expansion. Indeed, several culture systems have been identified to robustly 
maintain stemness of HSCs, upon co-culture with stroma cell lines (Moore et al., 1997a; 
Oostendorp et al., 2002; Shimizu et al., 2008). Among those systems, the fetal-liver derived 
stroma cell line AFT024 has been reported to qualitatively and quantitatively support long-
term self-renewal of co-cultured HSC for culture periods of up to 6 weeks (Moore et al., 
1997a). Since the molecular profile of this supportive stroma cell line has been identified 
through subtractive libraries and microarray analyzes (Hackney et al., 2002; Charbord and 
Moore, 2005), AFT024 stroma is a unique tool to investigate the key factors supporting HSC 
maintenance in vitro. In addition, AFT024 stroma has been used by many groups over the 
years for the maintenance of human HSCs (Thiemann et al., 1998; Punzel et al., 1999b, 2002; 
Lewis et al., 2001; Nolta et al., 2002; Hutton et al., 2006). Here, we provide new insights into 
the molecular mechanisms governing the maintenance of single HSC by continuous time-
lapse imaging (Schroeder, 2008, Schroeder, 2011; Eilken et al., 2009; Rieger et al., 2009). 
This allowed to dissect the heterogeneous HSC population by analyzing single cells 
individually over time and to reveal key molecules responsible for the reported HSC 
maintenance in AFT024-based co-cultures. 
 
6.1 Continuous time lapse imaging allows reliable long-term 
single-cell observation of the fates of HSCs and their progeny 
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Continuous observation is indispensable when studying dynamic biological processes, 
such as the behavior of living cells. Depending on the culture conditions and the cell type, 
cultured cells may follow different cell fates in vitro. Division of initially plated cells may 
lead to increased cell numbers and eventually single-cell identity and history will be lost. At 
the same time, the total number of cells may stay the same or only change slightly depending 
on the number of dying cells of the starting population. As an example, Moore and colleagues 
showed that the numbers of HSCs can be maintained when co-cultured with the AFT024 
stroma, over long culture periods. Without single-cell observation, however, opposing 
interpretations could be used to explain the observed HSC behavior: increased levels of cell 
division and/or reduced levels of cell death and/or quiescent/senescent cells that survive 
without division could lead to the same output. Published studies are mostly snapshot 
analyzes conducted on the population level or time-lapse imaging with low temporal 
resolution (Punzel et al., 2003), thus fail to provide single-cell data. On the other hand, 
studies with single-cell resolution (single cells plated on different wells of multi-well dishes) 
often fail to follow the fates of “generation 0” cells and their progeny over long culture 
periods (Kent et al., 2008; Sekulovic et al., 2011). Unraveling the biology behind such events 
requires a live-cell imaging method with short time intervals and post-acquisitional 
reconstitution of cellular history and genealogy. 
The imaging method established in the Schroeder group allows continuous monitoring 
of single cells with high temporal resolution over 2 weeks in vitro. This approach allowed to 
quantify the number of initially plated HSCs (generation 0 cells) and to follow their different 
fates (cell division, cell death, survival without any division) upon co-culture with different 
types of stroma cells. Fates of the HSC progeny could be monitored for two weeks of culture. 
In this timeframe, cells from different generations can be followed (tracked) with high 
resolution and low error rates (loosing identity and mixing cells coming from different 
“founder”). Another critical advantage of such high temporal resolution, single-cell imaging 
is the ability to define with high sensitivity the kinetics of the different cell fates. Thus, the 
exact time between the beginning of the co-culture and the fate of each single cell (division or 
death) could be determined. Through this approach, HSC behavior under maintenance 
conditions could be identified and also brings new insights into the behavior of in vitro 
culture of murine, bone-marrow derived HSCs cultured on AFT024 stroma. 
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6.2 Dexter-type AFT024-based co-cultures support HSC 
maintenance by preventing early cell death of murine HSCs  
As mentioned above, ex vivo culture of HSCs leads to progressive loss of stemness 
resulting in reduced repopulation potential upon transplantation into irradiated recipients. 
According to the current notion in the field, cell death and/or differentiation of cultured HSCs 
are the main reasons for the reported loss of stemness and subsequent reduced repopulation 
capacity. However, currently there is no direct evidence linking early cell death with loss of 
stemness.  
Here we report that the most striking difference between HSCs cultured under 
supportive (AFT024) or non-supportive (2018, BFC012) conditions in vitro was the early 
survival rate of HSCs. Freshly purified CD34-CD48-CD150+KSL murine cells cultured 
directly after isolation, showed significantly higher levels of survival/division on the AFT024 
stroma (80,0%±8,0%) compared to 2018- or BFC012-based cultures (27,9%±3,2% and 
20,6%±5,2% respectively). In non-supportive conditions, the majority of CD34-CD48-
CD150+KSL cells died (71,6%±5.8% on 2018 and 78,8%±4,2% on BFC012), during their 
initial generation (“generation 0” cells). Notably, co-cultures with the 2012 stroma, a stroma 
supporting intermediate levels of repopulating cells, resulted in intermediate levels of HSCP 
survival/proliferation. These results show for the first time that the capacity of fetal-liver 
derived stromata to maintain repopulating cells is linked with the initial survival/proliferation 
rates of co-cultured HSCs. Therefore, our analysis provides evidence that cell death is a 
major reason for the loss of stemness of mouse HSCs cultured under non-supportive 
conditions. 
Due to the high temporal-resolution of image acquisition, the cell-fate kinetics 
(experimental time until division or cell death) of HSCs and their progeny were monitored 
with high precision. Our data clearly demonstrate that differences in the HSC behavior appear 
early after the initiation of the culture; within the first 7 days of the co-culture >94% of the 
cells either divide or die (Figure 4.6, Results section). This is significantly shorter when 
compared with the conventional methods, which require 4 week of co-culture prior to the 
laborious/time-demanding transplantations which last for at least 16 additional weeks. 
Therefore, the time-lapse based, co-culture system described here constitutes a high-
sensitivity and fast system to readout differences in HSC behaviors in vitro.  
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High temporal resolution image acquisition and subsequent single cell tracking 
enabled us to precisely “reconstruct” the history of single cells and their progeny by 
generating representative cellular pedigrees. Thus, we could expand our cell-fate analysis 
also to later generations. Interestingly, monitoring the fates of the HSC progeny (later cell 
generations) revealed that the levels of division/survival on AFT024 and cell-death rates on 
2018/BFC012 stroma were constant over the first three generations. This suggests that the 
effect of the micro-environment is stable at least for the first three generations in vitro. To our 
knowledge, this is the first report providing such detailed analysis of the cell fates of murine 
HSCs under Dexter-type, long term culture, while highlighting the unique behavior of HSCs 
under self-renewing conditions. 
The behavior of human HSCs co-cultured with AFT024 stroma had also been 
analyzed. As mentioned in paragraph 3.4.2.3, murine AFT024 stroma has also been reported 
to maintain human HSCs (Thiemann et al., 1998; Punzel et al., 1999b; Nolta et al., 2002). 
Snapshot analysis of human umbilical cord blood (UCB) CD34+CD38- cells co-cultured with 
murine AFT024 revealed similar levels of “generation 0” cells undergoing division (84,4% ± 
4,8%), quiescence/senescence (3,1% ± 0,8%) or cell death (13,9% ± 1,8%) (Punzel et al., 
2003). However, Punzel and colleagues provided no data for the behavior of human HSCs 
under non-supporting conditions, in order to pinpoint potential differences in the 
proliferation/survival rates. Also, due to the low temporal resolution of their imaging 
(acquisition every 12-24 hours), the kinetics of the reported behaviors could not be precisely 
defined. Earlier studies implementing time-lapse imaging with intermediate temporal 
resolution (3 to 12-hour intervals) reported that the majority of CD34+CD38- human HSCs 
divided within the first 36 to 38 hours after culture initiation (Huang et al., 1999). 
Nevertheless, those cells were cultured in stroma-free conditions and their divisional history 
was based on the intensity of the PKH26 dye (decreasing brightness following cell division) 
rather than continuous tracking at the single cell level. Again, no comparison with non-
supportive conditions was performed in order to reveal the time frame when potential 
differences take place. 
Despite the fact that no direct comparison can be made between the two systems due 
to different culture conditions and species variation, we report that murine HSCs have a 
similar behavior as human HSCs at least for the initial generation under self-renewing 
conditions, since the majority of cells survive and proliferate in both scenarios. These results 
illustrate the potential value of the results of our study for clinical applications. 
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6.3 AFT024-based co-cultures also support survival/proliferation 
of multipotent progenitor cells 
Current HSC isolation approaches result in impure cell populations. Transplantation 
experiments revealed that the HSC purity of current sorting schemes is approximately 50-
60%, meaning that only half of the cells sorted for a stem-cell immunophenotype have stem 
cell function (Kent et al., 2009). This suggests that the current knowledge for stem-cell 
markers is limited and identification of additional, more specific markers is a prerequisite for 
HSC isolation with higher purity. It is currently challenging to characterize the remaining 
50% of the contaminating cells which are sorted as stem cells, but fail to read out as such.  
Since half of the sorted ‘HSCs’ have to be assumed not to be stem cells, but possibly 
some type of early progenitors, we sought to investigate the effect of the Dexter-type, long 
term culture also upon MPPs. Such analysis would reveal the specificity of the observed 
AFT024-mediated pro-survival effect upon co-cultured hematopoietic populations. It is 
important to note that different types of MPP populations have been reported. Based on their 
reconstitution potential, cell-cycle status and immunophenotype, Wilson and colleagues 
reported a putative hierarchy of different populations of MPP cells within the KSL cell 
compartment (Wilson et al., 2008). According to that hierarchy, the most primitive 
population of cells with the higher repopulation potential are the CD34-CD48-
CD150+CD135- KSL cells (HSCs). This is mainly the immunophenotype followed in the 
current study for HSC isolation, since the vast majority of CD34-CD48-CD150+ KSL are 
also CD135- (data not shown). In MPPs, CD34 is the first marker which turns on 
distinguishing them from stem cells (CD34+CD48-CD150+CD135-KSL were called MPP1) 
with CD48 being the next (CD34+CD48+CD150+CD135-KSL were called MPP2). Later, 
CD150 expression is lost (CD34+CD48+CD150-CD135-KSL were called MPP3) while 
CD135 finally turns on (CD34+CD48+CD150-CD135+KSL were called MPP4). In the 
current study, we used a slightly different combination of marker expression to isolate early 
MPPs (CD34+CD48-CD150-KSL) and followed Wilson’s protocol for late MPPs 
(CD34+CD48+CD150-KSL).  
Our analysis of “generation 0” cells showed a cell type-dependent support of the 
observed survival of hematopoietic populations, in the AFT024-based cultures. As mentioned 
previously (section 6.2) the majority of primitive HSCs in generation 0 divided 
(80,0%±8,0%). Almost half of the early MPPs divided in co-cultured with the supportive 
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stroma (54,4%±6,0%) compared with only one fifth of the late MPPs (18,6%±16,8%). 
Analysis of later generations revealed similar levels of cell division between HSCs and 
different MPP populations (around 75%) suggesting that after an early selection, the 
surviving cells are stably supported by the AFT024 stroma. This is the first demonstration, to 
our knowledge, that AFT024-based cultures affect cell fates based on the primitiveness of the 
co-cultured adult stem and progenitor cells. The positive effect of the AFT024 co-cultures 
upon more committed progenitors (colony forming unit-high proliferative potential mix-
lineage colonies, CFU-HPP-Mix and pro-b cell progenitors) has already been reported, since 
both types of progenitors could be expanded under the same culture conditions (Moore et al., 
1997a). However, the reported effects were observed in fetal-liver derived murine HSCs. In 
the human system, the reported purity of the sorted CD34+CD38-Lin- HSCs is below 1%. It 
is logical to assume that the majority of the surviving cells reported by Punzel and colleagues 
upon co-culture with the AFT024 stroma (Punzel et al., 2003), were progenitors rather than 
stem cells. Therefore, the positive effect of the AFT024 stroma upon progenitor cells could 
be also extended in the human system.  
Taken together, these findings regarding the support of both murine and human 
stem/progenitor cell populations on AFT024-based cultures are of potential clinical 
relevance. From transplantations conducted in the murine system, it is known that multipotent 
and committed progenitors are important for the short-term reconstitution of the blood system 
of the recipients, due to their short cell-cycle status. On the other hand, primitive HSCs are 
mainly quiescent and require long periods before generating differentiated blood cells. A 
culture system, supporting both stem and progenitor cells can be extremely valuable for 
subsequent transplantation experiments (or potentially for bone marrow transplantation in 
case of human patients), since it facilitates both short- and long-term blood regeneration.  
 
6.4 Direct contact is necessary for the survival of HSCs co-
cultured with the AFT024 stroma 
 After revealing the unique behavior of HSCs under supporting conditions, we sought 
to investigate the relevant molecules responsible for this interaction. To efficiently filter 
through the published list of genes preferentially or exclusively expressed in the AFT024 
stroma (Hackney et al., 2002; Charbord and Moore, 2005), I investigated whether adhesion 
molecules or secreted factors are responsible for the observed interaction between HSC and 
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stroma cells. This list (containing around 1000 genes) can be subdivided into three categories: 
i. genes coding for membrane, adhesion or extracellular matrix proteins (requiring cell-cell 
contact), ii. genes coding for secreted factors and cytokines and iii.transcription factors or 
proteins of the cytoskeleton. Since I was interested in the interaction of the stroma cells with 
co-cultured cells, the adhesion and the secreted genes were the main focus of this study. 
Revealing the underlying mechanism governing the interaction between the AFT024 stroma 
and the HSCs would allow efficient screening of molecules with desired properties from the 
entire gene list. 
It is important to note that currently there are no available data deciphering whether 
direct contact or secreted factors are responsible for the maintenance of mouse HSCs by the 
AFT024 stroma. Interestingly, studies attempting to reveal the nature of the interaction using 
human HSCs led to contradictory results. Initially, work from the Crooks group showed that 
human bone marrow- or cord blood-derived CD34+CD38- cells could be maintained only in 
direct contact with the AFT024 stroma, since non-contact cultures failed to do so (Thiemann 
et al., 1998). This observation, based on cobblestone-area forming cell assay and 
immunophenotypic analysis of cultured cells, was later confirmed by transplantation 
experiments using a xenograft mouse model (Nolta et al., 2002). At the same time, the group 
of Catherine Verfaillie further confirmed that AFT024 maintain human HSCs through direct 
contact, while identifying large-size O-sulfated heparan sulfate as one of the molecules 
responsible for the observed interaction (Punzel et al., 2002). This finding contradicted earlier 
results from the Verfaillie group in which stroma non-contact cultures supplemented with a 
cytokine cocktail (FL, SCF, IL-7) were sufficient to maintain human umbilical cord blood 
HSCs for at least 7 days capable of engrafting in the NOD/SCID mice (Lewis et al., 2001). In 
the same study, they also reported a stroma-free culture system (FCS, G-CSF, MIP-1a, IL-6, 
MCP-1, VEGF, IL-8, N-desulfated-O-sulfated heparin, Tpo, FL) with similar performance in 
maintaining engrafting HSCs. These studies challenged the requirement for direct contact 
with the AFT024 stroma, suggesting the AFT024 maintain HSCs through secretion of 
cytokines. Another study from the Lewis group further supported this concept, since BMP4 
was identified as one of the key molecules for the AFT024-mediated maintenance of human 
HSCs (Hutton et al., 2006). However, the fact that non-supportive stroma cell lines also 
express BMP4 in equal or higher doses than AFT024 challenged again their hypothesis. In 
conclusion, besides the extensive investigation, the mechanism through which AFT024 
maintain mouse or human HSCs is still unknown.  
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In order to investigate whether the observed effect in the murine system is governed 
by adhesion molecules or secreted factors, I performed a series of conditioned media 
experiments. In the initial experiments, generation-based analysis revealed similar levels of 
cell division between HSCs cultured on 2018 stroma with or without AFT024-conditioned 
media. These results suggest that AFT024 stroma requires direct contact to fully promote 
survival of co-cultured HSCs, since secreted factors are redundant for HSC 
survival/proliferation. Conditioned media are generally sensitive and the activity of contained 
secreted molecules may be easily irreversibly affected. To exclude potential effects of 
handling in the activity of secreted factors,  I also designed assays in which HSCs were in 
contact with 2018 cells, but the majority of the media was stably conditioned by neighboring 
AFT024 cells (without physical contact between the two stromata). AFT024-derived secreted 
factors had minor effect on the proliferation potential of HSCPs suggesting again that 
adhesion molecules are the main mediators of the positive interaction between HSCPs and 
AFT024 stroma. These results were further confirmed by the fact that HSCs did not survive 
in stroma-free cultures, thus highlighting the importance of the stroma in the observed 
interaction. 
In addition, we report no migration of HSCs towards the AFT024 stroma. These data 
contradict previously published data showing active migration of human umbilical-cord-
blood derived CD34+CD38- HSCs towards AFT024 cells shortly after co-culture initiation 
(Wagner et al., 2005). However, species variation may lead to the observed discrepancy.  
 Taken together our data illustrate that murine HSCs require direct contact to AFT024 
stroma cells to proliferate/divide, since stroma-free cultures resulted in massive cell death in 
Dexter-type media (Figure 4.13A).  
 6.5 Positive effect from AFT024 or/and negative from 2018 
stroma? 
 We report in this thesis that the majority of HSC proliferate/survive under supporting 
conditions (≈80%), while undergoes cell death in non-supporting conditions (72%-79%). 
This differential HSCs behavior may be explained by the presence of a (positive) factor 
promoting proliferation/survival exclusively expressed by the AFT024 stroma, which lacks 
from the 2018 stroma. Alternatively, the same behavior could be explained by the absence of 
a (negative) factor on the AFT024 leading to cell death of co-cultured cells, which is present 
on the 2018 stroma or by a combination of both scenarios. 
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 To address this, I initially performed a series of conditioned media experiments 
showing that 2018 stroma does not secrete any factor cell-death related factor or any inhibitor 
of proliferation/survival promoted by the AFT024 stroma. To investigate the effect of HSC 
adhesion to the different stromata, I performed experiments, in which AFT024 and 2018 cells 
were mixed in different ratios. A similar approach has been followed by Buckley and 
colleagues while investigating the potential of two AGM-derived stroma cell lines (EL08-
1D2 and UG26-1B6) to maintain HSC in non-contact cultures. UG26-1B6 stroma could 
maintain HSC in non-contact cultures, while EL08-1D2 required direct contact. 
Complementing the EL08-1D2 cultures with just 25% UG26-1B6 cells was sufficient to 
rescue HSC maintenance and multilineage reconstitution of mouse recipients in non-contact 
cultures (Buckley et al., 2011). Similar results were obtained in cultures with higher ratios of 
UG26-1B6 cells, suggesting that this stroma secretes one or more factors capable of 
supporting HSC maintenance, while EL08-1D2 did not.  
The analysis of the results presented in the current thesis showed no effects when 
mixing the AFT024 stroma compartment with 10% 2018 cells or vice versa. However, 
cultures comprising 50% of AFT024 stroma and 50% of 2018 stroma resulted in intermediate 
proliferation levels of co-cultured HSCs, suggesting that HSC cell-fate decisions are strongly 
dependent on the continued interaction with each stroma type. Indeed, quantification of the 
absolute time HSCs were adherent to each stroma type revealed that dividing HSCs were 
mostly adherent to AFT024 (75% of their lifetime), whereas dying HSC were mostly 
adherent to 2018 stroma.  
Interestingly, the analysis of the cell-death kinetics of HSCs cultured with AFT024, 
2018 or 2012 revealed that the slower death kinetics occurred during the 2018 co-cultures 
(Results, section 5.4.4, Figure 5.20). This result minimizes the likelihood of a negative, cell-
death promoting factor expressed by 2018 and rather suggests the absence of pro-survival 
factor(s) expressed by the supportive AFT024 cells. In addition, the fact that stroma-free 
cultures (in Dexter-type media) result in the cell death of virtually all cultured HSCs, whereas 
approximately 25% survived on 2018 stroma, further support that 2018 cell do not actively 
kill HSCs.  
To conclude, our analysis suggests that the observed differences in the HSC behavior 
upon culture with the different stroma is mainly the result of one or more pro-survival, cell 
surface or matrix factors expressed by the AFT024 stroma, while they are absent from the 
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2018 stroma.  However, an additional negative effect from the 2018 could not be entirely 
excluded.  
6.6. Confirmation of the gene-expression differences between 
supportive and non-supportive stroma 
 The AFT024 stroma cell line has been reported to qualitatively and quantitatively 
maintain co-cultured murine and human HSCs over long culture periods (Moore et al., 1997a; 
Thiemann et al., 1998; Punzel et al., 1999; Nolta et al., 2002). Published gene lists have 
revealed the molecular signature of AFT024 stroma (Hackney et al., 2002) consisting of 
around 1000 differentially expressed genes. These can be subdivided into three categories: i) 
genes coding for membrane, adhesion or extracellular matrix proteins (requiring cell-cell 
contact), ii) genes coding for secreted factors and cytokines and iii) transcription factors or 
cytoskeleton-related proteins. The results presented in the current thesis reveal that adhesion 
molecules are at least in part responsible for the AFT024-mediated maintenance of HSCs. For 
this reason, I further confirmed the differential expression of adhesion-related genes by qRT-
PCR experiments.  
 Around 170 genes predicted to be differentially expressed between AFT024 and 2018 
or BFC012 stroma were further analyzed. From those, 33 were indeed found to be 
exclusively or preferentially expressed by the supportive stroma. This means that only 20% 
of the published genes could be confirmed with more sensitive methods.   
 It is important to note that the untreated stroma was used for the generation of the 
subtractive library (Hackney et al., 2002) and for the microarray analysis (Charbord and 
Moore, 2005). However, irradiated stroma cells were used in the Dexter-type, long-term 
cultures reported to support HSC self-renewal. To better simulate the culture conditions and 
to reveal potential differences in the gene expression occurred from the stroma irradiation, we 
expanded our analysis in irradiated stroma cells cultured for two days in Dexter media. 
Irradiation reduced the fold differences in the gene expression between the two stromata, 
however it did not affect the list with differentially expressed molecules. 
 Multiple shRNA constructs were then designed against twenty of the differentially 
expressed genes and a variety of knocked-down stroma cell lines was generated. Continuous 
time-lapse imaging of Dexter-type co-cultures was implemented to monitor potential effects 
of the manipulated stroma manipulation upon HSCs cell fates. 
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6.7 DLK1, DPT and FAP are important for early HSC 
survival/proliferation, but DPT alone is essential for in vitro HSC 
maintenance in AFT024-based co-cultures 
 From the panel of eighteen candidate genes screened, the knock down of three 
proteins resulted in reduced proliferation rates of co-cultured HSCs.  
6.7.1. Delta-like 1 homolog (Dlk1) 
The murine delta-like 1 homolog (Dlk1) gene encodes a transmembrane protein 
containing six epidermal growth factor (EGF) like repeats, a protein domain found in the 
extracellular part of transmembrane proteins. A soluble form of DLK1 has also been 
identified (upon proteolytic cleavage of the extracellular domain) and reported to inhibit 
adipocytic differentiation of pre-adipocytic cells (Smas et al., 1997; Garcés et al., 1999; Mei 
et al., 2002) or osteogenic differentiation of bone marrow mesenchymal cells (Abdallah et al., 
2004; Sul, 2009).  
Knock down of DLK1 resulted in intermediate levels of proliferation/survival of co-
cultured HSCs (from 80,0%±8,03% on AFT024 to 58,6%±5,9% on AFT024-DLK1). It has 
been previously reported that over-expression of a transmembrane form of DLK1 in BFC012 
non-supportive stroma led to a 4- to 6-fold increase in the number of “cobblestone area” (CA) 
colonies generated by co-cultured HSCs (Moore et al., 1997b). Interestingly, exogenous 
addition of the soluble form of DLK1 resulted in a 2-fold increase of the number of CA 
colonies, in Dexter-type co-cultures. However, the maintenance of those CA colonies was 
transient (less than two weeks) and only low levels of repopulating cells were maintained in 
short-term, DLK1-expressing co-cultures, as shown by competitive transplantations. These 
results led authors to postulate that other factors might be necessary for the AFT024-driven 
maintenance of co-cultured HSCs, in addition to DLK1 (Moore et al., 1997b).  
In an attempt to identify the fetal liver stroma responsible for the hematopoietic 
maintenance and expansion occurring during fetal hematopoiesis, Chou suggested that 
DLK1+SCF+ fetal liver cells might play this role. According to their data, E15.5 
DLK1+SCF+ cells comprise a homogeneous population of bipotent hepatic stem cells giving 
rise to both hepatocytes and epithelial cells. Interestingly, E15.5 DLK1+SCF+ stroma could 
maintain the repopulation potential of fetal liver-derived HSC after short co-culture (4 days) 
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in media containing SCF, IL-6 and Flt3 (Chou and Lodish, 2010). Recent data from the same 
group showed that DLK1+ cells could maintain co-cultured HSC for periods up to 3 weeks 
(Chou et al., 2013). It is important to note that direct contact was a prerequisite for the in 
vitro maintenance of co-cultured HSCs, a result that confirms our observations. However, 
DLK1 was used as a marker to isolate those bipotent stroma cells and there was no evidence 
for a role of DLK1 in the described in vitro HSC maintenance. It is also not clear to which 
extend the E15.5 fetal liver-derived DLK+SCF+ cells described in those studies are related 
with the immortalized AFT024 stroma cells (isolated from the same organ at E14).  
Herein, we report that HSCs co-cultured on DLK1
KD
 stroma exhibit reduced levels of 
proliferation in generation 0. The levels of proliferation/survival of HSCs progeny 
(generations 1 and 2) are also reduced, while cell-death levels are slightly increased 
compared to the wild-type AFT024 stroma (Results, section 5.5.5, Figure 5.25). On the 
contrary, DLK1
KD
 stroma had no detectable influence on the survival/proliferation of early 
progenitors. Interestingly viral over-expression of Dlk1 partially rescued HSC 
survival/proliferation (1,9-fold increase compared to 2018 conditions), a result coinciding 
with Moore’s data (Moore et al., 1997b). Long-term in vitro assays (CAFC and LTC-IC) 
showed an impaired potential of DLK1
KD
 stroma to support HSC potential. However, in vivo 
transplantation experiments (the gold-standard method to show HSC function) revealed that 
co-cultures on DLK1
KD
 stroma had minor influence upon HSC numbers. Taken together 
these data suggest that DLK1 is in part responsible for the AFT024-driven 
survival/proliferation of HSCs in vitro, but it is not required for HSC maintenance as shown 
by the in vivo transplantations. Finally, the fact that the cleaved/soluble form of the protein 
has biological activity lead us to hypothesize that the cleaved domain of DLK1 might account 
for the minor positive effect of AFT024 conditioned media upon HSC proliferation.  
6.7.2.Dermatopontin (Dpt) 
Another candidate molecule that I identified as essential for HSC 
proliferation/survival upon co-culture with the AFT024 stroma is dermatopontin (Dpt), an 
extracellular matrix protein facilitating cellular adhesion to the matrix as well as matrix 
assembly (Superti-Furga et al., 1993; Forbes et al., 1994). Takeda and colleagues generated 
the Dpt knockout mice, in order to identify its biological role. Dpt-null mice had increase 
skin elasticity, a significant decrease in the dermis layer and irregularities in collagen fibril 
formation (Takeda et al., 2002). Dpt was initially purified in a complex with decorin (Dcn), a 
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matrix proteoglycan, from bovine dermis (Neame et al., 1989). It has been reported that Dpt 
forms a complex with Dcn augmenting the binding and the availability of transforming 
growth factor β1 (TGF-β1) to cells (Okamoto et al., 1999). The role of Dpt has been mainly 
studied in lung epithelial (Okamoto et al., 1999), human epidermal keratinocytic (Okamoto et 
al., 2010) or human fibroblastic cell lines (Kato et al., 2011).  
In the current thesis, I presented data of DPT
KD
 stroma showing impaired potential to 
support survival/proliferation of co-cultured HSCs and their progeny. DPT knock down also 
affected early progenitors, suggesting that DPT is important in the early stages of 
hematopoiesis. Furthermore, HSCs cultured on DPT
KD
 stroma showed reduced potential to 
form colonies in long-term in vitro assays (CAFC and LTC-IC). Most importantly, HSCs co-
cultured with DPT
KD
 stroma showed reduced levels of repopulation in recipient mice. 
Therefore, we provide the first evidence for a novel role of Dpt in hematopoiesis, as a key 
molecule for HSC survival/proliferation and most importantly for HSC maintenance in vitro.  
Next, I sought to investigate whether DPT is present in the in vivo bone marrow 
niche. DPT’s expression in the bone and cartilage has been previously reported by 
immunoblotting and northern analysis in porcine tissues (Forbes et al., 1994). In the current 
thesis, we provide a more detail expression profile of DPT in the different regions of murine 
bone marrow. To do this, we developed and implemented confocal imaging of bone marrow 
section from murine femurs preserving bone morphology and tissue architecture, which 
revealed that DPT is expressed by cell types functioning as HSC niches, such as bone 
surfaces, blood vessels and mature blood cells (megakaryocytes). 
6.7.3. Fibroblast activation protein (Fap) 
Finally, I also presented evidence for fibroblast activation protein (Fap) being another 
molecule involved in HSC proliferation and survival in vitro. FAP is a type II transmembrane 
glycoprotein (single-pass molecule with its C-terminal domain anchoring to the endoplasmic 
reticulum). It was first identified in cultured fibroblasts and named as F16 cell surface 
antigen, due to its reactivity with the respective monoclonal antibody (Rettig et al., 1986). 
Four years later, Fap was independently isolated from a melanoma cell line (LOX) and 
named “seprase” after its protease activity (surface expressed protease) (Aoyama and Chen, 
1990). Cloning of the two molecules (F16 and seprase) revealed that seprase was the 
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dimerized form of F16 (Scanlan et al., 1994) and the protein was finally designated fibroblast 
activation protein (FAP) (Rettig et al., 1994).  
FAP has reported dipeptidyl peptidase activity (removes dipeptides from the N-
terminus of substrate proteins) and endopeptidase activity (break peptide bonds between 
amino-acids localized away from the terminal protein domains) (Niedermeyer et al., 1998). It 
plays a functional role in matrix architecture and remodeling, due to its ability to degrade 
type I collagen (Cheng et al., 2005). Like DLK1, FAP has also a soluble form originating 
from cleavage of the extracellular protein domain (Lee et al., 2006). The soluble form of FAP 
is often called antiplasmin-cleaving enzyme (APCE), although soluble FAP (sFAP) is lately 
more preferable (Jacob et al., 2012). Interestingly, the FAP null mice have no obvious 
abnormalities (Niedermeyer et al., 2000).  
FAP’s expression has been detected in activated stroma cells, such as fibroblastic 
cells associated with different types of cancer (Kidd et al., 2012; Liu et al., 2012). It is also 
expressed in normal tissues during development, such as the human uterus and placenta 
(Dolznig et al., 2005) as well as in the adult bone marrow, where it can be used as a marker 
for mesenchymal stem cells (Bae et al., 2008). It is currently believed that FAP expression in 
healthy tissues is transient compared to its stable expression pattern in cells associated with 
wound healing or diseases (Jacob et al., 2012). However, a recent study using a transgenic 
mouse line allowing visualization of all FAP expressing cells reported expression in almost 
all adult tissues (Roberts et al., 2013). Deletion of FAP expressing cells using the diphtheria 
toxin system (administration of diphtheria toxin - DTX selectively kills cells expressing the 
diphtheria toxin receptor - DTR) resulted in a hematopoietic phenotype, since the numbers of 
committed progenitor populations were decreased in the bone marrow compartment 
(granulocyte-macrophage progenitor GMP, common lymphoid progenitor CLP, 
megakaryocyte-erythroid progenitor MEP, pro-erythoblasts and pro-B- cell progenitors) 
(Roberts et al., 2013). Interestingly, the number of MPPs was slightly increased, whereas 
HSCs remained unaffected by this manipulation. Another striking result of that study was the 
identification of FAP+, osteocalcin+ and osteopondin + bone-lining cells which also express 
Cxcl12 and KitL; two cytokines with key roles in HSC homing and normal hematopoiesis 
(Roberts et al., 2013). These data suggest a novel role of the FAP expressing stroma in in 
vivo hematopoiesis and especially in survival of committed progenitor cells. It is important to 
note that such manipulations are always limited by the specificity and off-target effects of the 
administered compounds (in this case DTX). The absence of an effect on the HSC 
- 111 - 
 
compartment might be related with the short time between DTX administration and bone-
marrow isolation (3 days). On the contrary, our data revealed a role of FAP in survival and 
proliferation but not maintenance of HSC under in vitro culture with AFT024 stroma. 
Comparing the effect of FAP knock down between HSCs and early progenitors, we found 
that FAP mainly affects HSCs. The different experimental approach (in vitro versus in vivo) 
may account for the observed discrepancies regarding the role of FAP in the different 
hematopoietic populations. 
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7. Experimental Procedures 
 
7.1 Molecular biology 
7.1.1. Restriction Digest – Dephosphorylation 
 For restriction digests, 1-5μg of backbone plasmid were digested with either one or a 
combination of different restriction enzymes in the suggested buffer for 1 hour or overnight 
in some cases. Heat inactivation of the different enzymes was performed as suggested in the 
manufacturer’s instructions.  
If the two ends of the digested backbone are compatible (blunt ends or sticky, 
complementary ends), de-phosphorylation is required to inhibit self-ligation or concatamers 
(two or more linear plasmids ligated together). During this reaction, alkaline phosphatase is 
added to remove the 5’ phosphate groups of the backbone DNA fragment, which are required 
by ligases to form the phosphodiesteric bond between the nucleotides of the backbone and 
insert DNA. The insert DNA fragment will not be treated and it will still be able to ligate to 
the vector through its 5’ phosphate group. Notably, the 3’ end of each insert will not ligate to 
the 5’ end of the backbone (due to the de-phosphorylation) and one break will be created on 
each strand of the recombinant DNA plasmid. This break will be later repaired enzymatically 
in the bacterial cell.  
 
7.1.2. Design shRNA oligonucleotides 
 
 Gene-specific shRNA oligonucleotides were designed using the online library of the 
Broad Institute (“The RNAi Consortium shRNA Library”) following the pattern below (listed 
in table 7.1): 
5' – CCGG – XXXXXXXXXXXXXXXXXXXXX – CTCGAG - XXXXXXXXXXXXXXXXXXXXX – TTTTT - G  3' 
3' -        YYYYYYYYYYYYYYYYYYYYY – GAGCTC – YYYYYYYYYYYYYYYYYYYYY – AAAAA – CTTAA 5' 
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Gene 
Cl
on
e 
Sequence 
scrambled 1 CAACAAGATGAAGAGCACCAACTCGAGTTGGTGCTCTTCATCTTGTTG 
 2 CTTACGCTGAGTACTTCGACTCGAGTCGAAGTACTCAGCGTAAG 
 3 TGGTTTACATGTTTTCTGACTCGAGTCAGAAAACATGTAAACCA 
 4 CCTAAGGTTAAGTCGCCCTCGCTCGAGCGAGGGCGACTTAACCTTAGG 
Thbs2 1 GCCCTATTGATGGGTGCTTATCTCGAGATAAGCACCCATCAATAGGGC 
 2 GCTGTAGGTTTCGACGAGTTTCTCGAGAAACTCGTCGAAACCTACAGC 
 3 CCATTCTATGAGCAGCTAGAACTCGAGTTCTAGCTGCTCATAGAATGG 
 4 CCAAGACAACTGCCCATACATCTCGAGATGTATGGGCAGTTGTCTTGG 
 5 CCACGTCAAGGACACTTCATTCTCGAGAATGAAGTGTCCTTGACGTGG 
 6 GATTCGTGCTGTTCTATAATGCTCGAGCATTATAGAACAGCACGAATC 
Dlk1 1 CTCAGGCAACTTCTGTGAGATCTCGAGATCTCACAGAAGTTGCCTGAG 
 2 GCTGGTGATGAGGAGATCTAACTCGAGTTAGATCTCCTCATCACCAGC 
 3 GACGGGAAATTCTGCGAAATACTCGAGTATTTCGCAGAATTTCCCGTC 
 4 CCATCGTCTTTCTCAACAAGTCTCGAGACTTGTTGAGAAAGACGATGG 
 5 CATCCTGAAGGTGTCCATGAACTCGAGTTCATGGACACCTTCAGGATG 
 6 CCACATGCTTCGCAAGAAGAACTCGAGTTCTTCTTGCGAAGCATGTGG 
Bgn 1 CCACTCAGAGACTCCCTATAACTCGAGTTATAGGGAGTCTCTGAGTGG 
 2 GCCATCCAATTTGGAAATTATCTCGAGATAATTTCCAAATTGGATGGC 
 3 GCCCTGGTCTTGGTAAACAATCTCGAGATTGTTTACCAAGACCAGGGC 
 4 GCTATTGAGTTGGAGGACCTACTCGAGTAGGTCCTCCAACTCAATAGC 
 5 CTCCCTGGTAGAACTACGAATCTCGAGATTCGTAGTTCTACCAGGGAG 
Mmp9 1 CCCTCTGAATAAAGACGACATCTCGAGATGTCGTCTTTATTCAGAGGG 
 2 CCAGGATAAACTGTATGGCTTCTCGAGAAGCCATACAGTTTATCCTGG 
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 3 GAGGCATACTTGTACCGCTATCTCGAGATAGCGGTACAAGTATGCCTC 
 4 CCACTTACTATGGAAACTCAACTCGAGTTGAGTTTCCATAGTAAGTGG 
 5 CAGTACCAAGACAAAGCCTATCTCGAGATAGGCTTTGTCTTGGTACTG 
Vcam1 1 CCAGATCCTTAATACTGTTTACTCGAGTAAACAGTATTAAGGATCTGG 
 2 CCCTTTGACCATCTGGAGATTCTCGAGAATCTCCAGATGGTCAAAGGG 
 3 CCAAATTGATTCTACACTCAACTCGAGTTGAGTGTAGAATCAATTTGG 
 4 CGAGGCTGGAATTAGCAGAAACTCGAGTTTCTGCTAATTCCAGCCTCG 
 5 CCAGATAGACAGCCCACTAAACTCGAGTTTAGTGGGCTGTCTATCTGG 
Dpt 1 CGTCCTCTATTCAAAGATATACTCGAGTATATCTTTGAATAGAGGACG 
 2 GAGGAGCATCTTTAGCAAGAACTCGAGTTCTTGCTAAAGATGCTCCTC 
 3 GCGAGGAGCAACAACCACTTTCTCGAGAAAGTGGTTGTTGCTCCTCGC 
 4 CTATAGCAAGAGGTGTCCATACTCGAGTATGGACACCTCTTGCTATAG 
 5 CTGGATCGTGAGTGGCAATTTCTCGAGAAATTGCCACTCACGATCCAG 
Tgfbi 1 GCCTTGGCATGGTTCTGTAAACTCGAGTTTACAGAACCATGCCAAGGC 
 2 CGAGTCTTTGTTTATCGAAATCTCGAGATTTCGATAAACAAAGACTCG 
 3 CCCAATGGGATTGTAACTGTTCTCGAGAACAGTTACAATCCCATTGGG 
 4 CCTCCAGAAGAACTGAACAAACTCGAGTTTGTTCAGTTCTTCTGGAGG 
 5 GCCATTGACATCCTCAAACAACTCGAGTTGTTTGAGGATGTCAATGGC 
Fap 1 GCCACTTCATATAGGACTTAACTCGAGTTAAGTCCTATATGAAGTGGC 
 2 GCACATTATGAAGCAGAAATTCTCGAGAATTTCTGCTTCATAATGTGC 
 3 GCCTATTCTTATTATGGTGATCTCGAGATCACCATAATAAGAATAGGC 
 4 CCCTTTGCTAATTCAAGTGTACTCGAGTACACTTGAATTAGCAAAGGG 
Col6a3 1 GCCATCAACAAAGTCGTCTATCTCGAGATAGACGACTTTGTTGATGGC 
 2 CCAAGGAAGTTTCAATACGAACTCGAGTTCGTATTGAAACTTCCTTGG 
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 3 CCCTCAGGTTATCATAGTATTCTCGAGAATACTATGATAACCTGAGGG 
 4 CCTTTCTCATATTGTGAACATCTCGAGATGTTCACAATATGAGAAAGG 
Dcn 1 CCTGTCTAAGAACCAACTAAACTCGAGTTTAGTTGGTTCTTAGACAGG 
 2 CGACTTCAATGGACTGAACAACTCGAGTTGTTCAGTCCATTGAAGTCG 
 3 GCCTGAAAGGACTGATTAATTCTCGAGAATTAATCAGTCCTTTCAGGC 
 4 GTCCGGTATTGGGAAATCTTTCTCGAGAAAGATTTCCCAATACCGGAC 
 5 CCTGAAGGACTTGCATACCTTCTCGAGAAGGTATGCAAGTCCTTCAGG 
Slc38a4 1 GACGCCATGAACAGCCAATTTCTCGAGAAATTGGCTGTTCATGGCGTC 
 2 GACGCCATGAACAGCCAATTTCTCGAGAAATTGGCTGTTCATGGCGTC 
 3 CGGAAATCTGACGTTCAACAACTCGAGTTGTTGAACGTCAGATTTCCG 
 4 CGTGCCTACCATCAAATACATCTCGAGATGTATTTGATGGTAGGCACG 
Slco2a1 1 CCACCACTTTGGGAAGTATAACTCGAGTTATACTTCCCAAAGTGGTGG 
 2 GCCTATGCCAACTTACTCATTCTCGAGAATGAGTAAGTTGGCATAGGC 
 3 GCTCGGTCTTCAACAACATTACTCGAGTAATGTTGTTGAAGACCGAG 
 4 ACAGGTAATCTACAAGGTCTTCTCGAGAAGACCTTGTAGATTACCTG 
Arhgdib 1 CACACATTTCATCACCAATATCTCGAGATATTGGTGATGAAATGTGTG 
 2 CGAGAGTCTAACCAAGTACAACTCGAGTTGTACTTGGTTAGACTCTCG 
 3 GACTGGCATGAGAGTGGATAACTCGAGTTATCCACTCTCATGCCAGTC 
 4 AGTGGATAAAGCCACATTCATCTCGAGATGAATGTGGCTTTATCCACT 
Igfbp6 1 GCTGTATGTGAAGCAATGAATCTCGAGATTCATTGCTTCACATACAGC 
 2 CGGCCCAATCCTGTTCAAGATCTCGAGATCTTGAACAGGATTGGGCCG 
 3 CGCAGACACTTGGATTCAGTACTCGAGTACTGAATCCAAGTGTCTGCG 
 4 AGATGGTCAAGGAAGCACTCACTCGAGTGAGTGCTTCCTTGACCATCT 
Ptx3 1 CGAGCTCATGTATGTGAATTTCTCGAGAAATTCACATACATGAGCTCG 
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 2 CTTTGACGAATCATTAGCATTCTCGAGAATGCTAATGATTCGTCAAAG 
 3 CCAATGTTCCATTTGGGAGAACTCGAGTTCTCCCAAATGGAACATTGG 
 4 GCATCCTGTGAGACCAATGAACTCGAGTTCATTGGTCTCACAGGATGC 
Serpinb2 1 GCAGTTATGGTATCACCACAACTCGAGTTGTGGTGATACCATAACTGC 
 2 GCTTTATCCTTTCCGTGTGAACTCGAGTTCACACGGAAAGGATAAAGC 
 3 CCACAGTTTGTGGCCGATCATCTCGAGATGATCGGCCACAAACTGTGG 
 4 ATTACCCACACGATACTATTTCTCGAGAAATAGTATCGTGTGGGTAAT 
 5 TGCTTACAGTATAACTCTATTCTCGAGAATAGAGTTATACTGTAAGCA 
Loxl1 1 CTATGACCTCCGAGTGCTATTCTCGAGAATAGCACTCGGAGGTCATAG 
 2 ACTGCCAGTGGATCGACATAACTCGAGTTATGTCGATCCACTGGCAGT 
 3 TCGCTACGTTTCTACAACAAACTCGAGTTTGTTGTAGAAACGTAGCGA 
 4 CTTCGTAAACCAGTATGAGAACTCGAGTTCTCATACTGGTTTACGAAG 
Tm4sf1 1 CTTGTGTCTCATTCAAGTAATCTCGAGATTACTTGAATGAGACACAAG 
 2 GCTTCCTGTATTTCACTGTAACTCGAGTTACAGTGAAATACAGGAAGC 
 3 CATTGTGGCATCACTGGGTTTCTCGAGAAACCCAGTGATGCCACAATG 
 4 GCTTTGCTCTACTTTCCTAATCTCGAGATTAGGAAAGTAGAGCAAAGC 
Table 7.1. List of shRNA sequences designed against candidate genes. 
 
7.1.3. Agarose Gel Electrophoresis 
 
Agarose gels were made by adding 1g agarose in 100ml 1xTAE buffer. The solution 
was heated in a regular microwave, until agarose crystals were completely dissolved. The 
solution was subsequently cooled down and 2ul of Ethidium Bromide (EtBr) were added at 
100mL solution. The last step was to pour the solution in the appropriate gel cassette 
including the comb(s) with the desired number of wells. 
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7.1.4. DNA extraction from Agarose Gel 
 
The DNA extraction was performed according to the “QIAquick Gel Extraction Kit” 
protocol (Qiagen, Cat No 28704).This protocol involves weighting the band extracted from 
the agarose gel, adding 3 gel volumes of buffer QG and incubating at 50oC (heating block) to 
dissolve the agarose. After it was completely dissolved, 1 volume of isopropanol was added 
and then 700μl of this solution were placed in a QIAquick spin column with a collecting tube 
and centrifuged for 1 minute at 13000 rpm. After discarding the flow-through, 750μl of 
buffer PE were added to the spin column and incubated for 5 minutes at room temperature. 
The next step was to centrifuge the spin column for 1 minute at 13000 rpm and discard the 
flow-through again. Then, this washing step with the buffer PE was repeat followed by an 
additional centrifugation without additional buffer PE, in order to remove the residual 
ethanol. The spin column was then placed in a new 1,5ml ependorf and 30μl of H2O were 
directly added on the membrane, incubated for 2-5 minutes at room temperature and then 
were centrifuge for 1 minute at 13000 rpm to elute DNA. The final step was to measure the 
DNA concentration in the spectrophotometer (NanoDrop ND-1000).  
7.1.5. Annealing of oligonucleotides (protocol from NEB) 
 
First, a tube with the following was prepared: 
Top strand DNA oligo (100μM) 10 μl 
Bottom strand DNA oligo 
(100μM) 
10 μl 
10x NEB Buffer 2 2,2 μl 
TOTAL 22,2 μl 
 
The tube(s) were heated at 95oC for 5 minutes and then placed on water with 
temperature of 70
o
C which was cooling down over night.  
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7.1.6. Phosphorylation of oligonucleotides  
 
A tube with the following reagents was prepared: 
1x buffer A (10x) 2 μl 
ATP 10mM 2 μl 
DNA (annealed oligos) 0,4 μl 
T4 PNK (Fermentas 10u/ul) 1 μl 
H20 14,6 μl 
TOTAL 20 μl 
 
The tube(s) were then placed at 37
o
C for 20-60 minutes (heating block). The PNK enzyme 
was then heat inactivated by putting the tube(s) at 75
o
C for 10 minutes.  
 
7.1.7. Ligation  
 
 During ligation, a double-stranded fragment of DNA (insert) is ligated to another 
double-stranded DNA molecule which contains an origin of replication (backbone plasmid). 
Ligation requires compatible ends between the two DNA fragments. This insertion is feasible 
by the generation of a phosphodiester bond between the 5’ phosphate and the 3’ hydroxyl 
group of the adjacent nucleotides of the two DNA fragments. This endergonic (requires 
energy) biochemical reaction is catalyzed by T4 DNA ligase, an enzyme which derives from 
the phage T4.  
To ensure that there is sufficient insert DNA to produce recombinant DNA molecules, 
the molar ratio of the insert has to be 3-4 times more than the backbone plasmid’s. To 
calculate the amount of insert to be used in a ligation, the following equation is used: 
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For the ligation, a tube containing the following reagents was prepared: 
 
Vector ( ≈150 ng) x μl 
Insert y μl 
Rapid ligation buffer  1 μl 
T4 ligase  1 μl 
H20 (13-x-y) μl 
TOTAL 15μl 
 
 The tube was left at room temperature for 60 minutes (or 4oC over night) and then the 
enzyme was heat inactivated at 65°C for 10 minutes. 
 
7.1.8. Transformation of DH5α E.Coli 
 
For transformation, the competent DH5α strain of E. coli was used. After thawing the 
bacteria for 5 minutes on ice, 50μl of the bacterial solution were mixed with the ligated DNA. 
The solution was incubated on ice for 15 minutes, then was heated for exactly 90 seconds at 
42°C and finally was placed on ice for another 2 minutes. Since Ampicilin is a bacterio-static 
antibiotic (competitive inhibitor of transpeptidase, an enzyme needed by bacteria to build 
their cell wall – ultimately this leads to cell lysis), the bacterial solution can be plated directly 
on the LB plates (containing Ampicilin) and incubated overnight at 37
o
C. Only the 
transformed bacteria containing the desired plasmid, which also includes the gene giving 
resistance to Ampicilin, will survive and grow as independent colonies in the plate. Single 
colonies were then picked, placed in a tube containing 3ml LB medium containing ampicilin 
and incubated over night on a shaker at 37°C.  
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7.1.9. DNA preparation (mini) 
 
DNA from single colonies was isolated by transferring 2ml from the bacterial culture 
(incubated overnight) in a 2.0ml tube and centrifuging at 13000 rpm for 1 minute, at room 
temperature (RT). The supernatant was discarded and the pellet was re-suspended in 250μl of 
buffer P1. 250μl of buffer P2 were then added and the solution was mixed by inverting the 
tube few times (bacterial lysis). In the next step, 350μl of buffer P3 were added to neutralize 
the reaction, the tube was inverted again for several times to ensure mixing and was 
centrifuged at 13000 rpm for 1 minute (RT). The supernatant was transferred in a new 1.5ml 
tube, 700μl isopropanol were added and the solution was again centrifuged at 13000 rpm for 
1 minute (RT). The supernatant was discarded this time, the pellet was washed with 250μl of 
70% ethanol and centrifuged at 13000 rpm for 1 minute (RT). The supernatant was discarded 
carefully, the pellet was air-dried before it was re-suspended in 30μl of H2O.  
 
7.1.10. DNA preparation (maxi) 
 
If higher DNA yield (amount and concentration) was necessary (i.e. for virus 
production), the bacteria were placed on 200-250 ml of LB medium supplemented with 
Ampicilin and incubated overnight on a shaker at 37°C. After 15-16 hours, the plasmid DNA 
was isolated using the QIAprep Plasmid Maxiprep Kit (Qiagen, Cat No 12362). The bacterial 
cells were harvested by centrifugation at 4600 rpm for 15 minutes at 4
o
C. The pellet was re-
suspended in 10ml of buffer P1, in which RNase (to degrade RNA) and LyseBlue (for visual 
confirmation of optimum buffer mixing preventing inefficient cell lysis and incomplete 
precipitation of genomic DNA, sodium dodecyl sulfate and cell debris in next steps) were 
added. Then, 10 ml of buffer P2 were added and the tube was mixed thoroughly by inverting 
the tube 6 times until a homogeneously blue-colored solution was achieved (cell lysis). 
Buffer P2 contains sodium dodecyl sulfate (SDS), a detergent which will dissolve the 
phospholipid membranes and cause the lysis of the bacterial cell wall. It also contains sodium 
hydroxide (NaOH), which will raise the pH causing the denaturation of cell proteins, DNA 
and high-molecular-weight RNA. However, the plasmid DNA remains supercoiled and 
remains in the solution. Important precautions in this step are to: 1. not vortex the tube 
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(shearing of genomic DNA) 2. not allow the lysis reaction to proceed for more than 5 minutes 
and 3. to close immediately the lid of the bottle containing buffer P2 to avoid acidification 
from the CO2 of the air. Subsequently, 10ml of chilled buffer P3 (contains potassium acetate - 
CH3CO2K) were added and the solution was mixed immediately again by inverting the tubes 
6 times (neutralization). In this step, the SDS will precipitate together with proteins, lipids 
and chromosomal DNA, since it is attached to cell membrane proteins. It is important to get a 
homogeneous colorless solution after the addition of buffer P3, which indicates the successful 
precipitation of SDS, genomic DNA and cell debris. If the solution still appears viscous the 
neutralization was not completed and additional mixing is required. In the next steps the 
tubes were places on ice for 20 minutes and then were centrifuged at 20000xg for 30 minutes 
to separate the precipitated solution from the solved plasmid DNA. An additional 
centrifugation step followed (15 minutes) if the solution was not separated.  During this time, 
the QIAGEN-tip 500 was equilibrated by applying 10ml of buffer QBT and allowing the 
column to empty by gravity flow. Then, the supernatant from the previous centrifugation step 
was transferred in the column and was allowed to pass by gravity flow (as in all following 
steps). The QIAGEN-tip was washed two times by adding 30ml of buffer QC. Then, 15ml of 
buffer QF were added to elute the DNA, which was later precipitated by the addition of 
10.5ml room-temperature isopropanol. After centrifuging at 4600 rpm for 45 minutes and 
discarding the supernatant, the pellet was washed with 5ml of 70% ethanol (EtOH). After a 
10-minute centrifugation, the supernatant was decanted and the pellet was left to air dry. The 
last step was to re-suspend the pellet in the appropriate volume of H2O (50-100μl) and to 
determine the DNA concentration by using the spectrophotometer (NanoDrop ND-1000). 
 
7.1.11. Glycerol stocks 
 
Positive clones (identified by screen digests) were stored at -80
o
C, after the addition 
of 700μl of bacterial over-night culture in 300μl 50% glycerin solution.  
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7.1.12. Sequencing 
 
Positive clones, screened by a digest and gel electrophoresis, were then sequenced to 
validate the DNA sequence. The first step was a PCR to amplify the DNA sequence to be 
confirmed. The following reagents were added in a well of a multi-well sequencing plate: 
BigDye (contains dNTP, 
Polymerase) 
0,5 µl 
BigDye buffer (5x) 1 µl 
template * x µl 
DMSO 0,1µl 
Primer (5µM stock) 1 µl 
Water (5-x) µl 
TOTAL 5 µl 
 
*The table below shows the amount of template to use in a cycle sequencing reaction 
(recommendation of the original protocol of Applied Biosystems) 
 
Template Quantity 
Single stranded 25 – 50 ng 
Double stranded 150 – 300 ng 
Cosmid, BAC 0,5 – 1 µg 
          
 
  
Then, a PCR was performed according to the following program: 
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Step Temperature Duration Number of 
cycles 
Initialisation 96
o
C 1 minute 1 
Denaturation 96
o
C 10 seconds 
35 Annealing 50
o
C 5 seconds 
Elongation 60
o
C 4 minutes 
Stanby 12
o
C ∞  
         
            
 The next step after the PCR reaction was to precipitate the DNA with ethanol. For this 
reason, 0.5µl of 125mM EDTA, 2.0µl of 3M Na-Acetate and 50μl 100% EtOH were mixed 
with each PCR product and the plate was incubated for 15 minutes at room temperature in the 
absence of light. The plate was then centrifuged at 2000xg for 30 minutes at 4
o
C and the 
supernatant was discarded. A second brief centrifugation step followed (180xg), 70µl 70% 
EtOH were added in each well and the plate was centrifuged again (2000xg, 15 minutes at 
4
o
C). The plate was inverted to remove the ethanol, centrifuged briefly (180xg) and rested for 
2 minutes in the dark to allow evaporation of residual EtOH. After this step, 20μl of HPLC 
H2O were added in every well and the plate was sealed. The plate was sequenced by an ABI 
3730 DNA analyzer. 
   
7.1.13. RNA extraction 
 
 For RNA isolation from AFT024, 2018 and other cell lines the RNeasy Mini Kit for 
Qiagen (Qiagen, Cat No 74106) was used. This kit allows isolation of up to 100μg RNA from 
100 to 10
7 
cells. It enables isolation of RNA molecules longer than 200 nucleotides, which 
results in an enrichment of mRNA molecules over most other RNAs which are sorter (i.e. 
5.8S rRNA, 5S rRNA, tRNA etc). Cells were harvested after a PBS wash, trypsinization, 
transfer to a polypropylene (RNase-free) tube, centrifugation at 1000 rpm for 5 minutes and 
re-suspension to buffer RLT (350μl for <5x106 cells or 600μl for >5x106 cells) supplemented 
with β-Mercaproethanol. After mixing the solution by pipeting, the sample was either frozen 
at -80
o
C or placed in QIshredder spin column (Qiagen, Cat No 79654) and centrifuged at full 
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speed for 2 minutes (lysate homogenisation). One volume of 70% EtOH was then added to 
the homogenized lysate and up to 700μl were transferred to the RNeasy spin column which 
was centrifuged at >10.000 rpm for 15 seconds. The flow through was discarded and the 
previous step was repeated until all the lysate was added to the column and centrifuged. Next, 
350μl of buffer RW1 were added to the spin column and the tube was centrifuged at >10.000 
rpm for 15 seconds (washing step). To digest the residual DNA, 80μl of DNase solution (10μl 
of DNase stock solution in 70μl of buffer RDD) were added directly on the silica membrane 
of the spin column and were incubated for 15 minutes at room temperature.  Another washing 
step with addition of 350μl of buffer RW1 and centrifugation followed. After discarding the 
flow through, 500μl of buffer RPE were added. The sample was centrifuged and additional 
500μl of buffer RPE were added to the column and centrifuged for 2 minutes. Then, the 
RNeasy spin column was placed in a new collection tube and they were centrifuged for an 
additional 1 minute to completely remove the residual ethanol contained in the RPE buffer. 
The RNeasy spin column was placed in a new 1,5ml tube and 30μl of RNase-free H2O were 
added to elute the RNA bound in the silica membrane upon centrifugation. The concentration 
of the eluted RNA was determined in a spectrophotometer (NanoDrop ND-1000). In addition, 
the quality of the eluted RNA was accessed by running few microliters of individual samples 
in a 1% agarose gel.  
7.1.14. cDNA synthesis 
 
For the reverse transcription of the mRNA produced during the RNA extraction 
method described above, the following reagents were added in a tube: 
Reagent Company Cat No Quantity 
Oligo(dT)12-18 (500 μg 
/ml) 
 Promega C1101 1 µl 
total RNA (2μg)   x µl 
dNTP mix (10mM each)   1 µl 
Sterile DNase- and 
RNase-free H20 
  (12-x) µl 
TOTAL   12 µl 
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The mixture was heated at 65
o
C for 5 minutes and then quickly chilled on ice. The 
samples were briefly centrifuged and then the following reagents were added: 
Reagent Quantity 
5x first strand buffer 4 µl 
0.1M DTT 2 µl 
RNase OUT
TM 
(40units/μl) 
1 µl 
 
The tubes were incubated at 42
oC for 2 minutes and then chilled on ice. Finally, 1μl of 
SuperScript II RT (Invitrogen, Cat No 18064-014, 200 units) was added to each tube (except 
from the control samples without reverse transcriptase, “-RT”), the solution was gently mixed 
by pipeting and then incubated at 42
o
C for 50 minutes. The reaction was inactivated by 
heating at 70
o
C for 15 minutes.  
7.1.15. Quantitative real time PCR (qRT-PCR) 
 
 All samples in the quantitative real time PCRs described in this study were performed 
in technical triplicates. First, 5μl of the primer mix containing the forward and reverse primer 
for every gene of interest (5mM) were added in each of the three wells of the 384-well plate 
(ABgene, TF-0384) designated for this gene (Figure7.1). Then, 5μl from the diluted cDNA 
(1/50) synthesized from RNA isolated from the different cell lines were also added to the 
respective wells. Finally, 10μl of 2xSybrGreen Mix (Applied Biosystems, Cat No 4367659) 
were added in every well. The plate was covered with the optical adhesive, transparent cover 
(Applied Biosystems , Cat No 4311971), centrifuged and placed in the Abi Prism 7500HT 
machine (Serial No 100252). The different steps of the PCR are described below: 
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Temperature time Cycles 
95°C 10min 1 
95°C 15sec  
40 60°C 1min 
 
 As a standard procedure, the dissociation (melting) curves illustrating the specificity 
of the different primer sets were also analyzed in every qRT-PCR. The normalization was 
done based on the GAPDH expression of the cell lines used. 
Figure 7.1. Experimental design of the qRT-PCR experiments used to compare gene expression 
in the AFT024 and 2018 stroma cell lines. 
 
7.1.16. Primer design for qRT-PCR 
 
 The gene-specific primers for qRT-PCR were designed using the online tool from 
IDT-DNA (http://eu.idtdna.com/scitools/Applications/RealTimePCR/). Primers are intron-
separated when feasible and are presented in the table 7.2 below: 
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Gene ID 
Protein 
Type 
Orientat
ion 
Sequence 
Dlk1 13386 
memb
rane 
forward GGCCATCGTCTTTCTCAACAAGTGC 
reverse CCTCGCCGCTGTTATACTGCAAC 
Ly6a 17067 
 forward TCTTCTTGTGGCCCTACTGTGTG 
reverse GGGCAGGTAATTGATGGGCAAG 
Trfc 22042 
 forward TTCTTGTGGCCCTACTGTGTGC 
reverse ACTGCTGCCTCCTGAGTAACAC 
Slc8a1 
20541 
 
 forward GCAAAGAAGAGGAGGAGAGGCGCATTG 
reverse ACCACAAGGGCCAGGTTCGTCT 
Npc1 
18145 
 
 forward CACGCCTCCGAAAGCTACCTGTTTC 
reverse CCCGATGTCTACTTTGTTCACCACCG 
Enpp1 
18605 
 
 forward TATGGACCTGCTGCTCGGTTGAGAC 
reverse GGTAAGGCCGGAAATGCTGGTTTGG 
Enpp2 
18606 
 
 forward AGGGTTTGTCCGCCCTCCGTTAATC 
reverse GCCACAGGACCGCAGTTTCTCAATG 
Enpp3 209558 
 forward CAGGGTGATGCAGAAGAACGGAGAC 
reverse CTCCCGGCTTGAGAACGGTGTATGA 
Ly6c 
17067 
 
 forward GCTACGAGTGCTATGGAGTGCCAAT 
reverse ACACCAGCAGGGCAGAAAGAAAGG 
Ly6e 
17069 
 
 forward CCCTTCTGGGCATGGAGCAAGTTCAT 
reverse CAGGGTGTAGCCAAGGTTGACATTCC 
Dpt 
56429 
 
Extra
cellul
ar 
forward CGAGGAGCAACAACCACTTTCTCTGC 
reverse GTCGTAGTCAGTCATCCGGCACA 
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matri
x 
Col1a2 
12843 
 
 forward GGATGAGGAGACGGGCAGCTTGAA 
reverse GAACGGCAGGCGAGATGGCTTATTTG 
Col5a3 
53867 
 
 forward TCCAAGGGACCAACTGGGAAGAGT 
reverse CACAGAGGCAGGAAACCCACAGAAG 
Col6a3 
12835 
 
 Forward GCCCATCACCACTCTAACCTCACAG 
reverse TTGAGTCTGCGAACGATCCTGCTG 
Col7a1 
12836 
 
 forward TGGGATGGTGAAGCCGAGATTAAGG 
reverse CAGCGCAGGGTATAGGCAGTACA 
Col8a1 
12837 
 
 forward CCTATGAGATGCCTGCGTTTACTGCC 
reverse GGTGAAGATGCCTGTCTGCGGATTG 
Col13a
1 
12817 
 
 forward CCAAAGGGAGAAGCTGGTGTTGAT 
reverse CGCCTCGTTGATGCTGCCATTA 
Tgfbi 
21810 
 
 forward GAAATCCTGGTTAGCGGAGGCATCG 
reverse CGGCAACAGGCTCCTTATTGACACTC 
Matn2 
17181 
 
 forward GCAGTATTCCACACAGGTCCGAA 
reverse TGGGTCACGGCTTTCTTCATTTCC 
Fn1 
14268 
 
 forward GCTGTGAAAGGGAACCAGCAGAGTC 
reverse CGGTGTTGTAAGGTGGAATGGAGCG 
Thbs2 
21826 
 
 forward GTGCTACTAATGCCACCTACCACTGC 
reverse CGTCACAAGCATCTCCGATTCCATCC 
Svep1 
64817 
 
 forward CAAATGCTTGCTCATGCCCAGACGG 
reverse CACACAGCGCCCACCATTCAAACAG 
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Bgn 
12111 
 
 forward CTTCAGTGCCATGTGTCCTTTCGG 
reverse GTCTAGCAGTGTGGTGTCAGGTGAG 
Dcn 
 
13179 
 
 forward CCAGTGTCATCTTCGAGTGGTGCAGT 
reverse GTCTAGCAAGGTTGTGTCGGGTGGAA 
Mmp9 17395 
 forward GCAAACCCTGTGTGTTCCCGTTCATC 
reverse GTAACCATCCGAGCGGCCTTTAGTG 
Ogn 
18295 
 
 forward CGACCTGGAATCTGTGCCTCCTAA 
reverse CGCTCCCGAATGTAACGAGTGTCA 
Ecm1 
13601 
 
 forward CCTTGATCTTGGCCTGCTTGGCTCT 
reverse TGGCGTCATCTCTCGCTGGTCTGAA 
Ctsb 
13030 
 
 forward ACTTGCTGTGGTATCCAGTGTGGG 
reverse GGAGGGATGGTGTATGGTAAGCAGC 
Sparcl 13602 
 forward CCGATCCACAAGGGAAACCTCACTG 
reverse GTAGCAAACAGGTGACAGGAGCTGG 
Fap 
14089 
 
 forward TTGACACCACCTACCCTCACCAC 
reverse CACTGCAAGCATACTCGTTCACTGG 
Adam9 
11502 
 
 forward AGGATATGGAGGAAGCGTGGACAGC 
reverse GGAAGAAGAAGACCAGAAGCCCGTC 
Itgb1 
16412 
 
Cell 
adhesi
on 
forward GTAGCAGGCGTGGTTGCTGGAATTG 
reverse TTCACCCGTGTCCCACTTGGCATTC 
Itga5 
16402 
 
 forward CTACTTGGGATACTCTGTGGCTGTGG 
reverse CGTTGTAGAGGGAGTGGATGTCTGAG 
Itga6 16403  forward GCTTCCATAGATGTCACCGCTGCTG 
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 reverse GCATCAGAATCCCGGCAAGAACAGC 
Shc 
20416 
 
 forward GGAGGTCTTACAGTCAATGCGAGCC 
reverse CAGGCACAGCTTCACACACCAAAC 
Abl1 
11350 
 
 Forward TTAGTGCGGGAGAGTGAGAGTAGCC 
reverse GTAGTGGAGTGTGGTGATGAGGCCA 
Pik3r1 
18708 
 
 forward CTGAGTACCGAGAGATCGACAAACGCA 
reverse CCAGCCACTCGTTCAGCTTCTTCTG 
Map3k
1 
26401 
 
 forward GGGACTGGGACTTTAATGGCTGTGA 
reverse GATCTCTTCCCTCAACGCTTCCACC 
Jnk2 
26420 
 
 forward GGGAGAGCTGGTGAAAGGTTGTGTG 
reverse GAACTCTGCGGATGGTGTTCCTAGC 
Pea-15 
 
18611 
 
 forward GGAGAGCCACAACAAGCTGGACAA 
reverse GCACACGGGTTCTGTAGTCAACCA 
Vcam1 
22329 
 
 forward GTGACAATGACCTGTTCCAGCGAGG 
reverse AAGGTGAGGGTGGCATTTCCTGAGAG 
NCca
m 
17967 
 
 forward CAGGCCAGACAGAGCATCGTGAATG 
reverse GCTTCTCGTCATCTTCCTCCTCGTTC 
Dd 
 
16847 
 
 forward CTGTGTAGTGTGAGGAGGTACGTGG 
reverse AAGCGCCGAGGGAATTGACAG 
Mapre
2 
212307 
 
 forward CCAAGAACATGGGCAGGAGAACGA 
reverse CCTCTGCTTCTGGCTCTTCCGTTTG 
LgalsS
3 
16854 
 
 forward TATCCTGCTGCTGGCCCTTATGGTG 
reverse CCTGTTTGCGTTGGGTTTCACTGTGCC 
Lgals8 56048  forward CTCCATCGGGTTCAGATTCAGCTCG 
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 reverse GCTTCGGGCATTGGTGTTCACTTCC 
Lgals9 
16859 
 
 forward TTGCTTCCTGGTGCAGAGGTCAGAG 
reverse TGGTAGGGTACGCGGTGTTGGTACT 
Nov 
18133 
 
 forward CTCTGCATCGTTCGGCCTTGTGAA 
reverse GCTTTCAGGGATTTCTTGGTGCGG 
Eda 
13607 
 
 forward AGCCTTTGGAACCGGGAGAAGATCCAC 
reverse CTTATTGCGGCGAACACGCCTACTTTCC 
Spn 
46194 
 
 forward CCTGATGAAGAGGCCACAACCACATC 
reverse GTACTAAAGAGCCCTGGCGAGACTTCC 
Cdh11 
 
12552 
 
 forward GGAGAGTACATGCCAAAGACCCAGAT 
reverse TGAGCCAGGCAGTTTCTTCCCTAT 
Cdh22 
 
104010 
 
 forward TGGCCTCTCAGGTTCCACTACAGTC 
reverse TCATGTCCGTGTTCTCGCCCACATC 
Fzd1 
 
14362 
 
 forward GGACATCGCGTACAACCAGACCATC 
reverse CGCGTACATGGAGCACAGGAAGAACTTG 
Lrp6 
 
16974 
 
 forward GCCCACTACTCCCTGAATGCTGACAAC 
reverse CCGAAGGCTGTGGATAGGAAGGATGAT
G 
Bsg 
 
12215 
 
 forward CGAAGTACATAGTGGACGCAGATGAC 
reverse GACCAGTTTCGCAAGCTCTCC 
CD82 
 
12521 
 
 forward GTCCTACAAACCTCATCCAGCTCGC 
reverse GACAAAGTACAGACCCAGCAAGCAGC 
Tspan
5 
56224 
 
 forward TCCAATGCAAGCCGAGAGCGATG 
reverse TGGTCAACTTCTGGTTTCTGCCTGG 
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Tspan
6 
56496 
 
 forward CTGGAGGGCTGTTATCCACAGAGAGATG 
reverse CACGAGACAGGCAGTAGGCAAGAAAG 
Gapdh 14433 
 forward CCCACTGAAGGGCATCTTGGGCTAC 
reverse GGGTGGGTGGTCCAGGGTTTCTTAC 
Table 7.2. List with the gene-specific primers used for the qRT-PCR analysis. 
 
7.2. Cell Biology (Cell Culture and Viral transduction)  
7.2.1. Culture of AFT024, 2012, BFC012, 2018, knocked down AFT024  
 
 Cell lines AFT024, 2012, BFC012 and 2018 were obtained from Kateri Moore, 
Mount Sinai School of Medicine, New York, USA. These cell lines were isolated from the 
fetal liver of E14.5 mice and were immortalized by the expression of large T antigen 
(Wineman et al., 1996). Cells were cultured in high glucose DMEM (Gibco, Cat No 11960-
085) supplemented with 10% FCS 14 (PAA, Cat No A15-101, Lot No. A10108-2429), 
0,1mM non-essential aminoacids 100x (Gibco, Cat No 11140-035), 1mM sodium pyruvate 
(Sigma, Cat No S8636), 2mM L-glutamine (Gibco, Cat No 25030-024), 5x10
-5M β-
Mercaptoethanol (Sigma, Cat No M3142-25ML) and penicillin/streptomycin (Gibco, Cat No 
15140-122), which was called “stroma media”. Cells were cultured on 33oC with 100% 
humidity and 5% CO2. They were passaged 1:5 to 1:6 every 3 days in 6 cm dishes with 2-3 
ml of media. Cells were trypsinized by adding 0.05% trypsin-EDTA (Gibco, Cat No 25300-
096) for 2-3 minutes which was then quenched by media containing serum. 
 
7.2.2. Thawing & Freezing 
 
When thawed, the plates were coated with 0.1% gelatin for 20 minutes prior to the 
addition of the cells. Frozen cells were thawed in the water bath (37
o
C) and then placed 
directly in the plate (media would have to be changed the next day to remove the DMSO). 
Alternatively, 9ml of media were added to the thawed cell solution and were centrifuged at 
1000rpm for 5 minutes at 4
o
C. The supernatant was decanted and the cell pellet was re-
suspended in 2-3 ml of stroma media (described above) prior to plating.  
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Cells were frozen in 10% DMSO in FCS 14 (PAA, Cat No A15-101, Lot No. 
A10108-2429), by first placed in cryo-containers (Nalgene Cryo, Cat No 5100-0001) 
containing isopropanol at -80
o
C and then in the liquid nitrogen tank. 
 
7.2.3. Lentiviral constructs 
 
To deliver the desired shRNA constructs (or open reading frames of genes of interest) 
and ensure their expression in the stroma cells, we used 3
rd
 generation lentiviruses. Generally, 
lentiviruses are a sub-class of retroviruses that have the unique ability to integrate their 
genome also in non-dividing cells, whereas retroviruses fail to do so. Lentiviruses are RNA 
viruses that generate their DNA by reverse transcription upon entering the cell. Their DNA is 
then randomly integrated in the genome of the host cell by the enzyme integrase (pro-virus 
stage) and it is inherited to the cell progeny. The 1
st
 generation of lentiviral vectors contained 
all the HIV genes besides the gene of the envelope (Naldini et al., 1996). In the 2
nd
 generation 
of vectors, only the reading frames of the gag, pol (encoding for the structural and enzymatic 
components of the virion respectively), tat and rev (for transcriptional and post-
transcriptional functions) were kept. Finally, in the 3
rd
 generation, the tat reading frame was 
additionally removed and an engineered 5’ LTR was used to ensure tat-independent 
transcription.  
 
The original lentiviral construct used in this study to generate the final lentiviral 
backbone constructs was a kind gift from C Baum. Briefly, the pLKO.1 vectors used in this 
study (Figure 7.2) contain the following domains: 
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Figure 7.2. depiction of the lentiviral constructs used in this study for stroma manipulation. 
 
 a human U6 promoter driving the transcription of the downstream shRNA by 
the RNA polymerase III, 
 a human phosphoglycerate kinase promoter (PGK) driving the expression of 
the tandem fluorescent protein tdTOMATO fused with the c-HA-Ras 
farnesylation signal for membrane anchoring of the fluorescent protein, 
 the ampicilin resistance gene (AmpR) for selection of the transformed DH5α 
bacteria driven by a bacterial promoter 
 the pUC origin of replication, which allows DNA replication of the plasmid 
independently of the replication of the genomic DNA (this origin of 
replication is derived from E.coli plasmid pBR322 and originally contained a 
mutation (in the Rop/Rom gene) that removes the regulatory constraints on the 
plasmid replication – bacteria can then produced not just 30-40 plasmids per 
cell, but up to 500) 
 the f1 origin of replication which allows DNA replication in the phage f1 
 an engineered 3’ self-inactivating long terminal repeat (3’ SIN LTR) without 
the U3 region which is essential for the replication of the lentivirus (contains 
the viral promoter in its RNA genome), therefore increasing the bio-safety of 
such vectors 
 U5 
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 SV40 ori 
 LacZ  
 the woodchuck hepatitis virus (WPRE) for enhancing the stability and increase 
the level of transcripts both in producer and target cells (Zufferey et al., 1999) 
 a central termination sequence (CTS) region 
 Rous sarcoma virus (RSV) U3 sequence 
 PSI 
 Rev response element (RRE) 
Since the promoter choice is a very important factor for robust shRNA expression, we 
chose the human U6 (RNA polymerase III, class III) promoter because: 1. of the relative 
simple promoter structure, 2. of the well-defined transcriptional starting site, 3. it lacks 
sequences that can lead to transcription beyond the initial transcription starting site, which 
can lead to creation of long dsRNA and can trigger interferon response and 4. this class 
naturally drive the transcription of small RNAs.   
 
7.2.3. Virus production 
 
 For the purpose of this study, 3rd generation lentiviral vectors with eco tropism 
(laboratory safety level S1) were used. HEK293 cells were used as the producer cell line, 
which plated in 60cm
2
 dishes (5x10
6
 cells per dish). The next day, the following plasmids and 
reagents were used for the transfection of HEK cells (table 7.3): 
 
Plasmid no Reagent Function Quantity 
391  Tropism (eco) 2ug 
392  gag gene 
(essential for 
viral structure), 
pol gene 
(integration of 
provirus) 
5ug 
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393  rev gene (reverse 
transcriptase) 
10ug 
plasmid of interest   5ug 
 CaCl2  50μl 
 H2O  to 500μl 
Table 7.3. List with DNA constructs used for the production of ecotropic lentiviruses. 
 After this, 500μl of 2xHBS were added to the mix while the sample was vortexed. 
HEK cells were placed in 10ml of “transfection media” (DMEM containing L-glutamine and 
110mg/ml Sodium Pyruvate (Sigma, Cat No S8636) and supplemented with 10% FCS, 1% 
penicillin/streptomycin (Gibco, Cat No 15140-122) and 20mM Hepes buffer (Gibco, Cat No 
15630-056), just before the addition of the mix mentioned above. After 12 to 24 hours, the 
media was changed to “stroma media” (which briefly consisted of high Glucose DMEM 
(Gibco, Cat No 11960-085) supplemented with FCS, non-essential aminoacids, L-glutamine, 
sodium pyruvate, β-mercaptoethanol and penicillin/streptomycin. One day later, the 
supernatant from every plate was first filtered through a 0.22μm filter, aliquoted and finally 
directly frozen at -80
o
C.  
 
7.2.4. Viral Transduction of stroma cells 
 
For efficient expression of shRNA constructs or open reading frames from selected 
genes, we used 3
rd
 generation lentiviral vectors for transduction of the stroma cell lines (for 
construct details see section 7.2.3). Briefly, 15000 stroma cells were plated on a well of a 24-
well plate in 2ml of “stroma media” containing viral particles from the engineered virus 
expressing the construct of.  The media was exchanged the next day by fresh “stroma media”. 
Cells were then passaged on 24-well, 6-well plate and finally in a 6-cm dish, before they were 
analyzed by FACS. Using FACS, the transduced cells, which were expressing tdTOMATO, 
were distinguished from the non-transduced ones, were sorted and re-plated in gelatinized 6-
cm dishes (250000-350000 events per plate). Later, a small number of vials from each 
genetically-modified stroma cell line was frozen at -80
o
C and liquid nitrogen.  
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7.3. Primary Cell Isolation 
7.3.1. Mouse strains 
 
Fluorescent reporter transgenic mice (B6J;129-Tg(CAG-EYFP)7AC5Nagy/J), which 
express a construct (pCX::EYFP) containing the yellow fluorescent protein (YFP) under the 
control of the chicken beta actin promoter coupled with the cytomegalovirus (CMV) 
immediate early enhancer (Hadjantonakis et al., 2002). The construct was introduced into 
(129X1/SvJ x 129S1/Sv)F1-derived R1 embryonic stem cells. The transgenic offspring mice 
were then backcrossed with C57Bl/6J mice for at least 10 matings and used in the current 
study. These mice enabled me to distinguish the isolated bone marrow cells from the co-
cultured stroma cells. In addition, mT/mG fluorescent reporter mice were also used. These 
mice express tandem Tomato protein fused with a membrane localization signal under the 
control of the pCAG promoter. The background of the mT/mG mice is also C57Bl/6J. It is 
important to note that previous results of the lab regarding the behavior of HSCs and MPPs 
on different stromata (Erin Drew, personal communication), were generated using YVI mice 
of mixed background and not C57Bl/6, which is the classical mouse strain used in 
hematopoietic research. Using mixed background mice can be problematic and introduce 
variation during experimentation, therefore these data were not used in the current thesis. 
 
7.3.2. HSC isolation – Mouse preparation 
 
The femur, tibia, pelvis and potentially the front legs of mice with the desired 
genotype were isolated and transferred to Dulbecco’s phosphate buffer saline DPBS (Gibco, 
Cat No 14190-169). The isolated bones were cleaned from residual tissue and muscle and 
then were mortared. The cell suspension was transferred to a 50ml falcon by filtering through 
a 100μm cell strainer (Schubert und Weiss, Cat No FALC352360) and then was centrifuged 
at 1000rpm for 5 minutes at 4
o
C. The supernatant was decanted and the cell pellet was re-
suspended in (2,5ml per mouse) FACS buffer (1mM EDTA, 5% FCS in PBS). Biotinylated 
lineage antibodies (table 7.4) were added (25μl each per mouse) and incubated for 20 minutes 
on ice. After a washing step with PBS, the cell solution was centrifuged again and re-
suspended as mentioned above. Streptavidin-labeled magnetic beads (Roth, Cat No HP571) 
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were centrifuged, re-suspended in FACS buffer and then added (25μl per mouse) to the cell 
solution which was incubated for 20 minutes on ice.  
 
Antibody Clone Company Target cell type 
CD3 145-2C11 13-0031-85 T-cells 
B220 RA3-6B2 13-0452-86 B-cells 
CD19 eBio1D3 13-0193-85 B-cell progenitors 
CD41 eBioMWRag30 13-0411-85 Thrombocytes 
Terr119 TER-119 13-5291-85 Erythrocytes 
Gr1 RB6-8C5 13-5931-85 Granulocytes 
Mac1 M1/70 13-0112-85 Macrophages 
Table 7.4. List of antibodies used in the lineage depletion of bone marrow cells.  
 
Additional FACS buffer was added to the solution (up to 10ml) and cells were 
transferred to a polypropylene round bottom (PP) tube (BD Falcon, product no 352063) and 
then placed in pre-chilled magnet (BigEasy EasySep magnet, Stem Cell Technologies, Cat 
No 18001) for 7 minutes. Lineage low (Lin
low
) and negative (Lin
neg
) cells were then 
transferred to a new PP tube in which they were centrifuged. The supernatant was decanted 
and the cell pellet was re-suspended in 200μl of FACS buffer. Finally, the antibodies for the 
HSC staining were added (table 7.5) based on the cell number (0,2μl Ab per 106 cells, except 
for CD34 for which 25μl were added per mouse, but not more than 50μl in total) and 
incubated for 30-45 minutes on ice. The cell solution was washed with PBS, centrifuged at 
1000rpm for 5 minutes at 4
o
C and re-suspended in FACS buffer (≈250μl per mouse). The 
cells were filtered through a cap of a polystyrene tube (BD Falcon, product no 352235) 
before analyzed with FACS. For the compensation samples, FACS buffer was added in the 
lineage positive cells (Lin
+
), cells were filtered through the cell strainer to independent tubes 
and then a single conjugated antibody was added per tube (one tube for each flurochrome). 
After 30 minutes incubation, cells were washed with PBS, centrifuged and re-suspended in 
FACS buffer.  
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Antibody Flurochrome Clone Company 
CD34 e450 RAM34 48-0341-82 
Sca1 PerCP Cy5.5 D7 45-5981-82 
CD150 PE TC15-12F12.2 115904 
CD48 APC HM48-1 17-0481-82 
cKit PE Cy7 2B8 25-1171-82 
Streptavidin APC e780  47-4317-82 
Table 7.5. List of antibodies used for HSC and MPP isolation from murine bone marrow.  
 
7.3.3. Flow cytometry 
 
The flow cytometry analysis was conducted in a FACS Aria I and later in a FACS 
Aria III (Beckton & Dickinson, Cat No 648282) equipped with a 405nm violet laser, a 488nm 
blue laser, 561nm yellow/green laser and a 633nm red laser. The 70mm nozzle was used for 
FACSorting of bone marrow cells and the 100mm nozzle for stroma cells. For multicolor, 
flow cytometrical analysis and sorting, single-stained samples were used to calculate the 
bleed-through of each flurochrome to all other channels. Using a specialized algorithm 
incorporated in the BD software, the percentage of bleed through was then subtracted for 
each fluorescent channel individually. HSCs and MPP populations were isolated followed the 
sorting scheme depicted in Figure 7.3. 
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Figure 7.3. Depiction of the gating scheme for isolation of HSCs and MPPs by flow cytometry. 
 
7.4. Time lapse imaging experiments 
7.4.1. Preparation of stroma cell monolayers 
 
Before the co-culture of freshly purified hematopoietic cells the with stroma, stroma 
cells were irradiated with 20Gy from a Co source (Gammacell II, Model GC 220 Type B, Cat 
No CDN-U13). A specific number of stroma cells (150000 AFT024 or 2012 and 125000 
2018) were plated on a well of a 12-well plate (Thermo Scientific, Cat No 150628) 
containing an ibidi insert (Ibidi, Cat No80209) 18 hours prior to irradiation. The day of the 
co-culture, the “stroma media” was exchanged with “modified Dexter media” (high glucose 
DMEM (Gibco, Cat No 11960-085), 10%ml FCS 14 (PAA, Cat No A15-101, Lot No. 
A10108-2429),  10% Horse serum (Gibco, Cat No 16050-122, Lot No 460470), 5x10
-5mM β-
mercaptoethanol, 10
-6
mM Hydrocortisone (Stem Cell Technologies, Cat No 07904) and 
penicillin/strepromycin (Gibco, Cat No 15140-122).  
 
7.4.2. Time-lapse imaging 
 
For the acquisition of the time-lapse movies, the Zeiss Axiovert 200M or 
AxioObserver.Z1 microscopes were used. Endogenous YFP signal was detected using the 
Zeiss Filter 46HE filter (Zeiss, Excitation BP500/25 DMR 25, Beam Splitter FT 515HE, 
Emission 535/30 DMR 25, Cat No 489046-9901-000). Motorized stages were utilized to 
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enable image acquisition in different positions and self-made incubators to ensure stable 
temperature of 37
o
C. Phase-contrast or brightfield pictures were acquired every 6 to 12 
minutes and fluorescent pictures every 15 minutes using a 5xPlan NeoFluar (numerical 
aperture 0,3), and recorded  by an AxioCamHRm camera (at 1388 x 1040 or 692 x 520 pixel 
resolution) using the Zeiss AxioVision 4.8 software or later. Mercury lamps (HXP or HBO, 
both Osram) or light-emitting diode based systems (LEDs, Lumencore, Laser 2000, Cat No 
1303749) were used for fluorescent illumination. 
 
7.4.3. Single-cell tracking  
 
 Single cell tracking and reconstruction of cells genealogy into trees was performed 
manually using Timm’s Tracking Tool (TTT). 
 
7.4.4. Statistical analysis 
 
 Results were analyzed using the non-parametric Mann-Whitney test (one-tailed) for 
data not following the Gaussian distribution, unless otherwise mentioned. Error bars are 
standard deviation (SD). 
 
7.5. Protein Detection  
7.5.1. Western Blotting (Immunoblot) 
 
Cultured cells were harvested, centrifuged at 12000rpm for 5 minutes, re-suspended 
in 20μl lysis buffer (4x LDS Sample) and placed at 95oC for 5 minutes. Self-prepared gels 
were used to run cell lysates and protein ladder (Amersham, Full range rainbow molecular 
weight marker 12000-225000 Da, GE Healthcare, Cat No RPN800E) in running buffer (20x 
NUPAGE MES SDS Running Buffer, Novex, Ref NP0002) at 200 Volts for 60-90 minutes, 
depending on the protein bands. Then, the protein bands were transfer into PVDF membrane 
and run at 30 Volts for 90 minutes in transfer buffer supplemented with 10% methanol (20x 
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NUPAGE Transfer buffer, Invitrogen, Cat No NP0006-1 ) Upon successful transfer, the 
membrane(s) was placed in 10% TBST (0.1M Tris HCl, 1.5M NaCl,  0.5% Tween-20) 
supplemented with 5% milk (blocking buffer) for 60 minutes at room temperature. 
Membranes were stained overnight at 4
o
C in blocking buffer containing the primary 
antibodies against dermatopondin (1:1000, rabbit anti-Dpt, Proteintech, Cat No 10537-1-AP), 
fibroblast activation protein (1:1000, CalbioChem, anti-Fap, Cat No OP188) or γ-Tubulin 
(1:1000, mouse anti γ -Tubulin, Sigma, Cat No T5326-200ul). Membranes were then washed 
three times for 5 minutes and subsequently stained in blocking buffer containing secondary 
antibodies conjugated with horseradish peroxidase HRP  (1:15000, anti-rabbit or anti-mouse 
HRP) for 60 minutes at room temperature. After three washing steps (5 minutes each), ECL 
chemiluminescent substrate (Lumigen PS-3, Cat No RPN2132V1) was prepared for the 
detection of HRP in the membranes, by mixing solution A (RPN2132V1) with solution B 
(RPN2132V2) at 40:1 ratio.  Membranes were then developed in a dark room using an X-ray 
film (FujiFilm Super RX, Cat No 47410 19230). Bands of each sample were quantified and 
their intensity was normalized against the band corresponding to the house keeping gene with 
ImageJ.  
 
7.5.2. Immunostaining of bone sections 
 
 Femurs from 8-week old female C57Bl/6J mice were isolated and fixed with 10% 
formaldehyde for 2 days, at 4
o
C. The fixed bones were decalcified in 10% cold EDTA for 2 
weeks (EDTA was replaced every 3 days), at 4
0
C. Then, they were embedded in 4% low-
melting agarose and were cut with a vibrotome (Microm HM 650V, Cat No 920120), 
generating 100υm thick sections. The sections were placed in a microscope slide and 
blocking buffer was added (1% BSA, 0.1% Triton-X, 5-10% normal donkey serum in PBS) 
for 60 minutes, at room temperature. Slides were washed with PBDs and Avidin/Biotin block 
(Vector Labs, Cat No SP-2001) was added. The primary antibodies were added in blocking 
buffer and incubated overnight at 4
o
C in a humidified chamber. Slides were then washed with 
PBS+0.1% Triton-X and the primary antibodies were added for 2 hours at room temperature. 
Slides were washed with PBS+0.1% Triton-X, then with PBS-DAPI (1:1000 dilution) and 
finally with PBS alone and were mounted with Vectashield mounting media (Vector Labs, 
Cat NoH-1000) in microscope slides for imaging.  
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7.6. Assays to assess HSC potential 
7.6.1. Cobblestone-area forming cell (CAFC) and long-term culture 
initiating cell (LTC-IC) assays 
 
Freshly purified cells (HSCs or different MPP populations) were sorted from YFP-
expressing transgenic mice (mice (B6J;129-Tg(CAG-EYFP)7AC5Nagy/J) as described in the 
“HSC isolation – Mouse preparation” chapter of the “Materials and Methods” section. A 
certain number of cells (starting population) was sorted directly in 96-well plates containing 
different pre-irradiated stroma. The cultures were maintained in Dexter media in the case of 
CAFC assays or 200μl Myelocult M5300 (StemCell Technologies, Cat. No 05350) 
supplemented with 10
-6
M hydrocortisone (StemCell Technologies, Cat. No 07904) and 1% 
penicillin/streptomycin (Gibco, Cat No 15140-122) per well for the LTC-IC assays, with 
weekly half-media changes. After 6 weeks of co-culture, the plates for CAFC were screened 
for cobblestone colonies. On the contrary, the wells of the plates for the LTC-IC assays were 
trypsinized and cells were transferred into new plates containing 200μl methylcellulose 
Methocult M3434 (StemCell Technologies, Cat. No 03434). Plates were screened by 
fluorescent microscopy for the presence of colonies after 2 additional weeks (8 weeks in 
total). 
 
7.6.2. In vivo transplantation experiments 
 
In vivo transplantations were performed using the CD45.1/CD45.2 congenic mouse 
system. In more detail, HSCs from CD45.1 were sorted according to the method described 
before. Different doses of HSCs (100, 350 or 1250 cells) were co-cultured with AFT024, 
2018, DLK1KD, DPTKD or FAPKD stroma for 7 days in Dexter media. Then, individual 
wells were washed and trypsinised before the contents of each well (including the co-culture 
media and PBS from the washing step) were transplanted into one sub-lethally irradiated 
CD45.2 recipient. All conditions were performed in quadruplicates. Peripheral blood was 
collected after 4 and 12 weeks to assess the percentage of chimerism in the recipient mice. 
Peripheral blood was first washed with PBS and erythrocytes were later lysed by ACK 
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(Ammonium-Chloride-Potassium) buffer (Life Technologies, Cat No A10492-01). Then, 
samples were stained with CD45.1-biotin, CD45.2-APC, Ter119-APC e780, B220-PE, 
Mac1-PE Cy7 and Gr1-PE Cy7. Addition of streptavidin-PB was done as a secondary step. 
Samples were then washed and analyzed by flow cytometry.  
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9. Abbreviations 
 
°C: degree Celsius 
 2-Me: 2-Mercaptoethanol 
AA4.1: cell surface antigen AA4 or CD93,  
AGM: aorta-gonad mesonephros region 
AM region: dorsal aorta/mesenchyme region 
BM: bone marrow 
BMP4: bone morphogenic protein 4 
Bmpr1a: Bone morphogenic protein receptor type 1a  
BSA: bovine serum albumin 
CA: Cobblestone area 
CAG: chicken beta actin 
CAFC: cobblestone area forming cell 
CB: cord blood 
CFC: colony forming cells 
CFU: cobblestone forming unit 
CFU-S: spleen colony forming unit 
c-Kit: kit oncogene 
CLP: common lymphoid progenitor 
CMP: common myeloid progenitor 
EDTA ethylene-diamin-tetraacetic acid 
EL: embryonic liver 
EPCR: endothelial protein C receptor 
E-SLAM code: EPCR, CD48, CD150 
ETP: earliest thymic progenitor 
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FACS: fluorescent-activated cell sorting 
FCS: fetal calf serum 
FL or Flt-3l: fms-related tyrosine kinase 3 ligand 
FL: fetal liver 
G1: gastrointestinal region 
G-CSF: granulocyte colony-stimulating factor 
GM-CSF: granulocyte macrophage colony-stimulating factor 
GMP: granulocyte/monocyte progenitor 
HC: hydrocortisone 
HS: horse serum 
HER model: Hematopoiesis is engendered randomly 
HIM model: Hematopoietic Inductive Microenvironments 
HOXB4: homeobox B4 
HSCs: Hematopoietic stem cells 
IL-3: interleukin 3 
IL-6: interleukin 6 
IL-6: interleukin 6 
IL-7: interleukin 7 
IL-8: interleukin 8 
IT-HSC: intermediate-term hematopoietic stem cell 
KSL: cKit+ or mast/stem cell growth factor receptor Kit, Sca1+ or stem cell 
antigen 1, Lineage- cells 
LDA LTC-IC: limiting dilution long-term culture initiating cell, 
LIF: leukemia inhibitory factor 
Lin: Lineage  
LTC-IC: long-term culture initiating-cell 
LT-HSC: long-term hematopoietic stem cell  
- 161 - 
 
Ly-bi HSCs: lymphoid-biased HSCs 
MCP-1: monocyte chemoattractant protein 1 
MEP: megakaryocyte/platelet progenitor 
MIP-1a: macrophage inflammatory protein 1-alpha 
MPP: multipotent progenitor 
My-bi HSCs: myeloid-biased HSCs 
NOD/SCID mice: non-obese diabetic severe combined immunodeficient 
proB: B-cell progenitor 
Pth: parathyroid hormone 
qRT-PCR: quantitative real time polymerase chain reaction 
Sca1: stem cell antigen 1 
SCF: stem cell factor 
SLAM code:  CD150, CD48 
SP: side population 
SV40T: temperature-sensitive simian virus 40 large T antigen 
Thy1: thymus cell antigen 1, theta  
Tpo: thrombopoietin 
TTT: Timm’s Tracking Tool 
UCB: umbilical cord blood 
UG region: urogenital ridges region 
VEGF: vascular endothelial growth factor 
YS: yolk sac 
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